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Relevant Definitions 
 
 
HIV infection:  For the purposes of this research, I will use the term “HIV infection” 
rather than AIDS (Acquired Immunodeficiency Syndrome) or HIV/AIDS. HIV infection 
represents the primary disease whereas AIDS is a progression of the HIV infection that is 
represented by specific opportunistic infections or cancers and/or a severely 
compromised immune system. Not everyone who acquires HIV infection develops AIDS 
and this is particularly true since the advent of effective treatment.  
 
HIV viral load: The term will be used throughout this thesis and represents the amount 
of HIV (i.e., copies of virus per milliliter) that can be detected in the blood or other 
bodily fluids (e.g., cerebrospinal fluid; semen) through a laboratory test. The primary test 
for monitoring HIV disease progression is a HIV Viral Load  (also known as HIV RNA 
PCR) measuring the amount of HIV in the blood. Viral load assays have become 
increasingly sensitive. When they were first developed, the lowest limit the test could 
measure was 400 copies per milliliter (ml). The most recent viral load assay can measure 
as little as 20 copies per ml.  
 
HIV viral suppression: A viral load result that is less than 20 copies per ml or “non-
detectable” is desirable because it represents HIV viral suppression. This does not mean 
that the person does not have HIV in their blood but that the amount of the virus is so low 
that the most sensitive test cannot measure it.  
 
Antiretroviral medications: This is the term for drugs that are used to treat HIV 
infection. They are typically abbreviated as ARVs. People with HIV infection are 
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prescribed more than one of these medications. HIV treatment will be discussed in more 
detail in the background section of this dissertation.  
 
Disease and Illness:  I will also use the terms “disease” and “illness” which represent 
different explanations of human experience. For the purposes of this thesis, disease is the 
biomedical interpretation and labeling of physiological malfunctions and biological 
disruptions while illness is the deeply personal and subjective experience and 
understanding of ill health and the related distress and suffering. These concepts will be 
discussed in more detail in the background chapter of this thesis (Kleinman, 1998; 
Erickson, 2008).  Discussion of HIV infection, HIV viral load and suppression, and 
treatment will pertain to disease. How people infected with HIV understand, give 
meaning to, and experience a “disease” will relate to illness. 
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Acronyms   
AIDS:    Acquired Immunodeficiency Syndrome  
ART:   Antiretroviral Therapy  
ARV:   Antiretroviral medications  
HIV:   Human Immunodeficiency Virus  
HLOC:  Health Locus of Control  
ID:   Infectious Diseases  
LOC:   Locus of Control   
MHLC:  Multidimensional Health Locus of Control  
PTSD:  Post-traumatic stress disorder  
VA:  Veterans Administration   
VHA:  Veterans Health Administration  
VACHS:  Veterans Administration Connecticut Healthcare System                
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Chapter 1    Introduction 
 
Overview of Research 
 
 Much has been studied and written about Human Immunodeficiency Virus (HIV) 
infection since it was first detected three decades ago. It is a disease that has been 
responsible for significant morbidity and mortality globally. From the beginning the 
epidemic has affected the lives of much of humankind in some way; those who were 
infected with the virus, those who cared for the ill, and those who were fearful of 
transmission.  
 HIV is an infectious disease that has been imbued with moral overtones and 
stigma, often multidimensional, creating an illness where responsibility is an overarching 
theme. The original stigma related to route of infection. Sexual intercourse among gay 
men and injection drug use (IDU) emerged early as the major routes of infection in the 
early years of the epidemic, and people were blamed for their behavioral roles in 
acquiring the infection (e.g., homosexuality, IDU). As the epidemic wore on, however, it 
became clear that there were also "blameless" individuals who, in the view of other 
societal members, acquired the infection through no "fault" of their own -- through 
maternal-child transmission, infected blood transfusions, and heterosexual intercourse. 
The latter was highly stigmatized for sex workers and those with multiple partners, but 
less so for the unsuspecting wives or partners of infected persons. This early separation of 
the "guilty" who were held responsible for their disease and the "innocent victims," who 
were not was a widespread and damaging social construction of the epidemic. Worse, 
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during this phase of epidemic there was no cure and no treatment for HIV/AIDS, which 
contributed to the fear of the disease and the people who had acquired it. Thus, since the 
inception of the epidemic, HIV has invoked feelings of hopelessness and powerlessness 
among those afflicted and among medical professionals.  
 Since the 1980s, great strides have been made in developing medications that can 
suppress the virus. The availability of effective treatment has considerably lengthened the 
lives of people infected with HIV, and this has led to its current status as a chronic 
condition rather than one that is acute and imminently fatal. The treatment regimen, 
however, requires strict medication adherence and ongoing health care and disease 
progression monitoring which places the onus of responsibility for maintaining viral 
suppression on the person who is ill, creating a second layer of stigma for those who are 
non-adherent. Complicating this picture is the fact that while treatment is effective for 
many of those who are adherent, viral mutations can develop independently despite 
rigorous adherence creating resistance to the medications, and non-adherence can also 
lead to failure of viral suppression and to disease progression. Thus, treatment regimens 
demand a high level of adherence and "self-policing", failure at which can lead to disease 
progression and further stigmatization of persons living with HIV. In sum, HIV is still an 
incurable disease that is not completely controllable even with strict medication 
adherence and health-enhancing behaviors and stigmatization now surrounds both 
acquisition of the virus and failure to adhere to treatment regimens.  
 This doubly stigmatized illness can take a great toll on the health and well-being 
of those infected. HIV infection is a unique vehicle for studying patient beliefs about the 
ability to impact the course of the disease and personal responsibility for its management 
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and health optimization. Strict adherence to HIV medication regimens is directly related 
to viral suppression and improved health outcomes but is notoriously difficult for patients 
to maintain. In order to optimize care and adherence, it is important to understand how 
people infected with HIV conceptualize their illness, their beliefs about personal 
responsibility for health and whether they believe they can impact the course of their 
disease. My research addressed these meaning-centered understandings and provides 
insight into the illness experience and the connections between conceptualization of 
illness, adherence to antiretroviral medications, health care visits, and health-enhancing 
lifestyle behaviors, and beliefs about disease management and the construct of 
responsibility. 
 In this dissertation, I explore how the relabeling and reconstruction of HIV 
infection from an “acute’ disease to one that is “chronic” affects how U.S. veterans 
infected with HIV come to understand and experience their illness and their role in 
disease management. I discuss how beliefs about responsibility for health and the ability 
to impact disease progression are based on how people conceptualize and experience 
their illness. It is my hope that illuminating how people infected with HIV think about 
their illness will contribute to gaining further insight into the contemporary lived 
experience of HIV infection that encompasses beliefs about responsibility, both for the 
disease and for health optimization, and the agency of the patient to impact the disease 
course now that treatment is available. A nuanced understanding of these issues will 
enhance theory building and practical applications regarding disease management. It will 
also inform health care practitioners of the illness experience of people with HIV 
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infection and the importance of holistic healing and treating the social body along with 
the physical body. 
  
Relevant Professional Background 
 
 I have been a nurse for 38 years and have had the opportunity, and the privilege, 
to participate in the healthcare of countless people. For the past 22 years, I have worked 
in infectious diseases clinical research primarily working with people with HIV infection. 
My previous work was in a large emergency department in Los Angeles where I provided 
emergency care to people in the early days of the epidemic. My cumulative research 
experience has included both retrospective and prospective studies through which I have 
followed patients from enrollment throughout the study period. Many of these studies 
lasted for multiple years because of the need for long-term follow-up, which is part of the 
FDA approval process for new drugs.  Clinical research requires a relationship of trust 
between the person participating in the research and those who are conducting the 
research. This is particularly true for people with HIV infection who have often been 
desperate for access to medications to treat their disease as the virus often became 
resistant to the treatment. While they were willing to participate in research to get newly 
developed medications that could control the virus, they were still concerned with being 
involved in ethical research that was as concerned about their well-being as the collective 
good. As a result of my work experience I have seen how the trajectory of the disease has 
changed since the early days of the epidemic and have had the opportunity to listen to the 
stories of people with this illness.  
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 When I began working in HIV clinical research in 1992, there was only one 
approved drug to treat the disease; AZT, which was toxic and not efficacious as a single 
therapy. There was desperation among those who were afflicted, their health care 
providers, and biomedicine to find a way to stem the morbidity and mortality caused by 
this virus. The fear and suffering was palpable. Twenty years later, there are over thirty 
antiretroviral medications that are available to treat the disease, which is now controllable 
for some people. The fear and suffering still exist but they are quieter, less palpable. HIV 
receded from the mainstream discourse once it became known that treatment was 
available and that life with the disease was prolonged. The activism that was the hallmark 
of the first two decades of the epidemic diminished. But treatment is not available to 
everyone, and even those who do have access have difficulty controlling the disease 
despite strict adherence to medication regimens. The virus has demonstrated its ability to 
develop resistance to all of the medications that have been discovered thus far. People 
living with HIV now have hope of living a longer life span, but it is a life that is 
constrained on many levels. I have listened to the stories about the stigmatization that 
they experience, from employers, health care providers, and their personal and the wider 
social network as a result of this disease. It constrains their lives, their relationships, their 
employment, and shapes how they view themselves. They have shared their fears, their 
distress, and the self-blame that is a pervasive theme among those who are afflicted with 
this disease. While my work experience may create a bias in terms of interpretation of 
this research, it also has provided a close lens for viewing this epidemic since its 
inception. I have also had the privilege of access to people with HIV infection who were 
willing to tell me their stories and talk about their disease.  
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  In this dissertation, I seek to illuminate sufferer meaning-centered understandings 
of their illness and the construct of responsibility as it relates to health optimization as 
well as their beliefs about their ability to impact the course of their disease. By giving a 
voice to their stories, I hope to enhance our understanding of the illness experience of 
people living with HIV infection. 
 
Preview of Chapters 
 In this first chapter I present a brief description of the background for my 
research. Furthering the understanding of the illness experience of this extraordinary and 
devastating disease will hopefully inform both health care and the wider social network.   
 In Chapter 2, I address the theoretical and conceptual underpinnings of my 
research by providing a brief overview of HIV infection, the course of the epidemic, and 
available treatment. Now that people infected with HIV are living longer, other co-
morbidities that impact physical and social health as well as the accelerated aging that has 
been identified in those with HIV infection have become significant factors affecting 
quality of life. A discussion of these factors illuminates how they intensify the distress 
and disruption caused by HIV infection. The concepts of personal responsibility for 
health and health locus of control (HLOC) are also explored in order to frame the 
construct of responsibility for this research as it relates to health optimization. 
Kleinman’s explanatory model is also discussed to help frame the narratives presented as 
part of the findings of the research. Finally, I describe the Veterans Health 
Administration, an integrated health system that provides medical care and treatment for 
veterans.   
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 Chapter 3 addresses some of the interconnected factors and social forces that 
impact the health of U.S. veterans that will help to situate this research on beliefs about 
responsibility for disease management and health optimization. It is important to have an 
understanding of how gender impacts health and how masculinity is shaped by military 
culture all of which influence health over the life course. The reframing of HIV as a 
chronic illness has had significant ramifications for people living with the disease. In this 
discussion, I address the validity of the acute-chronic labels that are applied by 
biomedicine and the impact of this dichotomy on both the emic and etic perspectives of 
HIV infection. Finally, I present a discussion of stigma, which will advance an 
understanding of the roots of the social burden of HIV infection.  
 In Chapter 4, I discuss my research site (VA Connecticut Health Care System at 
West Haven, CT), the design of my study and the research methods used, and provide a 
description of my study sample.  Chapter 5 presents narratives obtained through semi-
structured interviews related to how people infected with HIV conceptualize their illness 
and their beliefs about disease causation, responsibility, stigma, and the trajectory of their 
illness.  
 Chapter 6 presents the research findings from both qualitative and quantitative 
data to explore beliefs about disease management, health optimization, and the ability to 
impact disease progression. In Chapter 7, I provide an integrated analysis of the all of the 
data obtained through the research and situate it within the context of the social 
construction of illness and the resulting social suffering.  I also present some final 
thoughts and implications for the research. 
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Chapter 2    Underpinnings of the Research 
  
HIV Infection 
 
 
 Much has been experienced, studied, and written about HIV/AIDS since it was 
first detected over three decades ago. HIV has been identified as the pathogen that 
weakens, and often overtaxes, the body’s immune system potentially resulting in 
constellation of medical conditions and diseases known as Acquired Immunodeficiency 
Syndrome (AIDS). 
 HIV/AIDS represents a microcosm in which to explore how people understand a 
disease, how this information is shared, and the role of biomedicine in the construction of 
this understanding (Bolognone, 1986). Since its identification in the early 1980s, HIV 
infection has been steeped in symbolic meaning in no small part due to its association 
with bodily fluids (especially blood and sexual fluids) and lifestyle choices (e.g., 
intravenous drug use; sexual orientation) that are viewed by some as deviant and/or 
immoral (Schoef, 2001).  The disease has been viewed as a punishment for these 
behaviors and attributes, and those who acquire the infection are often “blamed” for their 
disease (Castro, 2005). HIV/AIDS is one in a long line of epidemics, which include 
tuberculosis and leprosy, that have created an environment of stigma, discrimination, and 
physical and social suffering (Herek, 1996). Beyond its stigmatizing effects, HIV/AIDS 
also impacts society on a macro level affecting biomedicine, the health care system, and 
the pharmaceutical industry (Herek, 1996). From a micro perspective, AIDS- related 
stigma affects the health of those infected with the virus (e.g., increased stress; 
deleterious effects on the immune system), access to health care (e.g., decreased access; 
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delayed testing and diagnosis) and quality of life (e.g., guilt and self-blame for acquiring 
the infection; social rejection and isolation; feelings of fear, hopelessness, and 
powerlessness) (Herek 1996; Fife and Wright 2000). 
 Initially little was known about the causal agent of HIV/AIDS and modes of 
transmission resulting in a lack of treatment options. What was apparent was that the 
prognosis was poor. There was much fear experienced by those who had acquired the 
disease as well as those who were concerned about transmission. An overwhelming aura 
of powerlessness and hopelessness was felt by those who were ill with the disease, the 
health care professionals who were trying to treat them, and the general public. The tide 
turned in the mid-1990s when combinations of antiretroviral medications (ARVs), which 
became known as highly active antiretroviral therapy (HAART), became available. 
Although elimination of the virus is still not possible, these medications, if taken as 
prescribed, can often suppress the virus. Viral suppression, along with decreasing the 
probability of developing opportunistic infections, decreases an individual’s likelihood of 
transmitting the virus to others, thus preventing further spread of the disease.   
 Yet, despite these advances, the sense of powerlessness surrounding the disease 
has not significantly diminished because of the emergence of the virus’ ability to mutate 
and become resistant to these medications. The availability of numerous medications to 
treat HIV infection over the last two decades has provided more treatment options, 
infusing hope and stimulating the transition of the disease from an “acute” fatal disease to 
a “chronic” manageable disease for those who have access to medical care and ARVs. 
For those with such access, the ability to treat the disease, slow its progression, and 
improve prognosis creates opportunities to impact the course of their disease. This can be 
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accomplished by strict adherence to their medication regimen, avoiding risky behavior 
that could lead to reinfection (e.g. unprotected sex, IDU), and doing what is necessary to 
keep the immune system as strong as possible through healthy lifestyle choices (e.g., diet; 
exercise).  Yet these behaviors and choices are meditated by beliefs about the virus and 
disease causation, the illness and its treatment, and the associated stigma experienced by 
many people living with HIV infection.  
 
HIV Epidemic and Antiretroviral Treatment (ART)  
 Although much progress has been made in the last three decades in diagnosing 
and treating HIV and AIDS, the epidemic has endured and remains responsible for 
significant morbidity and mortality and for much human suffering. In 2010 it was 
estimated that the number of people globally with HIV infection was 34 million with 2.7 
million annual new HIV infections (World Health Organization Progress Report 2011).  
Incidence of HIV has been decreasing globally since 2001; the number of new infections 
in 2011 was 20% lower compared to 2001. However, infections have begun to climb 
again in Eastern Europe, Central Asia, the Middle East, and North Africa (UNAIDS 
2012). In 2011, there were 1.7 million deaths globally related to AIDS compared to 2.3 
million in 2005 representing a 24% decrease (UNAIDS 2012). According to the CDC, in 
the U.S., people ages 45 to 54 years have the highest prevalence of HIV infection (CDC, 
2012) and by 2015, half of the people with HIV infection in the U.S. be will over age 50 
(CDC, 2014). The largest percentage of new infections (31%) in 2010 occurred among 
people aged 25-34 (31%), followed by those aged 13-24 (26 %) and those aged 35-44 (24 
%). Among older Americans, new infections occurred in 15% of people aged 45-54 and 
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5% of those aged 55 and over (CDC Fact Sheet New HIV Infections, 2012). What is 
equally significant is that the CDC estimates that 25% of people who have HIV infection 
are unaware and represent more than 50% of new infections (CDC Fact Sheet Estimates 
of New HIV Infections in the United States). 
 As I discuss the HIV epidemic it is important to remember that it involves more 
than the biologic process of viral transmission. As Schoepf expresses so well, 
“Disease epidemics are social processes: Spread of infectious agents  
 is shaped by political economy, social relations, and culture. A disease 
 of modernity and global population movement, AIDS has struck with  
 particular severity in communities struggling under the burdens of  
 poverty, inequality, economic crisis, and war. Many people who know 
 about the danger of sexual transmission, especially many girls and  
 women, cannot avoid becoming infected because they cannot control 
 the relations of power that put their lives at risk (2001:336). 
 
 The HIV epidemic has illuminated the health disparities that exist for many 
people in the U.S., and globally, constructing increased risk for acquiring HIV and 
impacting access to health care and treatment. Men who have sex with men (MSM) 
represent over half (63%) of the new HIV infections followed by those who acquire the 
virus by heterosexual sex among whom there is a higher proportion of African American 
women (25%), and those who engage in intravenous drug use (12%) (CDC Today’s 
HIV/AIDS Epidemic, 2013). In the U.S. these disparities affect African Americans and 
Latinos disproportionately. As of 2012, African Americans comprised 14% of the 
population but represented 44% of both new infections and those living with HIV 
infection (CDC HIV Surveillance Report, 2013; CDC Estimated HIV incidence, 2012). 
Those who identified themselves as Latinos, although comprising only 16% of the 
population, represented 21% of all new HIV infections and 19% of HIV infections. There 
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are numerous social, political, and economic factors that contribute to these disparities 
including poverty, lack of health insurance, homophobia, and stigmatization, 
incarceration rates, and immigration issues, all of which can increase risk and impact 
access to testing and treatment (CDC Today’s HIV/AIDS Epidemic, 2013). 
 The availability of ARVs to treat HIV infection has made a significant impact 
on disease suppression. As of 2012, more than 9.7 million people living with HIV were 
receiving ART in low- and middle-income countries (WHO 2013).  The first ARV 
became available in 1990 and aggressive clinical research over the past two decades has 
resulted in the current cadre of over 30 medications that can be used in various 
combinations to treat HIV infection.  Treatment has evolved from multiple medications 
prescribed multiple times a day to the recent advent of single-tablet regimens (STRs). 
These once a day tablets contain multiple medications and may revolutionize HIV 
treatment due to the ease of adherence in taking only one pill. 
 The amount of HIV found in the body, most often tested in the blood, is known as 
a viral load. ART medications work by suppressing the HIV viral load. Lack of 
suppression is not guaranteed, however, and has been attributed to medication 
intolerance, toxicity, drug interactions, the presence of resistant virus, and most 
commonly to non-adherence. (Conway et al., 2007; Mannheimer et al., 2002; Liu et al., 
2006; Paterson et al., 2000). Althoff et al. (2014) found that 22% of people with HIV 
infection in the U.S. did not have HIV viral load suppression with higher proportions 
found in women, young adults, non-whites, and those engaged in injection drug use 
(IDU). Although HIV viral suppression has contributed to improved clinical conditions 
and decreased mortality, research has found that the virus remains latent in reservoirs in 
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the body (e.g., brain, lymphoid tissue, genital fluids), and this makes eradication of the 
virus, and hence a cure, very difficult (Schrager et al., 1998; Chun, 1997, 2010; Finzi, 
1997). 
The need for strict medication adherence to maximize therapeutic benefit is 
evidenced by extensive research that has been conducted since the inception of ART 
(Conway et al., 2007; Mannheimer et al., 2002; Liu et al., 2006; Paterson et al., 2000). 
Adherence behavior has been well studied and is influenced by multiple factors including 
patient beliefs about treatment, disease and medication education, patient-health care 
provider relationship, social support, and the medications themselves (Friedland, 2006; 
Horne et al., 1999; Mostashari et al., 1998). Gao et al. (2000) found that a person’s 
experience with the disease and its treatment impacts adherence. The more symptomatic 
the individual’s illness, the more they are able to connect disease progression and 
adherence to their treatment. Research has also shown a statistically significant 
relationship between patients’ beliefs about ART efficacy and adherence to ART (Smith 
et al., 1997; Mostashari et al., 1998; Stone et al., 1998; Horne et al., 1998; Altice et al., 
2001). 
 A recent study by Moore et al. (2012) conducted between 1995 and 2010, 
followed 6,366 patients infected with HIV, 87% of who were taking ARVs. The findings 
demonstrated an estimated life expectancy of 73 years (Moore et al., 2012). The North 
American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) group 
concluded that "a 20-year-old HIV-positive individual on ART in the U.S. or Canada is 
expected to live into their early 70s, a life expectancy approaching that in the general 
population." Life expectancy was lower for people with a history of IDU, non-whites, 
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and those with lower CD4+ cell counts (i.e., less than 350) (Samji et al., 2013:e81355). 
HIV infection has, thus, been reframed as a “chronic” illness in the developed world and 
in the developing world where antiretroviral medication and medical care are available, 
but this does not necessarily translate into disease suppression. HIV treatment has been 
notoriously difficult due to complex regimens with often intolerable side effects, and it is 
also affected by other negative mediating factors that affect adherence such as mental 
illness, co-morbidities, and social conditions such as homelessness.  
 
Co-Morbidities 
 As effective treatment has become available for HIV infection, people are living 
longer and are experiencing comorbid conditions that are also common in an aging 
general population. There has also been a shift in the causes of death for people with 
HIV/AIDS from opportunistic infections to non-AIDS medical conditions (Sackoff et al., 
2006; Martinez et al., 2007; Palella et al., 2006; Smit et al., 2006).  These comorbid 
conditions include cardiovascular disease, renal and liver disease, osteoporosis and 
osteopenia, metabolic diseases such as diabetes, and cancer (Goulet et al., 2007; Onen et 
al., 2010; Hasse et al., 2011; Young et al., 2011). Approximately 75% of people living 
with HIV infection in the U.S. are over the age of 40 years and research on co-morbidity 
prevalence has shown that people with HIV infection have more co-morbidities and are 
prescribed more non-HIV medications than their counterparts of the same age that do not 
have HIV infection (Koram et al., 2013). The most prevalent co-morbid conditions 
include diabetes, neurocognitive impairment, chronic obstructive pulmonary disease 
(COPD), hypertension, osteoporosis, cardiovascular disease, and cancer. (Kilbourne et 
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al., 2001; Hasse et al., 2011; Rodriguez-Penney et al., 2013). People with HIV infection 
are experiencing higher cardiovascular disease rates than their counterparts who do not 
have HIV infection at time when the prevalence is decreasing in the general population 
(Silverberg, Hurley, and Prassad, 2013).  
 Deeks discusses accelerated aging in people with HIV infection who are taking 
antiretroviral medications. He outlines three contributory factors: infectious process and 
associated inflammation; consequences of antiretroviral medications; and what he terms 
as “host-related” factors that include other co-infections such as Hepatitis C and lifestyle 
behaviors such as alcohol use and smoking (Deeks, 2009). Goulet et al., (2007) in their 
work with The Veterans Aging Cohort Study (VACS), found that people with HIV 
infection who were over age 50 had a higher prevalence of hypertension, diabetes, 
vascular and pulmonary disease, and renal disease but were less likely to have substance 
abuse or a psychiatric diagnosis. They also found that HIV infection-associated 
comorbidities are typically medical or mental health conditions or related to substance 
abuse. They also noted that HIV progression had an exacerbating effect on some 
comorbidities.  
 According to the VA State of Care 2011, the most common co-morbidities found 
in people living with HIV infections and receiving care at the VHA include: depression 
(55%), hypertension (high blood pressure) (53%), dyslipidemias (high cholesterol; high 
triglycerides) (50%), anemia (30%), anxiety disorders (30%), Hepatitis C infection 
(26%), esophageal disease (25%), and diabetes (18%). Other important clinical 
conditions affecting HIV care included PTSD (16%), COPD (chronic obstructive 
pulmonary disease) (13%), heart disease (12%), and chronic renal failure (11%). 
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Contributions of Medical Anthropology   Anthropologists have made significant contributions to illuminating the individual, social, and cultural understandings of HIV infection and AIDS as well as the other factors that have shaped the spread of the disease and it’s resultant human suffering. It is in part, through their work that epidemics have come to be fully understood as social processes whose spread is shaped by social, cultural, political, and economic forces rather than just biological (Singer 1994: Schoepf, 2001; Castro and Farmer, 2005). The initial identification of risk groups for HIV infection by epidemiologists constructed the social groups that have been marginalized and stigmatized and created misperceptions of risk by the wider social world (Farmer, 1988; Bolton, 1992; Singer, 1994; Schiller et al., 1994; Herek et al., 1996; Link and Phelan, 2001). This public health strategy focused on individual agency ultimately placing responsibility on the afflicted person for their illness and ignoring the social, political, and economic forces that have framed and promoted the epidemic (Schoepf, 2001). Singer (1994) writes about the social dimensions of AIDS including its construction, transmission, and location as well as its disproportionate spread, “In the U.S. especially, AIDS is disproportionately a disease of the dispossessed, a disease of the socially condemned and denigrated, a disease of social outcasts and a disease of the poor” (Singer, 1994:944). Indeed, this is not just the case in the U.S., but globally. The critical medical anthropological perspective has contextualized the disease and illness by bringing into focus the social, political, and economic forces that have shaped the lives of those afflicted with HIV infection and the course of the 
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epidemic. Castro and Farmer (2004) conceptualized “structural violence” as a means of understanding the historical and structural factors that have shaped the suffering and stigma related to HIV and AIDS.   Anthropology also has helped to expose biomedicine’s role in constructing infectious disease as primarily biological in nature, an issue of pathogens, vectors or other transmission mechanisms, hosts, and immune systems (Bolognone and Johnson, 1986; Farmer and Kleinman, 1988; Farmer, 1994; Farmer and Good, 1991; Taylor, 2007). Through the use of ethnography and other qualitative research methods, anthropologists have illuminated the actual on-the-ground behaviors, local contexts, meaning-centered understandings and lived experience of HIV/AIDS and the importance of these insights in framing responses to the epidemic (Parker, 1987; Parker and Ehrhardt, 2001; Castro and Farmer, 2004; Mosack et al., 2005; Singer, 2013). Medical anthropology, along with other social science disciplines, has delved deeply into the roots, conceptualization, and psychological and physiological effects of stigma and discrimination related to HIV infection (Rhodes et al., 1995; Herek, 1999; Parker and Aggleton, 2003; Golub, 2003).  Stigma has been identified as a major driver of the personal and social suffering that is associated with living with HIV infection. My research will build on this foundation of knowledge about HIV-related stigma and social suffering and provide insight into the contemporary lived experience of this illness (Kleinman, Das, and Lock, 1997; Singer, 2006). Although many anthropologists have contributed to this knowledge base, the epidemic, the cultural meanings and social construction of the illness and disease, and the structural and institutional forces that shape and impact it are dynamic 
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entities that have evolved over the last three decades. It is important to remember the dynamic nature of culture and structural forces and continue to describe the evolution of how people conceptualize, experience, and suffer from, this socially and biologically complex and devastating illness.  
 
Theoretical Perspectives 
 
 In this research I used two different theoretical perspectives to understand the 
lived experience of veterans with HIV and their ability to adhere to treatment. The first is 
a psychological model of behavior related to locus of control (LOC) that has long been 
used in health research. The second comes from medical anthropology, Kleinman's ideas 
about explanatory models of disease. Each is discussed below. 
  
Health Locus of Control 
 
 “The experience of illness in and of itself challenges a belief in control 
  over one’s health” (Wallston and Smith, 1994) 
 
 Much work in understanding health behavior has been done using the idea of 
locus of control (LOC), a psychological concept that refers to beliefs about whether life 
events can be impacted by an individual’s actions (i.e., internal locus of control), by 
forces outside human control (i.e., external locus of control), or by a combination of both 
(Rotter, 1966; Wallston and Wallston, 1981; Christensen et al., 1991). The basic tenet of 
locus of control, which is based on social learning theory (SLT), is that a person’s 
behavior in a particular situation will be related to what s/he expects will happen based 
that behavior and how much s/he values that outcome (Rotter, 1966). Rotter 
conceptualized LOC as an expectancy construct in that people will expect that their 
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modified SLT for the health domain theorizing that to predict health-enhancing 
behaviors, a person must value health, believe that they can impact it, and believe that 
they are able to engage in these behaviors. This health value construct is thought be the 
mediator between beliefs about control over health and behavior (Wallston, 1992).  
 Self-efficacy has been found by some to be a more effective predictor of behavior 
than locus of control. It is a similar construct that refers to the belief in one’s ability to 
engage in a specific behavior whereas locus of control relates to outcomes (Bandura, 
1977; 1982). This difference is the basis for the use of locus of control for my research. 
Wallston et al. (1987) came to believe that LOC was not as effective a predictor of health 
behaviors as a solitary construct because multiple factors influenced these behaviors. 
They believed that the value that is placed on health is important to consider and should 
be included when studying locus of control. Wallston modified Rotter’s SLT to study his 
belief that perceived control is a broader and more encompassing way to look at behavior 
than LOC (Wallston et al., 1987). Thus, it was important to understand both dimensions –
feelings of responsibility health behavior and perceiving whether or not they can control 
their health. They theorized that control and responsibility represent different concepts, 
with the latter as beliefs about what should be done compared to control, which relates to 
what can be done (Wallston et al., 1987). 
Wallston and Wallston utilized the LOC framework to study beliefs as they relate 
to health-related behaviors (Wallston and Wallston, 1981) through the development of 
the Multidimensional Health Locus of Control (MHLC) survey.  It is a validated tool 
with 18 items and utilizes a 6-point Likert scale for responses. There are four subscales 
within this survey which have been labeled Internality, which is unidimensional and the 
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subscales of Chance, Doctors, and Powerful Other People which comprise the Externality 
scale, which is multi-dimensional (Wallston, Stein, and Smith, 1994).  
o Internal health locus of control (Internal HLOC) is the belief that a 
person’s actions and behavior determine their health  
o External dimension is composed of three subscales: 
 Chance represents the beliefs that one’s health status is due to 
chance or fate 
 Doctor is the belief that one’s health is controlled by doctors 
 Others is the beliefs that one’s health is due to others such as social 
support system or God 
   (Wallston et al., 1987) 
 
Individuals who assume personal responsibility for their health would be expected 
to engage in behaviors that would enhance their health such as adhering to medication 
regimens and attending medical appointments (Marshall, 1991). Although these 
dimensions were thought to be a continuum, research has shown that they are 
independent and that a person may have multiple beliefs about control. Wallston felt that 
the belief that control is possible was more significant than the locus of control 
(Wallston, 1992).  
However, just because a person believes that they can impact the course of their 
disease doesn’t mean that they are able to do what is necessary to do so. In order for LOC 
to be relevant, people must value health, believe that their behavior can impact their 
health, and believe that they are able to engage in the behaviors that are necessary to 
maximize health (Wallston, 2005; Christensen, et al., 1991). It must also be considered 
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that even though a person engages in strict treatment adherence and healthy behaviors, 
s/he may still not be able to impact the course of their disease. There are many factors, 
both structural and personal, that can mediate the ability to prevent disease progression 
despite the belief that control over health is possible. In addition, beliefs are socially 
constructed and dynamic and they will transform over time particularly when related to 
health and disease.  
Wallston reviewed health LOC research thoroughly and found that research on 
different diseases yielded different results regarding LOC. Research on diabetes and LOC 
has been indeterminate with some studies showing that a high internal LOC is associated 
with better adherence to treatment while others show no relationship. Studies of smoking 
indicate that people with a high internal LOC tend to be non-smokers while LOC does 
not appear to impact weight loss. A study of college students found that those who used 
birth control were twice as likely to have a high internal LOC (Wallston and Wallston, 
1978). Early work on the relationship between medication adherence in a number of 
diseases and locus of control was indeterminate (Wallston and Wallston, 1978). Research 
on health locus of control (HLOC) and chronic illness showed that those patients with a 
high internal HLOC had “higher level of adaptation to their illness when control was 
possible but adjustment was poor if personal control was hindered by circumstances” 
(Christensen et al., 1991). Burish (1984) noted that the health LOC for people living with 
a chronic illness is dynamic and may trend over time toward an external LOC. They 
relate this to feeling distress about the ability to control their health and that transferring 
some of the control to others (i.e., significant others) may help adjustment to the illness. 
Evans et al., (2000) found that belief that control over health is related to chance or luck 
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was associated with depression, hopelessness, and stress. Most of the studies, however, 
are not longitudinal and do not consider the dynamic nature of beliefs.  
Ubbiali et al. (2008) utilized the MHLC Form C with people infected with HIV to 
explore how they think about their disease and their beliefs about health. They found that 
people with HIV infection tended to have high Internal HLOC and low Chance HLOC 
scores. Their interpretation of the results was that people with HIV believe that they are 
able to impact their disease course. They also found that the Doctor HLOC scores were 
relatively high and the Others HLOC scores were low indicating a reliance on their 
doctors for controlling their health rather than their social network. Some more recent 
studies have utilized HLOC when looking at clinical outcomes. Burker et al. (2005) 
studied the relationship between HLOC and survival using the MHLC Form A in people 
with lung transplants. They found that those with a high Internal LOC lived longer post-
transplant. O’hea et al. (2005) conducted research on HLOC and adherence to 
medications for diabetes and recognized the importance of the external dimensions 
related to adherence and subsequent HbA1c levels.  
These more recent studies demonstrate the continued utility of the HLOC 
construct for at least some health domains, and I use it here to determine if beliefs about 
control over health exist for this population and where it is situated.      
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Explanatory Model 
 Belief systems, based on cultural, social, and psychological factors, along with 
lived experience provide the lens through which people view disease, it’s manifestations, 
and its treatment. Kleinman’s explanatory model of illness narratives is useful in eliciting 
how people think about, give meaning to, and experience their illness: how they live with 
it on a daily basis, how it affects their lives and the lives of those around them, and how 
they make decisions about treatment. It also provides a framework for understanding the 
concept of illness, the factors that impact the illness experience, and the associated 
suffering (Kleinman, 1988). He writes of chronic illness,  
 “The trajectory of chronic illness assimilates to a life course  
 contributing so intimately to the development of a particular  
 life that illness becomes inseparable from life history” (Kleinman, 1988). 
 
  
 Although there are common understandings between people who are diagnosed 
with the same disease because of the social construction of illness, each person’s schema 
for thinking about, and experiencing, illness is ultimately individualized because it is 
subjective and deeply personal.  
 With HIV infection, many people feel no symptoms but because they have been 
told that their body is harboring a virus that can be fatal without treatment, they still 
experience the illness and suffer because of the uncertainty that they must live with in 
anticipation of morbidity and mortality as well as the stigma that is associated with this 
disease (Mosack et al., 2005).  
 “Suffering becomes a process of social mediation and transformation. 
  It is experienced within nested contexts of embodiment: collective, 
 intersubjective, individual. It absorbs into the body-self the moral  
 world’s contradictory obligations/rights and the norms/contestations 
 of the body politic.” (Kleinman et al., 1997:xix) 
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 The personal and social suffering that many with HIV infection experience, and their 
understandings about their illness and the meanings that they assign, are socially and 
culturally constructed by the prevailing social, cultural, political, and economic forces 
that are at play (i.e., stigma, substance abuse, homelessness, military service).  HIV 
infection is what Singer (2004) terms an ‘oppression illness’ which relates to the long 
term effects of stigmatization and the internalization of blame. He takes illness beyond 
the physiological realm and situates it additionally as a social phenomenon that 
significantly affects health. I situate my research within the perspective that recognizes 
that health, disease, and illness are biological and social, and are affected by other forces 
all of which contribute to the social construction of illness. 
 
  
Responsibility for Health  
 
 The construct of responsibility for health has been present in the U.S. since at 
least the early 19th century and has its basis in the American cultural values of “individual 
rights and responsibilities” (Leichter, 2003). Its evolution accelerated in the 1970’s in 
response to, as Minkler writes, “A growing disillusionment with the limits of medicine, 
pressures to contain health care costs, and a social and political climate emphasizing self-
help and individual control over health” (Minkler, 1999).  
 Most of the historical research on responsibility for health has had a public health 
perspective focusing on prevention of disease (Minkler, 1999).  As more understanding 
has been gained about the ability to mediate risk factors, more onus has been placed on 
the individual for acquiring his/her disease (Gunderman, 2000; Brownell, 1991). 
Gunderson cites examples of substance abuse, smoking, sedentariness, and unprotected 
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sex as risk factors that are viewed as within the control of the individual. Those who 
don’t engage in health-enhancing behaviors are viewed as lazy and lacking both 
responsibility and control that creates a milieu where disease can be viewed as a personal 
and in some cases a moral failure (Brownell, 1991).  
 Yet this ability to avoid risk factors and enhance health may not be feasible given 
the social, political, cultural, economic, and biological factors that may impede or prevent 
the lifestyle choices and behaviors necessary to avoid or mitigate disease (e.g., food 
deserts in urban areas). Using the example of obesity and the impact of social, cultural, 
and economic factors, Brownell writes, “humans gain weight when their environment 
promotes highly palatable food, rising portion sizes, increasing amount of sugar in foods 
and beverages” (Brownell, 2010). It is clear that the factors that are in play at both macro 
and micro levels must be taken into consideration in the discussion about personal 
responsibility for health (Chan and Reidpath, 2003).  Some diseases are not avoidable or 
controllable and considering the other factors at play, it might be said that no disease is 
preventable for everyone.  
The focus on control creates an atmosphere in which individuals are 
responsible for their health- to themselves, their family, their employer, 
and to the nation as a whole. When individuals do not meet the implied 
responsibilities, they are blamed and are assumed to have negative 
personal characteristics. (Brownell, 1991:308) 
 
 
 Health has become a personal and moral responsibility under which people are 
blamed for their unhealthy behavior according to norms that have been socially and 
culturally constructed (Becker 1986; Marantz 1990). Minkler writes that for Americans, 
being in control is an “important cultural and ideological underpinning of American 
health promotion efforts, which have in turn helped to shape their uniquely individual 
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focus” (Minkler, 1989:21). Yet the political and economic factors that affect health 
cannot be minimized. Syme (1997) found that people with higher economic means have 
an increased ability to engage in health-enhancing behaviors compared to those in lower 
socioeconomic categories who have less control over the social and economic factors that 
affect health.  
 For those who have acquired a disease, especially one that is chronic, the concept 
of responsibility for health may have a different connotation because the focus is often on 
disease management and preventing or limiting disability.  People with chronic diseases 
are expected to engage in health-enhancing behaviors that can include diet, exercise, 
treatment adherence, adequate rest, and smoking cessation.  
 
Veterans and the Veterans Health Administration 
 
 The Veterans Health Administration (VHA), which is part of the Department of 
Veteran’s Affairs, provides health care for 8.3 million veterans annually at its  
1,700 plus facilities that include medical centers, outpatient clinics, and extended care 
facilities. It is recognized as the major integrated health care system in the U.S. 
(Department of Veterans Affairs 2011). In additional to medical care, the VHA also 
provides programs and domiciles for substance abuse as well as programs for mental 
illnesses including PTSD, housing, and transportation among others.  The VA motto, “To 
care for him who shall have borne the battle and for his widow, and his orphan,” 
established in 1959, is based on words from President Abraham Lincoln’s second 
inaugural address in 1865. 
There are approximately 22.3 million Veterans in the U.S. as of 2012 
(Department of Veterans Affairs Statistics at a Glance 2013). The VHA is recognized as 
29  
the major integrated health care system in the U.S. (Department of Veterans Affairs 2011) which means that Veterans who are enrolled in the VA health care system may 
receive care at any VA facility at any time. The VHA also utilizes an electronic medical 
record system that allows VHA facilities around the country to access a patient’s medical 
record optimizing continuity of care. In additional to medical care, the VHA also 
provides many support services including programs and domiciles for substance abuse 
and mental illness including PTSD, as well as housing and transportation. Veterans are 
not prohibited from seeking health care from both the VHA and private health care 
providers. In an effort to optimize access to care, the VHA is now focusing on an 
outpatient system for care rather than the hospital-based system it has utilized historically 
(Department of Veterans Affairs State Summary 2010). 
 
Not all veterans are eligible to receive health care without cost. Eligibility for 
health care is related to what the VHA defines as a service-connected rating which is 
based on whether the Veteran has an illness or disability that is directly related to their 
military service. According to the VA Health Care Overview website, veterans may be 
eligible for health care and medications for little, if any, cost based on criteria that 
include, but are not limited to, the following: Purple Heart recipient status, prisoner of 
war status, catastrophic disability, and an income below the income threshold.  There are 
eight priority enrollment groups with Groups 1 and 2 having the highest priority for cost-
free health care and groups 7 and 8 consisting of those whose income are above the 
defined VA national income thresholds. Many veterans have some financial 
responsibility for their health care in the form of co-pays (VA Health Care Benefits 
Overview 2012). 
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 The majority of living veterans alive today have served during periods of major 
warfare, while only approximately a quarter served during peacetime (U.S. Census 
Bureau 2010). As of 2011, Vietnam veterans represent 35% of current veterans, along 
with 22% from the Gulf Wars, and 19% from World War II and the Korean War with the 
rest being peacetime veterans (Profile of Veterans, 2013). According to the Profile of 
Veterans 2011 based on data from the 2011 American Community Survey, male veterans 
are older, more likely to be White non-Hispanic and married, less likely to be uninsured 
and live below the poverty line, and to have higher income levels than their non-veteran 
counterparts (2013:19). The survey also found that the median age for male veterans was 
64 years compared to 41 years for non-veterans (Profile of Veterans, 2013). 
 Veterans represent 13% of people in the U.S. who are receiving care for HIV 
infection. Statistics show that 40% of these veterans receive their care for HIV at VHA 
facilities making it the largest provider of HIV care in the U.S. (Department of Veterans 
Affairs 2011). In 2009, about 1 of every 250 veterans receiving health care at a VHA 
facility was infected with HIV (Department of Veterans Affairs 2011). Of the veteran 
population receiving care at a VHA facility who are infected with HIV, 68% are between 
the ages of 40 and 59 and 20% are over the age of 60. (U.S. Department of Veterans 
Affairs, HIV/AIDS website 2013). According to the CDC, the proportion of HIV infected 
veterans in care at a VHA facility who are over the age of 50 (64%) is more than double 
the estimated percentage for the HIV positive population in the U.S. (27%) 
(CDC.HIV/AIDS Surveillance Report, 2005).  
 According to the Department of Veterans Affairs National HIV/AIDS Strategy 
Operational Plan 2011, 91% of HIV infected veterans in health care were on 
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antiretroviral therapy and 96% of newly identified HIV positive Veterans were linked to 
health care. All antiretroviral medications approved by the Food and Drug Administration 
are available on the VHA formulary. In 2009, 84% of HIV positive veterans on 
antiretroviral medications had a viral load less than 400 copies/ml, which was considered 
non-detectable (Department of Veterans Affairs 2011).  
 Goulet et al. (2007), in their work with The Veterans Aging Cohort Study 
(VACS) provide some comparison between veterans living with HIV infection and their 
non-veteran counterparts. They found that the similarities include being non-white, 
having a lower socio-economic status, and acquiring HIV infection through IDU or 
heterosexual sex. 
 The VA Connecticut Healthcare System, where this research took place, serves 
veterans in southern New England and is part of the VA New England Healthcare 
System. The VA Connecticut Healthcare System (VACHS) is comprised of the medical 
center in West Haven, an ambulatory care center in Newington, and six community-based 
primary care centers in Danbury, New London, Stamford, Waterbury, Winsted, and 
Windham (U.S. Department of Veterans Affairs VA Connecticut Healthcare System 
2013) 
 The VA Connecticut Healthcare System, where this research took place, serves 
veterans in southern New England and is part of the VA New England Healthcare 
System. The VA Connecticut Healthcare System (VACHS) is comprised of the medical 
center in West Haven, an ambulatory care center in Newington, and six community-based 
primary care centers in Danbury, New London, Stamford, Waterbury, Winsted, and 
Windham (U.S. Department of Veterans Affairs VA Connecticut Healthcare System 
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2013) 
 
Summary 
 This chapter has provided information about HIV as a disease and an epidemic as 
well as a demographic and clinical profile of contemporary U.S. veterans.  I have also 
discussed some of the theoretical perspectives that underpin the research. In the following 
chapter I explore other social forces that shape the illness experience of veterans to 
enhance our understanding of how they think about and experience HIV infection. 
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Chapter 3    Interconnections 
 
 
Overview 
  
 There are many issues that underpin research about HIV infection and beliefs 
about responsibility. In this chapter I provide a brief overview of some of the 
interconnected factors and social forces that impact the health of U.S. veterans that will 
help to situate this research on beliefs about responsibility for health optimization and 
disease management. These factors include socioeconomic status, masculinity and 
gendered health, military culture and service experience, illness chronicity, and stigma. 
The fact that military veterans comprise the participant population gives rise to questions 
about the impact of masculinity gender norms and military service on health. In this 
chapter, I provide a brief overview of Western masculinity norms and military culture 
and service to understand how they shape beliefs about health and illness and health-
seeking behavior and feed into each other in the social construction of masculinity over 
the life course in order to contextualize my study population as veterans.  
 I also address the issues of chronicity and stigma attached to HIV because these 
are important aspects of the social construction and experience of HIV/AIDS. With the 
advent of effective treatment, HIV infection has been reframed by biomedicine as a 
chronic illness. The concept of chronicity has many ramifications for both the person 
living with HIV infection and the global community, and has significantly impacted the 
burden of illness. A major contributor to this burden is the stigma that has been a 
hallmark of this disease since its emergence. 
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Masculinity and Gendered Health 
 
 Given the gender homogeneity of the study population, it is important to have 
some understanding of the role of masculinity as it relates to the domain of health. This 
discussion provides a brief overview of the research and theory regarding the relationship 
between gender and health.  
 Gender has been identified as an influential factor in health risks and health care 
seeking behavior and how men experience illness (Sabo, 2000). In 2011, the life 
expectancy for men was 76.3 years compared to 81.1 years for women in the United 
States (CDC National Vital Statistics Reports in October 2012). Along with a shorter life 
expectancy, men also have increased mortality due to heart disease, cancer, diabetes, and 
unintentional injuries (CDC Men’s Health, 2010). Studies of men’s health care seeking 
behavior have shown that men are less likely than women to seek medical care, including 
help for substance abuse and depression, are also less apt to report psychosocial issues 
(Galdas et al., 2005) and have a tendency to ignore symptoms of ill health (Sharpe and 
Arnold, 1998). 
 Research on gender and health has shown that there is a high consensus in 
Western society about what constitutes masculine and feminine characteristics 
(Courtenay, 2000; Williams and Best, 1990; Street et al., 1995). Specifically, Western 
masculinity norms include the achievement of success and status, emotional control, risk-
taking, violence, dominance (particularly over women), virility, avoidance of “feminine 
behaviors”, and  self-reliance (Mahalik et al., 2003; Addis and Mahalik, 2003; Good et 
al., 1989).  Gender stereotypes for men include the following attributes: independence, 
inexpressive, aggressive, ambitious, analytical, assertive, competitive, dominant, athletic, 
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and invulnerable, among others (Edley and Wetheral, 1995; Kilmartin, 1994; Courtenay, 
2000). Feminine stereotypes include characteristics such as: emotional, gentle, loyal, 
sensitive, understanding, yielding, and gullible. Traditional Western masculinity norms 
include high risk behaviors such as smoking, unprotected sexual activity, and substance 
abuse (Courtenay, 2000). These norms, for both men and women, constitute, in part, the 
construction of gender which impact health in that illness “can reduce a man's status in 
masculine hierarchies, shift his power relations with women, and raise his self-doubts 
about masculinity'' (Charmaz,1995:268).  
 Sabo (2000) traces the trajectory of theories regarding men’s health over the last 
three decades of the 20th century beginning in the 1970’s when the gender exploration 
began. The initial work sought to understand the role of conforming to traditional 
masculinity norms (i.e. toughness, self-reliance, stoicism) on the determination of health 
outcomes. The following decade did little to advance the understanding of gender and 
illness beliefs, and experience. During this time period, the sex-role theory was 
predominant, focusing on the impact of gender expectations of traditional masculinity on 
morbidity and mortality. This was also a time of emerging activism for gay rights and the 
beginning of the HIV epidemic. The 1990s brought gender identity to the forefront, 
which Sabo defines as the “individual manifestations of masculine or feminine traits and 
cultural practices that are better understood as expressions of wider institutional 
processes” (Sabo, 2000:135). Feminist ideology was instrumental in the inclusion of 
other factors such as class, race, ethnicity and the power differentials that exist at multiple 
levels.  
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 In the United States men construe and construct masculinity by avoiding healthy 
behaviors such as not utilizing sick time at work, dangerous driving habits, and 
participation in sports that are prone to injury and disability (Courtenay, 2000; Mahalik et 
al., 2003). Men are also less apt to get heath care for depression and substance abuse, 
among other health conditions (Galdas et al., 2005). Traditional masculinity is related to 
reduced utilization of preventative health care and health care seeking for medical and 
mental health issues as well as aggressive and violent behavior (Mahalik et al., 2003).  
“By dismissing their health needs and taking risks, men legitimize themselves as 
the “stronger” sex. In this way, men’s use of unhealthy beliefs and behaviors 
helps to sustain and reproduce social inequality and the social structures that, in 
turn, reinforce and reward men’s poor health habits” (Courtenay, 2000:1397).  
 
Monynihan’s (1998) work with young men who had been “cured” of testicular cancer 
found that few were experiencing depression or anxiety and none had sought mental 
health care. She found that while they felt a need to demonstrate “self-control” in public, 
many admitted to allowing themselves to experience in private, the emotions associated 
with a life-threatening disease (Moynihan, 1998).  “By successfully using unhealthy 
beliefs and behaviors to demonstrate idealized forms of masculinity, men are able to 
assume positions of power -- relative to women and less powerful men -- in a patriarchal 
society that rewards this accomplishment” (Courtenay, 2000:1397).  Courtenay also notes 
that some men construct different forms of masculinity by adopting health-enhancing 
choices but that this is not the dominant behavior.  
 It is not gender alone that affects how and when men seek care for health 
problems but socioeconomic status, occupational factors, and lifestyle “choices” may be 
more influential (Galdas et al., 2005; Lee and Owens, 2002). These authors noted that 
while the significance of the beliefs about, and socialization into, what constitutes 
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masculinity is an emerging research theme, these definitions are variable and that most of 
the research to date has been based in Western belief systems.  
 What has been omitted from most discussions about gender and health are the 
social, economic, and political forces that contribute to the construction of gender and 
illness. For veterans, these structural factors have a significant impact on health, 
particularly regarding the military institution, culture, and service.  
 
Military Culture and Service: Impact on Health 
 
The U.S. military is an institution that has been shown to significantly impact 
health, social networks, life trajectory, and other socioeconomic factors for veterans 
(Modell & Haggerty, 1991; MacLean & Elder, 2007; Wilmoth et al., 2010). Both military 
culture and military service shape and reinforce gender roles and serve as contributing 
factors to veterans’ health trajectory. 
Military Culture 
 
 The United States Armed Forces is comprised of the Army, Navy, Marine Corps, 
Air Force, Coast Guard, and the National Guard, the latter being a reserve military force. 
Veterans from the last two decades are from military conflicts named Operation Enduring 
Freedom (OEF), which began in Afghanistan in 2001, and Operation Iraqi Freedom 
(OIF), which was initiated in 2003 and became known as Operation New Dawn in 2010. 
Those who served in these conflicts are referred to as OEF/OIF veterans, a term often 
heard at VHA facilities in the last decade. 
 Enculturation into the military occurs on many levels (e.g., individual, 
community, and institutional) and requires, according to military ideology, the 
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relinquishment of individual agency for the collective good. Smith and True call the 
military a, “total institution’’ with high levels of social integration, regimentation, and 
social control.” (Smith and True 2014:6). Titunik writes that, “Because war requires such 
a high degree of cohesiveness among members of a military unit, this most violent and 
aggressive of enterprises ironically requires qualities of submissiveness, obedience, and 
fidelity to one’s fellow comrades in arms” (2000:236). Those who join the military 
become part of a community, albeit one that is hierarchical. Authority is “depersonalized” 
in the military in that respect is given to those higher in rank rather than based upon 
personal attributes (Titunik, 2000). 
 It is during basic training (i.e., boot camp) that the socialization and enculturation 
process is initiated. Basic training, which typically lasts 8 to 12 weeks, is the military’s 
main source of socialization and it represents “the intentional disruption of civilian 
patterns of adjustment, replacement of individual gratifications with group goals, 
inculcation of unquestioning acceptance of authority and development of conformity to 
official attitudes and conduct” (Arkin and Dobrofsky, 1978:158). Basic values, such as 
tradition, ‘esprit de corps’, unity and community, are instilled during boot camp (Goertzel 
and Hengst, 1971). While each branch of the military has its own code of values, the 
overarching ones are honor, courage, loyalty, respect, selflessness, service, and integrity 
(Kuehner, 2013). For example, the Army values include loyalty, duty, respect, selfless 
service, honor, integrity, and personal courage (U.S. ARMY, 2014), whereas the Navy 
embodies honor, courage, and commitment (Navy, 2014). These values are in 
juxtaposition to the pervasive incidence of sexual assault that occurs in the U.S. military 
for women and to a lesser degree, men. The reported rates in the military are comparable 
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to, and are potentially higher, than for civilians (Turchik and Wilson, 2010), While there 
are many factors that may contribute to this behavior (e.g., substance use; historical 
sexual abuse), military culture plays a role in that it promotes the acceptance of violent 
and sexist behavior (Morris, 1995). Honor is represented, in part, by taking responsibility 
for one’s actions, and commitment is exemplified by obeying orders. The hierarchal 
structure of the military has perpetuated sexual assault because of the power differentials 
that exist, primarily for women but for men as well, creating  “male-dominated and 
loyalist environments in which women are both the minority and desired sexual objects 
for men” (Turchik and Wilson, 2010:271) (Henry, Ward, and Hirshberg, 2004).    
Along with the norms and values that are instilled, basic training entails learning 
the rituals of military life, the language, and the discipline.  These rituals are how the 
military fosters social control (Burk, 1999; Hauser, 1973). Hierarchy, rituals, and 
language are also learned through the socialization process in boot camp (Dunivin, 1994). 
The emphasis on inspections and drills fosters conformity to discipline and to authority, 
which are also reinforced by uniformity in dress and other activities (e.g., salutes) 
(Hauser, 1973). Discipline is the hallmark of the military social system and demands “the 
total individual’s conformity to a prescribed role, including one’s behavior, attitudes, 
beliefs, values, and definitions” (Arkin and Dobrofsky, 1978:158). 
 The other significant impact of the military aside from its enculturation is the 
masculine warrior image that is the face of the military and represents its goal of 
preparing for and conducting the activities of war.  The military creates a “cult of 
masculinity” (with accompanying masculine norms, values, and lifestyles)” that values 
dominance, achievement, and power (Dunivin, 1994:534). At its core is the belief that 
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soldiering is a masculine role with accompanying norms, values, and lifestyle. This 
“masculine mystique” of the independent, competitive, aggressive and virile man is 
promoted during boot camp (Dunivin, 1994:536). The military, and war, are typically 
viewed as “men’s work”. “Through relative physical isolation, community insulation, and 
behavior modification, the traditional prototype of masculinity is molded by the military 
in the belief that war and military are masculine domains” (Arkin and Dobrofsky, 
1978:166).  While this model is slowly evolving as a result of more women entering the 
military in combat roles and some increased tolerance of homosexual soldiers, most of 
the participants in this study represent an older generation of veterans and are a product 
of the traditional military model that stresses the dominant masculine male (Segal et al., 
1993; Bicknell, 2000). This underscores the beliefs in hierarchy and obedience, which 
can be considered part of the patient-physician relationship, one that is hierarchical and 
requires adherence to orders.  
 Exploring the social structural factors related to military service, the effect of the 
military on life trajectory is based on whether a person enlists during war or peace time 
and whether enlistment is voluntary or mandatory (MacLean and Elder, 2007). During 
peacetime, racial inequalities among veterans are reduced because “it appears that 
military service improved the life chances of African Americans, while eroding the life 
chances of whites” (MacLean and Elder, 2007:177). Vietnam veterans were more likely 
than their non-veteran counterparts to have a college degree and report increased 
marijuana and alcohol use during and  after military service. (Robins et al., 1974; Robins, 
Helzer, and Davis, 1975; MacLean and Elder, 2007; Mazur, 1995).  
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 In 1990, African-Americans were underrepresented in the military but that had 
changed by 2000 when they were overrepresented as compared to the general population 
(Lutz, 2008). Non-whites were also underrepresented in the Vietnam War (Mazur, 1995). 
Lutz, in her research on who joins the military, demonstrated that,  
“… among race, socioeconomic status, and immigration status, socioeconomic 
status is the only significant predictor of having ever served in the military. Class 
differences in military enlistment likely reflect differences in the non-military 
occupational opportunity, structured along class lines.  This research shows that 
the all-volunteer force continues to see over-representation of the working and 
middle classes, with fewer incentives for upper class participation” (Lutz, 
2008:185).  
 
Another important predictor of military service in the general population is family 
income; people from lower socioeconomic means are more likely to enlist in the “all 
volunteer” military forces (Seeborg, 1994; Lutz, 2008). According to Defense.gov (2014) 
in their report on “Who is Volunteering for Today’s Military?” 90% of those who 
enlisted in the military through 2005, had a high school diploma compared to those not in 
the military and more were from the middle rather than lower socioeconomic classes. 
Veterans Health 
 
“Military veterans’ culture transcends ethnicity. Their work as soldiers 
shapes their health practices and their susceptibility to particular mental 
and physical health risks.” (Hobbs, 2008:340) 
 
 As noted previously, as of 2011, Vietnam veterans represented 35% of current 
veterans, along with 22% from the Gulf Wars, and 19% from World War II and the 
Korean War with the rest being peacetime veterans (Profile of Veterans, 2011). Military 
service can affect health by increasing the prevalence of smoking and the physical and 
psychological stress related to combat duty (Dobkin and Shabani, 2009). Vietnam 
veterans are in much worse health than non-veterans and this disparity increases with age. 
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Veterans, in general, have much higher rates of depression and anxiety than non-veterans 
and that disparity also increases with age (Dobkin and Shabani, 2009). Wilmoth et al. 
found that, 
 
  “Overall veterans seem to experience better health relative to nonveterans around 
 retirement age [66], but decline more rapidly over time, such that veterans have 
 poorer  health than nonveterans among the oldest old. These trends are 
 particularly noticeable among veterans with wartime service overall and veterans 
 from WWII and Korea in particular (Wilmoth et al., 2010:753). 
 
 Older veterans, aged 45 to 64, tend to report more than two chronic medical 
conditions (diabetes, hypertension, heart disease, cancer [excluding non-melanoma skin 
cancer], stroke, chronic bronchitis, emphysema, asthma, and kidney disease), being in 
fair or poor health, and more serious psychological distress compared to their non-veteran 
counterparts (Kramarow and Pastor, 2012).  
 From 2006 to 2010, those who received mental health care at VHA facilities 
represented 38% of OEF/OIF veterans and 28% of all other veterans indicating that 
mental health issues for veterans are on the rise (United States Government 
Accountability Office, 2011). The most common mental illness diagnoses in 2010 for 
these veterans included adjustment reaction, depressive disorder, episodic mood disorder, 
neurotic disorder, and substance abuse disorder (United States Government 
Accountability Office, 2011). 
 According to the Substance Abuse and Mental Health Services Administration 
(SAMHSA), three-quarters of Vietnam veterans have both PTSD and a substance abuse 
disorder (SAMHSA, 2014) and 20% of veterans from the current wars in Iraq and 
Afghanistan have major depression or PTSD (Kramarov and Pastor, 2012). Mental health 
issues continue to rise. According to the VA Quality Enhancement Research Initiative, 
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the percent of Gulf War veterans being treated for mental health conditions increased 
from 21% in 2003 to 37% in 2013 (Quality Enhancement Research Initiative Fact Sheet 
Mental Health, 2013). 
 Mental illness among veterans is further complicated by a diagnosis of HIV 
infection.  Approximately 63% of veterans living with HIV infection have at least one 
mental health diagnosis (Nurutdinova et al., 2012). Justice et al. (2004) conducted a 
comparative study of psychiatric and neurocognitive disorders between HIV infected and 
non-infected veterans and found that veterans who are living with HIV infection are more 
likely to have symptoms of depression and current substance abuse. Alcohol abuse has 
equal prevalence in those with HIV infection and without it but along with depression, 
and substance abuse, the prevalence increases with age.   
 In sum, military culture and service contribute to the construction of masculinity 
along traditional lines and affect the life course and health of those who serve. The health 
of veterans is affected on many levels both physically and psychologically, and there is a 
greater prevalence of alcohol abuse and substance use. These effects, in synergy with 
HIV infection, the co-morbidities of aging, and other social structural constraints place a 
disproportionate health burden on veterans. An additional contributor to this burden is the 
reframing of HIV infection as a chronic illness. 
 
Chronicity 
 
 There has been much discussion about the evolution of HIV from an “acute” 
illness with high mortality to one that is considered “chronic”. Chronic illnesses can be 
defined as those that persist for more than three months and are “not self-limiting” (Von 
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Korff et al., 1997:1097) or as Allotey et al. write “serial acute episodes with multiple 
interactions with the health care system” (2011:450).  HIV infection is a chronic disease 
in that it has an “uncertain course, a prescribed treatment regimen, requirement for self-
care, some degree of stigma, changes in roles and relationships, and psychological 
distress”(Swendeman, 2009:1322). 
 Chronic illness requires a significant amount of self-care since most of the 
disease management is done on a daily basis rather than periodically in the formal health 
care setting (Siegal and Lekas, 2002; Corbin and Strauss, 1995). The self-care that is part 
of managing a chronic illness, which some label self-management, is composed of health-
enhancing behaviors, treatment adherence, self-monitoring, disease and symptom 
management, and the effects of the illness itself, which are related to impacting the 
course of the disease (Von Korff et al., 1997; Emlet et al., 2011)  
 Corbin and Strauss (1995) talk about three different types of work that comprise 
self-care in chronicity: 1) “illness work” that entails treatment adherence, symptom 
management, and prevention of acute illness; 2) “everyday life work” that relates to the 
continuation of activities of daily living; and 3) “biographical work” that refers to the 
reconstruction of life, which can be required because of the consequence of the illness 
(e.g., limitations; outcomes). Ferzacca (2010) writes about the suffering of those 
diagnosed with diabetes and their “work” to control their disease such that “This 
willingness to work operated symbolically as the mark of a useful, disciplined, and 
productive self. Such work, indexed by the obtainment of “control” measured 
biochemically in blood glucose levels, is rewarded as a practical, rational, mental, and 
moral achievement” (2010:160).  Bury writes about disruptions in biography caused by 
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chronic illness referring particularly to the effects on social relationships and the work 
entailed to maintain them (Bury, 1982). This “work’ is not often recognized as such even 
though it represents individual agency in impacting the course of disease (Conrad, 1990).  
It is invisible work for most people only recognized within their personal social network 
and by their health care providers.  
 Several researchers recommend similar behavior change goals that can be used 
for all chronic illnesses, including adoption of a healthy lifestyle (e.g., sufficient sleep, 
moderation in use of alcohol, good nutrition, weight control, smoking cessation, exercise, 
and regular health care); adherence to treatment protocols, particularly medications; 
stress, anger, and depression management; and effective communication with health 
professionals (Swendeman, 2009; Barlow and Wright, 2009; Lorig et al., 2001). Those 
who are ill are expected to adapt to this work despite disability, uncertainty, and barriers 
to adherence and health-enhancing behaviors (Sigel and Lekas, 2002). Thorne and 
Paterson (1998) discuss the shift from the sick person as patient to partner in the health 
care relationship but write that not everyone who is ill with a chronic illness is capable or 
desirous of taking on disease management.  
 HIV was labeled as a chronic disease in the late 1980’s once the initial drugs 
became available for treatment (Colvin, 2011) but it was not generally accepted as such 
until more effective treatment became available in the mid-1990’s when HAART became 
available (Siegal and Lekas, 2002). In truth, HIV infection was never easily defined as an 
acute illness. It is most often characterized by a long asymptomatic period, often years, 
during which the immune system is being weakened and ultimately overwhelmed if 
treatment is not efficacious or not available. For those living with HIV infection, the self-
46  
care required includes enhancing immune systems, controlling symptoms and minimizing 
disease progression (Siegal and Lekas, 2002). As the quote below suggests, although 
chronic and manageable, HIV is experienced as a series of acute episodes as in many 
chronic diseases. 
 “HIV continues to be experienced by many, through intermittent acute episodes 
 of symptoms of disease with underlying worry about disease progression and 
 worry about perpetuity and life-threatening nature of the illness, rather than a 
 relatively low-level, long-lived condition ’under control‘” (Kendall and Hill, 
 2010:175) 
 
 Colvin writes, “…treatment narratives that celebrate HIV’s long-awaited arrival 
as a chronic condition mask the persistence of the local and global structural conditions 
that produced vulnerability and infection in the past and continued suffering and poor 
therapeutic adherence in the present” (Colvin, 2011:4). He talks about the inadequacy of 
the acute and chronic dichotomy in that it doesn’t address the often acute phases of 
chronic illness. For those with HIV, the effects of a weakened immune system and side 
effects from medications can cause periods of ill health. This labeling not only affects 
how the person living with a “chronic” illness experiences their illness but also the 
political and economic forces that shape funding and activism (Colvin, 2011).  
 The inadequacy of the acute-chronic dichotomy is also discussed by Manderson 
and Smith-Morris (2010) in their work on chronicity and the illness experience. They 
write that this categorization is effective for biomedicine and for discourse about disease, 
but that it discounts the significance of the subjective illness experience. They advance a 
nuanced understanding of the political-economic and hegemonic forces that construct and 
influence this chronic-acute dichotomy that contributes to the “invisibility of suffering” 
(2010:11). The self-care model of chronic illness that shifts the burden to the person who 
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is ill discounts the inherent suffering, disruption, and uncertainty that must be endured. In 
relation to HIV, they say that, “the very presence of categories of experience that inhabit 
both chronic and acute categories, infectious and yet long-term, demonstrate the 
declining explanatory power of the chronic-acute paradigm (and its variations)” 
(Manderson and Smith-Morris, 2010:12). The distress and uncertainty still persist even 
for those with HIV viral load suppression even though they have been told by 
biomedicine that their disease is chronic and that death is not imminent (Siegal and 
Lekas, 2002). “The underlying embodiment of AIDS, especially through its symptomatic 
ups and downs, is truly chronic” (Kendall and Hill, 2010:176). As Bury notes, chronic 
disease engenders chronic worries and disruptions that don't show up as medical issues: 
 Chronic illness involves a recognition of the worlds of pain and suffering, 
 possibly even of death, which are normally only seen as distant possibilities or the 
 plight of others. In addition, it brings individuals, their families, and wider social 
 networks face to face with the character of their relationships in stark form, 
 disrupting normal rules of reciprocity and mutual support. (Bury, 1982:169) 
 
 This aspect of chronicity speaks to the importance of the illness experience and 
meaning-centered understandings that people use to make sense of their lives and 
determine how to live with their illness. Biomedicine's labeling of acute and chronic 
disease does not take into consideration how people experience their illness and 
intensifies their burden on all levels.  This construction of HIV infection by biomedicine 
as a chronic illness and the perpetuation of this distinction by those with disproportionate 
political and economic power contribute to the burden of those living with HIV infection. 
A significant contributor to this suffering is the stigma that affects those living with HIV 
infection.  
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Stigma 
 
 “Throughout history, the stigma attached to epidemic illnesses and the social 
 groups linked to them has often hampered treatment and prevention, and has 
 inflicted additional suffering on sick individuals and their loved ones.”  
 (Herek et al., 1996:2).  
 
 As the quote above shows, stigma adds to the suffering that is a significant aspect 
of the lived experience of many individuals who are infected with HIV. It is experienced 
on an individual level, but it is a socially constructed phenomenon. Understanding this 
phenomenon of stigma can provide insight into how the social suffering of people with 
HIV infection comes into being.  
 Much effort has been made to conceptualize stigma but it has proven difficult. 
Often the literature addressing stigma begins with Goffman’s definition, an “…attribute 
that is deeply "discrediting”, “tainted”, “discounted” (Goffman 1963:3). Discussions of 
stigma generally center on stereotypes and negative attributes, as in Goffman’s 
conceptualization, rather than the power relations that create and perpetuate stigma.  
 
 “What is most poignant about Goffman’s description of stigma is that it suggests 
 that all human differences are potentially stigmatizable. As we move out of one 
 social context where a difference is desired into another context where the 
 difference is undesired, we begin to feel the effects of stigma. This 
 conceptualization of stigma also indicates that those possessing power, the 
 dominant group, can determine which human differences are desired and 
 undesired (Coleman, 1986: 212) 
 
 Goffman did seminal work on stigma in the 1960’s, writing that it was related to 
values and social norms; those who don’t conform are perceived as different or deviant 
(i.e., sex workers, drug addicts). He identified three characteristics that connote 
difference: 1) blemishes of individual character for which he uses homosexuality as an 
example, 2) abomination of body represented by physical deformity, and 3) tribal stigma 
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of race, nation, or religion (Goffman, 1963) such that “Perceptually, stigma becomes the 
master status, the attribute that colors the perception of the entire person.” (Goffman 
1963: 219). 
 The definition of stigma has evolved since Goffman’s work. Jones et al. (1984) 
identified six “dimensions of stigma” that affect the stigmatizing process: 1) the degree to 
which the condition can be concealed; 2) the course and appearance of the condition; 3) 
its disruptiveness (defined as its effect on social interaction); 4) whether the afflicted 
person is responsible for acquiring the condition; 5) whether it is unattractive or repulsive 
in nature; and 6) if it is a threat to others (Jones et al., 1984). The work of other social 
scientists such as  Stafford and Scott defined stigma as a “characteristic of persons that is 
contrary to a norm of a social unit” did little to advance the conceptualization of stigma 
(Stafford and Scott 1986:80). Crocker and Lutsky mirrored Goffman in their definition of  
stigma as an “attribute, or characteristic, that conveys a social identity that is devalued in 
a particular social context” (Crocker and Lutsky, 1986:505).  The historical contributions 
to a conceptualization and theory of stigma  reveal the difficult evolution of defining a 
ubiquitous but slippery social force. 
 Link and Phelan (2001) wrote one of the first works that recognized that power 
differentials are inherent when stigma is viewed in the context of social, political, and 
economic forces (Link and Phelan, 2001). From this perspective, people distinguish and 
label the differences in others and associate these differences with undesirable or negative 
attributes resulting in a separation into “them” and “us”. This power differential between 
the dominant group who label and those that suffer from the stereotyping is what allows 
stigmatization to lead to discrimination and inequity (Link and Phelan, 2001). People 
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with HIV infection have been labeled as “different” and stereotyped with negative 
attributes (i.e. deviant; immoral; uncooperative, non-adherent, and responsible for their 
illness) and have been categorized as an “out-group”. Stigmatization allows dominant 
groups to legitimately create power inequities for marginalized groups on many levels 
(i.e. social; economic; political; health care treatment and access). Prior to Link and 
Phelan’s work, the conceptualization of stigma focused on the individual or groups being 
stigmatized and those who stigmatize. This focus has largely ignored the social, 
economic, and political forces that create and contextualize who is stigmatized. Parker 
and Aggleton (2003) moved conceptualization forward by advocating for the need to 
“reframe our understandings of stigmatization and discrimination to conceptualize them 
as social processes that can only be understood in relation to power and domination” 
(Parker and Aggleton, 2003:16). This work has advanced the understanding of stigma in 
terms of its origin, function, and the forces that create and perpetuate it. 
 Much research has been done to understand the various shapes and forms of 
stigma. Stigma that impacts an individual has been defined as primary while that which 
affects those close to the individual such as family, friends, and significant others is 
termed secondary stigma (Herek, 1999). Bond et al. (2002) have described three types of 
stigma; self-stigmatization which is related to feelings of blame and shame; perceived 
stigma which is often driven by fear of disclosure of a stigmatized condition; and enacted 
stigma which is the resulting status loss and discrimination. Others refer to self-
stigmatization as internalized or “felt stigma” (Green, 1995; Siegel and Lekas, 2002; 
Herek, 1999). Internalization of stigma can lead to self-doubt, lower self-esteem, 
depression, immunosuppression, and even premature death (Fife and Wright, 2000). 
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Other effects of stigma include depression and anxiety, social isolation and fractured 
social and familial relationships, as well as loss of employment and decreased access to 
health care (Varas-Diaz, 2005; Herek, 1999). Institutional discrimination relates to the 
stigma that is associated with access to health care, employment, and social interactions 
that occur at the levels of the local social support system and the wider social world 
(Herek, 1999). 
 
HIV Related Stigma 
 
“Throughout history, the stigma attached to epidemic illnesses 
and the social groups linked to them has often hampered 
treatment and prevention, and has inflicted additional suffering 
on sick individuals and their loved ones.” (Herek et al., 1996:2) 
 
 As the opening quote for this section suggests, the impact of the AIDS epidemic 
has been enormous for both the individuals who are infected with HIV infection, the 
wider social community, and those in the healthcare field. It is a disease that is associated 
with death, fear, uncertainty, stigmatization and discrimination. It has brought 
marginalized populations, such as intravenous drug users and homosexuals, to the 
forefront of society’s awareness creating an additional layer of stigma and resulting in 
health care inequities. “Vast majority of AIDS patients would often be stigmatized in a 
negative manner even if they were healthy” (Kelly et al., 1987:789). Familial and social 
networks have disintegrated for people infected with HIV affecting their ability to cope 
with a long-term illness with an uncertain outcome. Stigma is an important issue in this 
epidemic because it increases the suffering of people who are infected with HIV, 
ultimately affecting their quality of life and access to diagnosis and treatment.  
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 Because HIV infection has historically been viewed as primarily affecting people 
who are considered to be “abnormal” or “deviant” and are violating the norms of society 
(i.e. intravenous drug users; homosexuals; sex workers), this results in isolation, 
rejection, and discrimination and the extension of the same stigma to other sufferers who 
do not share these attributes. The creation of risk groups by epidemiologists since the 
advent of the epidemic, while epidemiologically logical and useful for understanding the 
disease, had the unfortunate consequence of fostering the social concept of “in-groups” 
(non-infected, non-deviant people) and “out-groups” (infected deviant people), creating a 
distinct line between “us” and “them” (Herek et al., 1996; Link and Phelan, 2001). HIV 
emerged primarily in stigmatized populations such as homosexuals, intravenous drug 
users, and immigrants, and the initial response of screening those individuals who were 
thought to be at risk, were discriminatory and set up the non-traditional way that HIV is 
handled as opposed to other infectious diseases (Frieden and Douglas, 2005). 
 Although most individuals with HIV/AIDS cannot be identified by their 
appearance, there are some physical manifestations that people have come to associate 
with the disease. Early in the epidemic, Karposi’s Sarcoma, a medical condition that was 
manifested by purple lesions, became a hallmark of the disease and a means of 
identifying people who were infected. Although this condition has become rare in people 
with HIV/AIDS due to the use of antiretroviral medications, the current association of 
lipoatrophy (loss of fat in the face and extremities) and lipodystrophy (i.e. abnormal fat 
distribution) with the disease has become the new "mark” of the disease as Goffman 
would term it. Lipoatrophy is manifested by facial and extremity fat tissue wasting which 
results in an emaciated look. With lipodystrophy, fat is often redistributed to the back of 
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the neck (i.e., buffalo hump) or abdominal area which makes the person look physically 
disproportionate and in ill health 
 Stigma related to HIV/AIDS is not only imposed by society and other social, 
economic, and political forces but self-imposed as well (i.e., internalized stigma). 
Disclosure of HIV infection often also results in disclosure about lifestyle choices, sexual 
orientation, or substance abuse. Lack of knowledge, fear, contagion and other factors 
contributed to the stigmatization of people infected with HIV and those believed to be at 
risk for contracting the disease. Due to the fact that the early cases of HIV infection were 
identified in homosexual men, the disease quickly became associated with this 
marginalized population. As it became apparent that the disease is transmitted through 
bodily fluids, sexual activity and sharing needles during intravenous drug use became 
primary risk factors for infection. This contributed to the identification of groups who 
were already marginalized within society as different or abnormal. There were also some 
who believed that these people deserved HIV infection as punishment for violating the 
norms of society. Interestingly, people infected with HIV are stigmatized to a greater or 
lesser degree based on how they acquired the disease. Hemophiliacs and other people 
who require blood transfusions as well as children are viewed as innocent victims who do 
not deserve HIV infection because they did not participate in lifestyles that are 
considered immoral or illegal. While homosexual sex and intravenous drug use remain 
the major routes of transmission, heterosexual sex has become a more prevalent mode of 
transmission. Taking a critical anthropology perspective, Paul Farmer writes, “the 
variability of AIDS lies not in its modes of spread nor in the mechanisms by which the 
virus saps the host. It lies, rather, in its clinical course, which varies according to the 
54  
patient’s social condition, and according to society’s ways of responding to a deadly 
pathogen.” (Farmer, 1997:525). Stigma has been a barrier to people seeking HIV testing 
and accessing health care. The literature provides evidence of people with HIV/AIDS 
who feel that the stigma they experience is worse than the disease (Mosack et al., 2005). 
Singer (2004) discusses ‘oppression illness’ which refers to long-term effects of 
experiencing stigma (and the internalization process that often results in self-blame). The 
synergism of experiencing the social trauma of stigma and discrimination (e.g., racism, 
sexism, sexual orientation), which is often layered and multidimensional, and 
internalizing guilt, blame, and self-hatred ultimately affects the course of the disease 
(Baer, Singer, and Susser, 2013). 
 Historically in the U.S., AIDS has been associated with negative attitudes, stigma, 
and discrimination.   
 “AIDS stigma represents a set of shared values, attitudes, and beliefs that 
  can be conceptualized at both the cultural and individual levels. At the cultural 
 level, AIDS stigma is manifested in laws, policies, popular discourse, everyday 
 social practices, and the social conditions of persons with HIV (PWHIVs) and 
 those at risk for infection. At the individual level, it takes the form of behaviors, 
 thoughts and feelings that express prejudice against persons infected with HIV” 
 (Herek et al., 1996:2).   
  
 Given society’s fear of transmission and lack of knowledge, many people with 
HIV/AIDS live in varying degrees of social isolation. Some do not tell anyone, not even 
friends or family, that they are infected with the virus for fear of discrimination and 
rejection. Others disclose their HIV infection with deleterious results. Many live in fear 
of exposure which results in the lack of social support that many with this disease 
experience. To what degree it is self-imposed is questionable, but it is clear that many 
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people who have discussed being infected with HIV have been stigmatized as a result of 
their declaration. 
 Jonathan Mann wrote eloquently about the political economy of HIV and the 
health disparities it created:  
 “… as the HIV epidemic matures and evolves within each community and 
 country, it focuses inexorably on those groups who, before HIV/AIDS arrived, 
 were already discriminated against, marginalized, and stigmatized within each 
 society. Thus, in the United States the brunt of the epidemic today is among racial 
 and ethnic minority populations, inner city poor, injection drug users, and 
 especially women in these communities” (Mann, 1997:11) 
 
Stigma is socially and culturally constructed and it is contextualized. Jones et al., write,  
 “Designations of stigma have histories, and the public definition of deviant 
 behavior is itself changeable. Interpretations of stigma… are open to reversals of 
 political power, twists of public opinion, moral crusades, and the impact of social 
 movements” (Jones et al., 1984: 44).  
 
 Stigma is what some people think about and do to other people and it is 
contingent on power differentials based on social, political, and economic forces. Singer 
(2004) makes the point that HIV/AIDS is not only a biological entity but also a social 
process that has influenced who has become infected with HIV and how they are treated 
within their personal and the wider social network. Much work remains to further the 
understanding of this phenomenon in terms of how it is created and perpetuated and the 
impact of structural factors on the experience of stigma in the epidemic. There is a need 
for the development of a bio-social theory of stigma that is grounded in critical medical 
anthropology in order to incorporate the individual, social, cultural, economic, and 
political dimensions of this phenomenon. Interventions to impact stigma must be multi-
faceted and multi-level and address the individual, community, and structural factors 
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particularly in terms of the power differentials that contribute to its creation and 
persistence. Parker and Aggleton suggest that the goal of research should be help mitigate 
the suffering related to stigma of not only those who are living with HIV infection but to 
those who are at risk of contracting the virus. (Parker and Aggleton, 2003)    
 HIV/AIDS will not be the last epidemic nor will it be the last disease to generate 
stigma and create health inequities. Early research on the SARS epidemic has shown that 
there are similar patterns of stigmatization based on high morbidity and association with 
groups that have been labeled as different (i.e. homosexuals and intravenous drug users 
for AIDS and Asians for SARS) even though the modes of transmission are different 
(Des Jarlais et al., 2006:563). Gaining insight into what creates and perpetuates the 
stigma associated with HIV infection will help to impact the social suffering from it and 
inform interventions to combat this obstacle to equitable and effective health care for all. 
 The information in this chapter provides a foundation for understanding some of 
the social forces that impact the health of veterans, with a particular focus on HIV 
infection, as well as other co-morbidities (e.g., mental illness, substance abuse). The next 
chapter presents the research methods used in this study and my study sample for the 
research into the lived experience of HIV among veterans.  
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Chapter 4    Research Methods 
 
In this chapter, I provide a description of the research and its objectives, an 
overview of the main study, a description of the research setting, sample design, 
participant characteristics, data collection methodology, and the analyses of the 
quantitative and qualitative data. 
 
Overview 
 My dissertation research was a substudy of a larger project conducted at the VA 
Connecticut Healthcare System in West Haven, CT.  It was embedded in a pilot 
feasibility study of an incentive system designed to reward people infected with HIV for 
viral load suppression (Farber et al., 2013). The main study, which utilized monetary 
incentives to reward patients for HIV viral load suppression, provided an opportunity to 
explore beliefs about responsibility related to health and disease management.  I used a 
mixed-methods study design to elicit information about how people infected with HIV 
conceptualize the virus, their illness, and their beliefs about their responsibility for 
management of their disease and their perceived ability to impact its course. Data were 
collected from people who were currently prescribed antiretroviral medication for HIV 
treatment. Quantitative data were collected through the utilization of the 
Multidimensional Health Locus of Control (MHLC) Form C, which was customized for 
HIV infection. Patients were asked to complete the MHLC) Form C survey as well as 
participate in an optional semi-structured interview in order to describe how patients 
understand and experience their illness and their beliefs regarding their ability to affect 
their own health. Medical record review was done to obtain descriptive statistics and the 
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outcome data that included incentive study visit attendance and HIV viral load data. 
Patient attendance at the incentive study visits (i.e., main study), which corresponded 
with routine HIV health care visits during the year on study, served as a marker for 
responsibility for health and HIV viral load suppression data were used as a measure of 
the ability to impact the course of the disease. All of the patients who enrolled in the 
incentive study were asked to participate in the research that comprises this thesis. 
Analysis focused on determining how these meaning-centered understandings relate to 
the quantitative measurement of health locus of control (HLOC) and outcome data (HIV 
Health Care Visit Attendance; HIV Viral Load Suppression) in order to provide insight 
into the connections between conceptualization of illness, responsibility for health, and 
beliefs about the ability to impact the course of disease from an emic perspective. The 
study was approved by the IRBs at the VA Connecticut Healthcare System in West 
Haven, CT and the University of Connecticut.  
Research Objectives: 
 To gain insight into how people infected with HIV conceptualize the disease and 
their schema for thinking about it.  
 To utilize the theoretical framework of Locus of Control (LOC) utilizing the 
Multidimensional Health Locus of Control (MHLC) survey customized for HIV 
and semi-structured interviews to gain insight into the construct of responsibility 
for health and how people infected with HIV understand and experience their 
illness.   
 To better understand the social construction of illness and the construct of 
responsibility as it relates to health. 
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 To understand the connection between conceptualization of illness, responsibility 
for health, and beliefs about the ability to impact disease progression to determine 
if these beliefs translate to agency and positive health outcomes. 
 
 The research was conducted with U.S. military veterans at the VA Connecticut 
Healthcare System (VACHS) in West Haven, CT. This site provided a distinct 
environment in which to study the concept of personal responsibility for health. The 
veterans who participate in the VA health care system, an integrated medical system, 
have access to medical care, medications, diagnostics and treatment, and other support 
services (e.g., substance abuse treatment programs; transportation; housing) with little, if 
any, financial responsibility. This represents a system where many of the barriers to 
adherence and disease management are greatly diminished, or eliminated, providing 
opportunities to optimize health.  
 
Hypothesis 
 To date research on responsibility for health and medication adherence has used 
psychological models, including health locus of control (HLOC) that assesses the extent 
to which individuals believe that health is impacted by their own actions rather than other 
forces outside their control. Individuals who believe that their own behaviors and actions 
determine their health (high Internal HLOC) are expected to participate in health-
enhancing behaviors, including adherence to medication regimens, to optimize 
therapeutic benefit resulting in HIV viral load suppression.  
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Description of the Main Study 
“A Study of Financial Incentives to Reduce Plasma HIV RNA Among Patients in 
Care” 
The main study in which this research was embedded was a small one-site pilot 
feasibility study to determine if monetary incentives could improve HIV viral load 
control. The research was conducted at the Infectious Diseases Clinic at the VA 
Connecticut Healthcare System in West Haven, CT. It was designed to reward patients 
for viral load suppression and collaterally for attending routine HIV care visits and to 
improve communication between patients and their health care providers regarding 
symptoms that the patients experience that might impact adherence and quality of life 
(Justice, AC et al., 1999; Kilbourne et al., 2001; Johnson et al., 2003; Cunningham et al., 
1998). Suppression of, or improvement in, HIV viral load was chosen as the target for the 
incentive because it does not have the same potential for  “gaming” as adherence, which 
can be “gamed” because pill counts can be manipulated (Farber et al,. 2013).  
The study design involved four study visits over the course of a year at three-
month intervals and a symptom survey that was administered at the first and final study 
visits. The timing of the study visits was designed to coincide with the typical HIV care 
visit schedule. HIV health care providers typically order HIV viral load tests every three 
months in order to monitor disease progression. The amount of the incentive, $400 per-
person per-year, was calculated based on the annual amount of money that the “health 
care system” would save if a person infected with HIV suppressed the virus. This viral 
suppression translates to reduced HIV infectiousness and transmissibility (Farber et al., 
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2013). The incentive program was designed to reward improvement in HIV viral load 
control as well as achievement of viral suppression. 
All veterans who participate in the ID clinic for their HIV care were eligible for 
the study.  Those who consented to the study were asked to attend their quarterly routine 
HIV care visits and have a HIV viral load test done prior to the visit. The participant 
would meet with their health care provider for a routine care visit to review the HIV viral 
load test result and would then meet with a member of the research team for an incentive 
study visit. The participant was eligible for a $100 incentive at each of four visits (i.e., a 
potential total of $400 over the course of the study year) if the HIV viral load test showed 
viral suppression or if it was lower than any previous viral load result over the previous 
year.  
In order to be eligible for the incentive, the participant had to have their blood 
drawn for a HIV viral load assessment prior to the visit in order for the results to be 
available and they had to attend their scheduled clinic visit. Having blood drawn for 
routine testing prior to the visit is a common practice in the ID clinic so that the health 
care provider can discuss the results with the patients during their appointment and make 
adjustments to medications as necessary. If participants were eligible for an incentive 
payment they were given a voucher that they could take to the cashier to receive cash. 
The voucher could be cashed in at any time but a cashier was always available during the 
time the clinic was in session so that the ability to get cash was immediate.  
Participants were informed by the research staff associated with the study that 
they could help to suppress their HIV viral load by taking all of their anti-HIV 
medications as directed and communicating with their health care provider regarding any 
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symptoms that might affect their adherence so that changes could be made to their 
regimens if necessary to optimize therapeutic benefit.  
The study was conducted from January 2010 through July 2011. There were 78 
male Veterans who consented to participate in the study but one was found to be 
ineligible. During the course of the study, three participants died, three relocated, and two 
were lost to follow up. 
For analyses, the HIV viral load results for the year in which each patient was 
enrolled in the study was compared to the results from the year prior to study enrollment. 
Given that the study was a small feasibility study, it was not powered to identify 
significant differences in the outcome measure of HIV viral load. The results showed that 
the incentives were potentially responsible for a 12% increase (i.e., from 57 to 69 %) in 
suppressed HIV viral loads. (Farber et al., 2013) There were limitations to the study that 
included potential regression to the mean and the small sample size. The results of the 
study were published in AIDS and Behavior in 2013 (Farber et al., 2013). 
I was a member of the research team for this the main study. I was not involved 
with the study at its onset but joined the team as a Research Coordinator around April of 
2010. My responsibilities included conducting the study visits, determining if participants 
were eligible for an incentive payment, providing the incentive voucher if appropriate, 
and counseling the participants who were not eligible for an incentive payment. I was 
also involved in the medical record review, data collection and maintenance, assuring that 
the regulatory requirements were met, and was an author on the paper. During my work 
on the main study, I was approached by the Principal Investigator who asked if I was 
willing to design and conduct a qualitative research component for the study to elicit 
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information about how the study participants viewed incentivizing viral load suppression. 
I was also given the opportunity to study additional relevant constructs and domains.  The 
design of the main study provided an opportunity to explore beliefs about responsibility 
for health and disease management and gain insight into whether the study participants 
believed they could impact the course of their disease.    
Enrollment in the main study began in January 2010. Once this substudy received 
IRB approval, all of the patients in the main study were approached at their next study 
visit and asked if they were willing to participate in this research. For those who 
expressed willingness to participate, the process of informed consent was conducted and 
the participants were asked to sign an amended informed consent form that included 
information about the MHLC survey and the semi-structured interview. By signing the 
amended informed consent form, the participants acknowledged their willingness to 
complete the MHLC survey. There was a separate section embedded in the amended 
informed consent form that provided an opportunity to consent to the optional semi-
structured interview.  
 
Research Setting  
The Infectious Diseases Clinic at the VA Connecticut Healthcare System at West 
Haven, Connecticut 
The VA Connecticut Healthcare System (VACHS), often called VA Connecticut, 
offers primary and specialty care to Veterans in southern New England and is part of the 
VA New England Healthcare System. VA Connecticut is comprised of the main medical 
center in West Haven, an ambulatory care center in Newington, and six community-based 
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primary care centers, in six cities: Danbury, New London, Stamford, Waterbury, 
Winsted, and Windham (U.S. Department of Veterans Affairs VA Connecticut 
Healthcare System 2013). The main medical center in West Haven, where this research 
was conducted, is a Clinical Referral Level 1 Facility with 230 beds that provides 
“primary, acute, tertiary, and long-term care”. For the fiscal year 2009 there were 
approximately 5500 hospital admissions and over 600,000 outpatient visits in the VA 
Connecticut Healthcare System. 
http://www.va.gov/opa/publications/factsheets/ss_connecticut.pdf)  
It is a teaching hospital with academic affiliations with the Yale University 
School of Medicine and the University of Connecticut Medical and Dental Schools. 
(vaww.visn1.va.gov). There are also affiliations with numerous other educational 
programs including nursing, pharmacy, social work, physical therapy, and occupational 
therapy (http://www.connecticut.va.gov/about/index.asp). Research is a primary focus of 
the VHA and the VACHS conducts local research in various disciplines (e.g., psychiatry; 
medicine; surgery; and neurology) as well as participation in national research programs 
including the National Laboratory for Tuberculosis and Other Mycobacterial Diseases, 
the Mental Illness Research, Education and Clinical Center (MIRECC), the National 
Center for PTSD, the National Center for Research in Alcoholism and Substance Abuse, 
and the Clinical Epidemiology Center. 
The Infectious Disease (ID) Department at the VACHS provides primary and 
specialty care for veterans with HIV and other infectious diseases. At the time of the 
study there were approximately 150 veterans who utilized the Infectious Diseases 
Department for their HIV care. The primary clinic for both HIV care and general 
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Infectious Diseases is conducted weekly on Friday mornings. Due to the high volume 
there is a small overflow clinic session on Monday afternoons that is dedicated to general 
infectious diseases and not HIV care. 
The Department of ID consists of the following personnel: the Chief of ID who is 
the physician who oversees the administrative and clinical functions of the department: 
several Attending Physicians; a Physician’s Assistant (PA-C) who is certified as an 
American Academy of HIV Medicine Specialist who assists the Chief with clinical care; 
an Administrative Assistant; a physician who directs the infection control program; and a 
number of Infectious Disease Fellows that changes yearly. A fellowship provides an 
opportunity for a physician to pursue an education in a specialty area and usually lasts for 
two to three years. The physicians, with the exception of the Fellows, are all board-
certified in ID. I fulfill the role of the Infectious Disease Research Coordinator as part of 
my full time work for the Yale University HIV Clinical Research Program along with a 
Research Assistant. 
During the HIV clinic sessions, patients are seen by their HIV health care 
provider by appointment and are offered HIV care with the option of receiving Primary 
Care services as well. Typically there are three to four ID Fellows and the PA-C who see 
patients during the Friday morning clinic sessions with two to three attending physicians 
who provide supervision. The ID clinic is conducted in the Specialty Care Clinic, an area 
which consists of many examinations rooms that are utilized by multiple specialties 
during a given clinic session. The nursing staff sees all of the patients before their 
appointment which enhances continuity of care as they are a stable presence in the 
Specialty Care Clinic and come to know the patients well. There is a large waiting area 
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that is utilized by all of the veterans who have an appointment with any of the specialty 
clinics being conducted.  
When clinic is not in session, much of the communication regarding HIV care 
occurs between the patients and the PA-C whose responsibilities include triaging patients 
by phone or in person when medical problems arise, prescribing medications and refills, 
and arranging any support services that are necessary (e.g., programs for substance or 
alcohol abuse; housing; transportation). There are many social and economic issues that 
impact a person’s health and this is particularly true for the veteran population and those 
who are infected with HIV (e.g., lack of social support; homelessness; lack of 
transportation; and PTSD). The Infectious Disease physicians and PA-C at the VACHS 
who provide care to the veterans with HIV infection are very responsive to the social and 
economic needs and constraints of their patients. 
The main study and this embedded substudy were conducted primarily during the 
Friday morning clinic sessions although several patients were seen during the Monday 
afternoon clinic session. I assisted with the implementation and data collection of the 
main study and conducted the data collection for the substudy. The MHLC surveys and 
the semi-structured interviews were administered in either an exam room in the Specialty 
Care Clinic that was dedicated to ID Research or in in a private office located in the 
Department of ID. Patients who could not participate in the survey and/or interview on 
Friday mornings were seen at their convenience in a private office in the Department of 
ID.  
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Sample Design 
All HIV+ patients participating in healthcare in the Infectious Disease clinic at the 
VA Connecticut Healthcare System in West Haven, CT who had been prescribed HIV 
combination therapies for at least one year and were participating in the main incentive 
feasibility study were eligible to participate in the survey and the semi-structured 
interview that comprise this research. There were 78 male participants who enrolled in 
the main study. 
Survey 
All of the 77 participants who enrolled in the main study were asked to participate 
in the survey component of the research. There were 78 participants who consented to the 
main study but one was found to not be eligible. Participation in the survey was optional 
and participants were informed that refusal would not impact their participation in the 
main study. 
Semi-structured Interview 
All of the participants who completed the survey were invited to participate in the 
semi-structured interview. Participation was optional and participants were informed that 
refusal would not impact their participation in the main study. 
 
Participant Characteristics 
The study population reflected the patients who received health care for their HIV 
infection in the Infectious Disease clinic at the VA Connecticut Healthcare System in 
West Haven, CT. At the time this research was conducted, there were approximately 150 
veterans with HIV infection who participated in this clinic; only two of who were female.  
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 There were 78 participants who enrolled in the main study and 69 of those 
individuals consented to complete a MHLC survey. The number of participants who 
completed a survey and subsequently consented to an interview was 57. A comparison of 
the demographic and other relevant characteristics for all three groups is presented in 
Table 4.1.  This comparison was conducted to show the differences and similarities of the 
groups and to assure that no selection bias existed for the survey and interview groups.   
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Table 4.1 Participant Characteristics 
Participant Characteristics Main Study 
(n=78) 
Number (%) 
MHLC Survey 
(n=69) 
Number (%) 
Interview 
(n=57) 
Number (%) 
Gender    
Male 78 (100) 69 (100) 57 (100) 
Female 0 (0) 0 (0) 0 (0) 
Age, years     
Mean 59.4 60 60 
Range 25-79 25-79 25-79 
Years of HIV (+) diagnosis    
Mean 14.9 14.8 14.3 
Range 3-28 3-28 3-27 
Ethnicity    
        Non-Hispanic 70 (90) 61(88) 49 (86) 
        Hispanic 6 (7.5) 5 (7) 5 (9) 
        Unknown 2 (2.5) 3 (5) 3 (5) 
Self-reported Race    
       Black/African American 42 (54) 36(52) 28 (49) 
       White 29 (37) 26(38) 23 (40) 
       Unknown 7 (9) 7(10)  6 (11) 
Level of Education, highest 
completed 
   
       Elementary School 1 (1) 1 (1) 1 (2) 
       9th Grade 5 (6) 3 (4) 2 (3) 
       High School/GED 23 (30) 23 (33) 20 (35) 
       College 5 (6) 5 (7) 5 (9) 
       Unknown 44 (56) 37 (54) 29 (51) 
IDU    
      Current 0 (0) 0 (0) 0 (0) 
      History 40 (51) 35 (51) 27 (47) 
      No history 31 (40) 27 (39) 23 (40) 
      Unknown 7 (9) 7 (10)  7 (12) 
Alcohol Abuse    
      Current 4 (5) 4 (6) 4 (7) 
      History 38 (49) 33 (48) 27 (47) 
      No history 29 (37) 25 (36) 19 (33) 
      Unknown 7 (9) 7 (10)  7 (12) 
Mental Illness    
     Depression 30   (39) 26 (38) 19 (33) 
     Anxiety 12   (15) 12 (17) 11 (19) 
     PTSD 9    (10) 6 (8) 5 (9) 
     Schizophrenia 3    (4) 3 (4) 3 (5) 
     Bi-polar disease 1    (1) 1 (1) 1 (2) 
     1 or more psychiatric       39 (50) 33 (48) 26 (46) 70  
diagnoses 
Religious Affiliation 66 (85) 58 (84) 47 (83) 
Hepatitis C 41 (53) 35(51) 28 (49) 
Homelessness 3 (4) 3 (4) 2 (4) 
• Percentages may not equal 100 due to rounding. 
 
 
The analysis of the participant characteristics of the MHLC survey participants 
(n=69) is presented here because they are the focus of my research and the interview 
participants (n=57) are included within this group. Data from the interview participants 
(n=57) were used for my qualitative analysis.  These participants are a subset of the 
MHLC survey participant group and do not differ from the overall group in any 
significant characteristics. 
 The study population was homogeneous in terms of gender; all of the participants 
were men. There were only two women who participated in the Infectious Diseases 
Clinic for their HIV care at the time of the study but did not attend an HIV health care 
appointment during the main study enrollment. Women represent only 0.01% of the 
Infectious Diseases Clinic patient population.  The average age of the participants was 60 
years with a range of 25 to 79 years. The interquartile range was 50 to 64, which reflects 
an aging population living with HIV. The CDC has noted that 31% of those with HIV 
infection are over age 50 (Department of Health and Human Services Administration on 
Aging).  
 In terms of substance abuse, 51% of the participants have a history of IDU 
although none report current use. Current alcohol abuse was reported by only 6% of the 
participants but approximately half noted historical abuse. Data on substance abuse was 
collected in part because of the potential negative effects these conditions can have on 
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immune health, adherence to medication regimens, and other health issues. Co-
morbidities such as Hepatitis C infection and mental illness can have a detrimental effect 
on HIV infection that is often multiplicative.  
 Almost half  (48%) of the participants have more than one psychiatric diagnosis 
with depression being the most prevalent at 38%. This data was collected through 
medical record review indicating that there was a medical diagnosis. The incidence of 
serious mental illness is only 4% in the general U.S. population according to the National 
Institute on Mental Health. According to the U.S. Government Accountability Office, 
from 2006 through 2010, 38% of veterans of the most recent wars in Afghanistan and 
Iraq while 28% of all other veterans accessed mental health care at the VHA (U.S. GAO, 
2011). 
 An additional co-morbidity that affects immune health is Hepatitis C, which was  
 
diagnosed in 51% of the study participants. In terms of structural issues, 4% of the men 
 
had issues with housing. According to the 2013 Annual Homeless Assessment Report  
 
(AHAR) to Congress, veterans comprise 12% of the homeless population in the U.S.  
 
(U.S. Department of Housing and Urban Development, 2013). 
 
Informed Consent 
All patients enrolled in the study were asked to sign a consent form prior to the 
conduct of any of the study procedures. The consent form discussed the main study as 
well as the MHLC survey and the interview, both of which were optional. Patients could 
choose not to consent to the survey or the interview, which did not affect their 
participation in the main study. Patients who consented to participate in the interview 
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were also asked to sign the Department of Veterans Affairs Consent for Use of Picture 
and/or Voice Patients Form 10-3203.  
 
Data Collection Methodology 
 
Quantitative Method 
Multidimensional Health Locus of Control (MHLC) Form C  
All patients enrolled in the main study were asked to complete the 
Multidimensional Health Locus of Control (MHLC) Form C (Appendix A), which was 
customized for use with patients who are infected with HIV (Wallston and Wallston 
1978). This survey provides insight into whether people believe they are responsible for 
their health, whether health is under the control of others (e.g., physicians; powerful 
others such as God), or due to external forces such as fate or chance. Form C of the 
MHLC survey was designed to study people with chronic illnesses such as HIV infection 
and can be customized to reflect the disease being studied.  It is a validated tool with 18 
questions with response options based on a 6-point Likert scale. The scale has been 
determined to be moderately reliable based on Cronbach alphas in the .60-.75 range 
(Wallston 1993). 
There are four subscales within this survey, which are encompassed within two 
dimensions: 
 Internality, which is unidimensional, is the belief that one’s health status is 
 affected by one’s actions and behaviors (e.g., I am directly responsible for my 
 HIV getting better or worse)  
73  
Externality, which is multidimensional, and is comprised of the following 
 subscales: 
Chance – the belief one’s health status is affected by chance, luck, or fate. (e.g., 
 If my HIV worsens, it’s a matter of fate) 
Doctors – the belief that doctors determine one’s health. (e.g., Following my  
 doctor’s orders to the letter is the best way to keep my HIV from getting any 
 worse) 
Others is the belief that powerful others affect one’s health (e.g., friends, family, 
 God) (e.g., Other people play a big role in whether my condition improves, stays 
 the same, or gets worse) 
(Wallston, Stein, and Smith, 1994). 
For the purposes of this research, these constructs will be referred to as Internal HLOC, 
Chance HLOC, Doctor HLOC, and Others HLOC.  
 
The MHLC survey was administered from January to July 2011. Of the 78 
patients who enrolled in the main study, 69 completed the survey. I administered the 
MHLC surveys with occasional assistance from the PA-C who was another member of 
the research team. The following table (4.2) provides information regarding the number 
of participants and the reasons for lack of participation.  
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Table 4.2. Overview of Participation in MHLC Survey 
Main Study Participants n = 78 
Number of participants who completed a survey 69 
Number of participants who did not complete a 
survey 
9 
    Reasons for lack of participation  
            Passed away during study 3 
            Relocation 3 
            Lost to Follow Up 1 
            Unable to offer participation due to             
missed study visits 
1 
            Ineligible 1 
 
Qualitative Method 
Semi-Structured Interviews 
All patients who enrolled in the main study and consented to complete the MHLC 
survey were invited to participate in a semi-structured interview. The interviews allowed 
me to gain insight into the emic perspective of being infected with HIV and the concept 
of control of and responsibility for disease progression and overall health. The interview 
questions were developed to elicit information regarding the following constructs: 
• conceptualization of HIV (i.e., how do they think about it) 
• how do they think about and experience their illness 
• beliefs about responsibility for HIV  infection 
• beliefs about responsibility for health 
• beliefs about responsibility for disease progression (i.e., viral suppression)  
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• beliefs about ability to impact the course of the disease (i.e., affecting the  
  amount of virus; efficacy of antiretroviral medications; suppression of  
  HIV without medication). 
An interview guide (Appendix B) was developed to provide consistency of data 
collection during the interviews. The interviews were approximately 30-60 minutes in 
duration and took place in a private room in either the Specialty Care Clinic or a private 
office in the Department of ID at the patient’s convenience. A VA-approved recording 
device was utilized to audiotape the interview with the written consent of the participants 
and interview field notes were taken to augment the audiotape.  
I conducted all of the semi-structured interviews, which occurred between 
December 2010 and July 2011. Of the 78 patients who consented to the survey, 69 
completed it. I planned to conduct at least 30 interviews in order to achieve cultural 
saturation and gain insight into the shared beliefs of the population and the range of 
variability of these beliefs (Trotter et al., 2001). Over the course of conducting the 
interviews, it became apparent that the participants wanted the opportunity to talk about 
their illness, their beliefs, and their suffering. For many, their HIV infection was a secret 
that they only spoke with their health care providers about. They rarely talked to their 
providers about their illness and they seemed to savor the opportunity to talk to someone 
without fear. I decided early on to conduct interviews with all of the participants that 
consented to the interview. It hopefully was beneficial to the participants but it was 
definitely valuable for the research. Their stories, their lived experiences, and their 
schemas for thinking about their illness were very distinct.  
The following table provides information regarding the number of participants 
and the reasons for lack of participation.  
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Table 4.3.  Overview of Participation in the Semi-Structured Interview 
Main Study Participants  n = 78 
Number who participated in the   
interview 
57 
Number who did not participate in the 
interview 
21 
        Reasons for lack of participation  
     Passed away during study 3 
     Relocation 3 
     Lost to follow up 1 
     Unable to offer participation       
due to missed study visits  
2 
     Declined participation  7 
Consented but not able to     
schedule before end of study 
closure 
4 
     Ineligible 1 
 
It is important to note that the participants completed the survey, and frequently 
the interview as part of their study visit. Given that they typically waited for a period of 
time prior to their appointment with their HIV health care provider and then had their 
study visit, it was a considerable request to then ask them to review, discuss, and sign an 
informed consent form, then complete a survey, and potentially participate in an 
interview. It was a significant investment of time for which they received no 
compensation aside from the incentive payment for which they may have been eligible. 
They were always offered the opportunity to schedule the interview at a time that was 
more convenient and while some took advantage of this opportunity, many stayed and 
completed both study components. 
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Medical Record Review 
I also collected data through medical record review for each participant for 
characteristics that would provide descriptive information about the study participants in 
addition to insight into co-morbidities that impact the quality of life and create additional 
suffering of those infected with HIV. Information regarding the following variables was 
collected: 
• age 
• gender 
• self-reported race and ethnicity 
• number of years of HIV infection 
• diagnoses of mental illness  
o Number of diagnoses 
o Schizophrenia 
o Bipolar Disorder 
o Depression 
o Anxiety 
o Post-Traumatic Stress Disorder (PTSD) 
• Level of education 
• Hepatitis C infection 
• Current or history of intravenous drug use (IDU) 
• Current or history of alcohol abuse 
• Current or history of homelessness 
• Self-reported religious affiliation 
78  
Data collected as part of the main study, which were used as outcome data for this 
research included: 
• the number of monetary incentives the participant received over the course 
of the main study which served as the marker for viral suppression. This 
was the outcome measure for the ability to impact the course of their 
disease.  
• the number of study visits the participant attended over the course of the 
main study which corresponded to incentive care visits with their health 
care provider. This active participation in their health care served as a 
measure of responsibility for health. 
 
Analyses 
Overview 
 The mixed method analysis integrated data from ethnographic interviews and 
surveys assessing Health Locus of Control (HLOC) to describe how patients understand 
their illness, their beliefs about responsibility for health, and their perceived ability to 
affect their own health.  The data from the MHLC survey was analyzed to gain insight 
into HLOC and perceived responsibility for disease management and progression. The 
analysis of the qualitative data from the semi-structured interviews complemented the 
survey data by providing rich textual information to illuminate beliefs about illness, 
responsibility for disease management and health maintenance, and the perceived ability 
to impact the course of disease progression. Viral load data for the year of study was 
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utilized to analyze whether HLOC, and beliefs about responsibility and agency translate 
into HIV viral suppression, which impacts disease. 
 
Quantitative Analyses  
All analyses were performed using SAS software v9.2 (SAS Institute, Inc.). An 
alpha level of 0.05 was used to assess statistical significance. 
Data collected on the following variables were used in the analysis: 
• Patient characteristics  
o age 
o gender 
o self-reported race/ethnicity 
o years of HIV infection 
o level of education 
o diagnoses of mental illness 
o Hepatitis C infection 
o current or history of intravenous drug use (IDU) 
o current or history of alcohol abuse 
o current or history of homelessness 
• MHLC dimensions  
o Internal HLOC 
o Chance HLOC 
o Doctors HLOC 
o Others HLOC 
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• Outcome Variables 
o Incentives received (i.e., HIV Viral Load Suppression): the number 
of monetary incentives the participant received over the course of 
the main study which represented viral suppression and served as 
the proxy measure of the ability to impact disease progression.  For 
the analysis we dichotomized this outcome variable into those who 
always had viral suppression at all time points during the study 
year and those who did not always achieve viral suppression.  
o Visits attended (e.g., HIV Health Care Visits): the number of HIV 
Health Care Visits the participant attended over the course of the 
main study which corresponded to routine care visits with their 
health care provider. This served as a proxy for individual 
responsibility for one's own health.  For the analysis we 
dichotomized this outcome variable into those who always 
attended their HIV Health Care Visits and those who did not 
always attend all of their visits.   
 
The outcome data was available from the main study. I determined that the HIV 
viral load data would be an effective measure of impacting the course of the disease for 
this purposes of this research.  This is based on the fact that the main indicator of disease 
progression for HIV infection is viral load suppression. The choice of HIV Health Care 
Visits as a measure of responsibility is based on the importance of routine health care 
visits for monitoring disease progression. At the Infectious Diseases Clinic, patients are 
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expected to attend routine health care visits as determined by their health care provider. 
For the main study, patients were scheduled to see their health care provider every three 
months and to have a HIV viral load drawn prior to the visit so that the results would be 
available for the visit. Those individuals who assume responsibility for their health would 
be expected to attend these visits, which made them an effective marker for responsibility 
for the purpose of this research.  
A data dictionary was developed that defines the values for the variables (see 
Appendix C). 
The MHLC Form C was scored so that the HLOC data could be analyzed on both 
an individual and aggregate level. The median was used to determine the value that 
constituted a ‘high’ HLOC for each dimension (Wallston et al., 1994). Values above the 
median were considered a high HLOC for that dimension.  Descriptive analysis was 
performed including frequency and measures of variability. Based on these findings, 
further analysis was performed utilizing multivariate analysis. 
Chi Square analysis was conducted to determine if there was an association 
between the MHLC dimensions (Internal, Chance, Doctors, Others) and the outcome 
variables (i.e., All HIV Health Care Visits Attended/Not all Visits Attended; Always HIV 
Viral Load Suppression during the study year /Not Always HIV Viral Load Suppression 
during the study year).  
Univariate analysis was conducted to compare the relationship between the 
MHLC dimension variables (Internal HLOC, Chance HLOC, Doctor HLOC, Others 
HLOC) and the participant characteristics with the outcome variables. Odds Ratios and 
95% Confidence Intervals were calculated for the MHLC dimension variables and 
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participant characteristics to predict the outcomes of interest. The variables that were 
identified as significant (alpha=0.2) in the Univariate analysis were then utilized in a 
stepwise logistic regression analysis to identify what variables were independently 
associated with the outcomes variables. This multivariate logistic regression analysis was 
used to identify what variables predicted whether the participants: 
o received all of the incentives or missed at least one  incentive  
o attended all of the incentive visits or missed at least one. 
 
Qualitative Analyses 
The qualitative data obtained in the semi-structured interviews allowed me to tap 
into the emic perspective of people living with HIV infection and gain insight into beliefs 
about responsibility for health and the perceived ability to impact the course of the 
disease. I conducted all of the interviews and took interview notes in conjunction with 
audiotaping the interviews. I listened to the voice files repeatedly and read my interview 
notes to ground myself in the data. Relying on listening to the interviews rather than 
reading transcripts to do coding, allowed me to maintain a more human and subjective 
sense of the data. The voice inflections, the pain that was often evident in their voices, 
made the data more animate. 
In order to identify relevant themes and constructs, I created a matrix on an Excel 
spreadsheet that included, among other variables, responses to key interview questions 
and the descriptive characteristics obtained through medical record review. I was able to 
visualize the data through color-coding which facilitated in the identification of themes 
83  
and connections. The matrix was created to integrate the analysis of the qualitative and 
quantitative data and included the following variables: 
• responses to the key interview questions 
• the descriptive characteristics obtained through medical record review 
• the MHLC scores for the four dimensions (i.e., Internal HLOC; Chance 
HLOC; Doctors HLOC; Others HLOC) 
• the number of monetary incentives the participant received over the course 
of the main study which served as the marker for viral suppression 
• the number of incentive study visits the participant attended over the    
course of the main study which corresponded to routine care visits with 
their health care provider. This served as a marker for responsibility for 
health. 
 
Integrated Analysis of Qualitative and Quantitative Data 
The intent of the analysis was to determine if beliefs about responsibility for 
health and the ability to impact disease progression translate to positive outcomes (i.e.; 
HIV viral load suppression; active participation in health care). The quantitative data 
from the MHLC survey and the rich data from the semi-structured interviews provided 
information about how people infected with HIV think about their illness and the two 
constructs that are the foundation of this research. The MHLC data and the participant 
characteristic data were analyzed to determine if any of the variables impacted these 
outcome variables. It is the availability of outcome data that lends uniqueness to this 
research.   
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Chapter 5    Conceptualization – How do people with HIV infection  
  think about HIV? 
 
 
 In order to understand whether people infected with HIV believe they can impact 
their disease progression and what they believe about their own responsibility for their 
health, it is helpful to gain insight into how they conceptualize and experience their 
illness. How do they think about it? Do they think about it as anything other than a 
disease or a virus? Who or what do they believe is responsible for their acquisition of the 
virus?  I asked these questions of HIV-infected patients during semi-structured 
interviews, and my questions prompted narratives about their beliefs about disease 
causation, responsibility, stigma, and the trajectory of their illness.  
 
Thinking about HIV 
 
 In this section I discuss how people infected with HIV think about their illness 
and why some “don’t think about it”. 
 
 
"I don’t think about it." 
 
 Surprisingly, approximately one-third of the participants said that they don’t think 
about their HIV infection, but this response had many layers of meaning. For some it 
related to beliefs about the disease being controllable and its contemporary 
characterization as a “chronic” disease. In addition, with the increase in life expectancy 
for HIV infection, people are living relatively normal life spans and have begun to 
experience the co-morbidities and symptomology that come with aging. Thus, for many 
older HIV infected people, other medical conditions, including cardiovascular disease 
and diabetes, may have more immediate impact and sometimes overshadow the illness 
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stigma and marginalization of HIV disease throughout the epidemic has constructed an 
environment where HIV infection remains a “hidden thing” that can adversely affect 
health and quality of life and intensify the suffering that is part of the entirety of the 
illness experience.  
"It’s controllable".  
 
[I] Don't think about it. It’s controllable. At this stage it’s a positive thing 
that’s controllable. It’s up to me to do everything I need. Don’t think about 
HIV. Only focus on having meds and taking them.  
(African-American man in his 50s with HIV diagnosis for almost 20 years) 
 
 
 Some participants said that they don’t think about HIV because they think about 
their disease as being “under control” or “controllable”. Yet there are many nuances to 
beliefs about HIV infection being “controllable”. Most viewed “control” as a result of 
taking antiretroviral medications. They talked about the level of virus in the body 
decreasing or becoming non-detectable when taking antiretroviral medications and the 
importance of adherence. Suppression of their HIV viral load by adhering to treatment 
provided them evidence that their disease was controlled and that perhaps it was not 
important to worry about it. As this participant, who is one of the oldest patients and has 
been living with HIV infection for almost 20 years noted: 
 Medical science has prolonged life if you do what you’re told to do. 
 
 
 In contrast to the earlier years of the HIV epidemic, medication regimens are now 
less complex (lower pill burden) and more tolerable (fewer side effects) so they are easier 
to work into a daily routine. There are now single tablet regimens that consist of one pill 
that contains multiple antiretroviral medications. For those who are fortunate enough to 
have access to these medications and can tolerate them, HIV treatment is far less 
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cumbersome than it was a decade ago. Many who are infected with HIV are no longer 
living their lives around the disease. The prevalence of HIV-related symptoms and 
opportunistic infections has decreased to the extent that many patients are asymptomatic, 
which is expressed in the lived experience of not feeling sick and feeling like they can 
live a “normal life” as this man who is in his mid 60s with a 20 year history of HIV 
infection noted:  
People [are] dying every day, you know, from something. It [HIV] might 
be a death sentence but people with HIV are living longer than people that 
are healthy. 
 
 
 Some participants talked about knowing people who died because they hadn’t 
taken antiretroviral medications, had poor adherence, or had not changed risky behaviors 
or lifestyle choices (e.g., IDU; unprotected sex). This “survivor” perspective also 
contributes to the perception of the controllability of the disease, as noted by this 
survivor:  
So many people refuse treatment. They just ignore risky behavior and 
didn’t have opportunity to see death like I have.  
 
 
 Many patients recognize that “doing what I’m told to do” has allowed their 
disease to transition to a chronic state, at least biologically. As the participant quoted 
above suggests, older HIV patients have seen the horror of death in the early phase of the 
epidemic before effective drugs were available and may have greater adherence to their 
treatment because of this. 
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"I’m living with it." 
 
I really don’t think about it. I’ve had it for so long that I don’t give it any 
weight at all.   
(Caucasian man in his late 50s who has been diagnosed with HIV 
infection for almost 20 years) 
 
I had it so long, it is what it is. I’m living with it. I’m alive at least. 
(Younger participant who has had HIV infection for at least five years) 
 
  HIV as a Chronic Condition 
 
 The evolution of HIV infection within biomedicine and especially in developed 
countries from a deadly acute illness to one that is chronic is a shift from the old rhetoric 
that characterized the past decade. It has significantly reframed the disease for people 
infected with the virus as well as for the broader society. In the early days of the 
epidemic, HIV infection was viewed as a fatal illness although there was often a long 
period of latency during which most carriers were asymptomatic. Many of my 
participants talked about the disease as chronic, which for them had the connotation of 
manageability rather than fatality. People with HIV infection now talk about being able to 
live a normal life span.  
 This is also how HIV health care providers now talk about the disease with their 
patients, and this has encouraged those with access to HIV care and treatment to think 
differently about the disease. The participants used phrases such as “it’s no longer a death 
sentence” and as a disease that may be “someday curable”. One man in his 60s who has 
been diagnosed for over 10 years said that he thinks about it “less now because taking 
meds has been helping all these years.” This transition to thinking about the disease as 
chronic in the minds of those infected is also influenced by the length of time the 
individual has been infected with HIV. For the participants who consented to do the 
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interview component of the study, the average length of HIV infection was 14 years. This 
illuminates the extended illness experience that characterizes chronicity that the study 
participants have endured and helps us understand how they have integrated their illness 
into their lives to the extent that they don't need to think much about it.  As one of the 
younger participants who has had a diagnosis of HIV infection for only a few years said:  
Now it’s basically a part of me so there are days I wake up and forget I 
even have it. 
 
 
"It's a medical condition." 
 
 Some participants talked about HIV as a medical condition like diabetes, 
hypertension, or other “chronic” diseases. They talked about it as a “challenge” in terms 
of controlling viral loads and as something that they needed to learn to accept since it is 
not yet curable. This is the essence of chronic disease – it is not curable but is often 
controllable – and the affected must make the effort to control it. Thus, participants didn’t 
discuss or acknowledge distress or suffering due to HIV, but rather spoke about it as just 
another disease that they have integrated into their lives, but one that demands vigilance 
to control. As this participant notes, HIV is no longer experienced as a moral failing. It is 
a chronic disease: 
I have to live with it on a daily basis; have to accept it. It’s part of me. A 
challenge. It’s part of my life. I have to live with it. It’s a condition like diabetes 
or high blood pressure… something you have to live with and accept. I don’t 
think about it, it’s the cards dealt to you. 
(Caucasian man in his late 40s who has been diagnosed for over 10 years) 
 
 
"I have so many other things that now I forgot about this [HIV]." 
 
 Part of the chronicity component of long-term HIV infection is the presence of 
co-morbidities such as diabetes and hypertension. In the U.S., the population with HIV 
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infection is aging due to the availability and efficacy of antiretroviral therapy that has 
resulted in longer life expectancy. With this prolonged life span comes the risk of 
acquiring other conditions that are prevalent in non-HIV-infected, aging populations. 
Recent research has shown that people infected with HIV have higher levels of 
cardiovascular disease and liver disease, which is primarily related to comorbid Hepatitis 
C infection. The interesting twist in the history of HIV is that for those whose HIV 
infection is under control, non-AIDs related co-morbidities often become more 
worrisome than HIV, an idea that was unthinkable in the early phase of the epidemic. The 
comments below attest to this; 
  I don’t even think I have the virus anymore. I have old age problems. 
 (Caucasian man in his late 60s who has been diagnosed for a few years) 
 
 
I got everything. COPD (chronic obstructive pulmonary disease). I got heart 
trouble. I got leukemia. Have prostate cancer. So many other things that now I 
forgot about this. 
 (Caucasian man over 60 years of age who has been diagnosed for almost 20 
 years) 
 
Got so many things wrong with me. Diabetes. Too preoccupied with body pain 
 to think about it.” 
 (Hispanic man in his mid 50s who has had HIV infection for over 10 years) 
 
 
 “It’s a hidden thing.” 
 
It’s [having HIV] a hidden thing. I’m ashamed of it.  
(African-American man in his 60s who has been living with HIV infection for 
 almost 15 years) 
 
  HIV Stigma: Rejection and Isolation   
 
 Silence, secrecy, and isolation characterize the lives of many living with HIV 
infection. For many diseases (even with cancer, that was once as stigmatized as is HIV), 
it is expected and acceptable for people to talk about their illness as a means of dealing 
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with the stress of being ill. Talking about HIV, however, is not part of the acceptable 
discourse within society because of the enduring if somewhat irrational fears of contagion 
and the morality issues that hold people responsible for acquiring their disease. This 
constrains people from talking about their illness and sharing their fears and distress, 
ultimately increasing their suffering. 
 The social isolation and stigma of living with HIV infection is still an overarching 
theme for most of the participants and shaped their conceptualization of the disease. The 
need to hide or minimize the impact of HIV infection compared to other chronic 
comorbidities played a significant role in why they often don’t think about it and in how 
they think about it when they do. Many participants talked about how the social 
construction of the meaning of HIV contributed to how they viewed themselves as 
“dirty” and their appropriate interactions with others as though they were “untouchables.”  
 Given society’s still tangible fear of HIV transmission, continuing lack of 
knowledge, and moral judgments about those who are HIV-infected, many people with 
HIV/AIDS live in varying degrees of social isolation. Some do not tell anyone that they 
are infected with the virus, not even friends or family, for fear of rejection. Others who 
have disclosed their HIV infection, experienced rejection and decided to keep their 
disease a secret in the future. Many live in fear of exposure, which often results in the 
withdrawal of social support from family and friends that many with this disease still 
experience. The issue of stigma is still important in this epidemic because it increases the 
suffering of people who are infected and ultimately affects their quality of life. This 
perceived stigma results in feelings of social isolation and a need to keep HIV secret from 
others, including friends and family. This stigma and secrecy is ultimately internalized.  
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Stigma: Social Networks 
"People still have stigma on it. They have no idea that I’m one of them people." 
 Am I really that bad off where I really worry about people accepting or rejecting 
 me. You know am I really that bad? 
(African-American man in his mid 50s who has been living with HIV infection for 
almost 20 years) 
 
 The feelings of being ‘untouchable” and “dirty” and the fear of disclosure, 
affected the lives of most of the participants. Those who said that they had not disclosed 
their illness to anyone spoke about the need to isolate themselves. Most had not felt 
actual rejection or stigma but rather lived in fear of it. They have accepted the now dated 
societal view of the disease and those who have acquired it – that they are untouchables 
to be avoided and cast out. As this participant who has had HIV infection for eight years 
noted: 
People still have stigma on it. They still think that if you touch them then you 
catch it. If you kiss me you catch it. People are naïve about what HIV is. 
 
The participants were aware of the stigma of HIV. They referred to it. They internalized 
it. They lived in fear that people would find out they were “positive” (for HIV).  
[I] Don’t usually talk about it… It would ostracize [me from other] people. People 
I know would avoid me and talk about me. Family doesn’t know. From time to 
time it bothers me but don’t let it get me depressed. Meds received from the VA 
are helping me.  
 
I’ve learned I have to manage my own health. I can’t rely on anyone in this 
 regard. Isolate myself. Don't tell people I have HIV. 
(Caucasian man in his 60s who has only had HIV infection for a few years) 
 
 Many of the participants I interviewed had experienced telling a friend about their 
illness and then been distanced or rejected. Others had heard friends talking negatively 
and with a lack of compassion about people who were known to have HIV infection. 
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These experiences were a strong deterrent to disclosing their illness as this man in his 
mid 50s with a diagnosis of less than 10 years noted:  
Been around friends who have talked about it negative. Wouldn’t socialize with 
people like that and they deserve what they get and all this other stuff. They have 
no idea that I’m one of them people. 
 
One of the older participants who has been living with HIV infection for almost 20 years 
shared, 
 
 I had this HIV for the longest, all these years you know, and that’s a terrible 
 disease and I got through it alright. You know, can’t tell anybody, ya know. You 
 know if people find out they’ll be scared to come near you. 
 
  
 Many don’t even tell their families or partners for fear of rejection or 
disappointing them, as this man, who was diagnosed with HIV infection a few years ago, 
noted:  
 I think about people I hurt. My family by getting involved with drugs.  
 
 This fear of disclosure affected their social support system, often narrowing it to 
only the closest confidants as indicated by this participant:  
 People think bad about it. My wife and family know about it. No one 
  talks about it. 
 
 One participant said that he will only talk to people who are also infected. He has 
not disclosed his illness to his family but has a group of friends who have HIV infection. 
They support each other emotionally and make sure that each of them takes their 
medications and attends their health care appointments. He has created his own support 
system that only includes people that he identifies with and with whom he is comfortable. 
 Some don’t tell their family or friends because they’re concerned about further 
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disclosure to a wider social network, as this man in his 60s with a seven-year history of 
known HIV infection shared:  
Mother and sis don't know. Two of three kids know and someone at 
 work. Don't talk about it.  If I told my sis everyone would know. 
 If people knew they would treat me different… wouldn't believe  
how I got it. 
 
   
 One of the more significant themes in the participants' stories was that even 
though some had disclosed their illness to family members it did not create an 
environment of support. I asked why they didn’t talk about it with the people who did 
know, and most said that their family members didn’t bring it up in conversation, didn’t 
ask them about their illness or how they were feeling. One said that his mother would 
occasionally ask if he was taking his medications but there was no other discussion. They 
perceived this as discomfort and disapproval. It’s hard to conceive of having a serious 
illness, one that is often fatal, and not feel comfortable talking about it to those who are 
closest to you -- your family, significant others, and friends -- or have them ask you how 
you are feeling, simply showing concern. They were not able to articulate why they 
didn’t initiate conversations about their illness. Was it because they didn’t want to make 
their family or friends feel uncomfortable? Were they concerned about being rejected or 
judged? Most said it was because they didn’t think about the HIV. This denial is a 
significant component of “I don’t think about it”. It weakens patients' support systems, 
which ultimately increases their suffering, but they suffer silently. 
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Stigma: Sexual and Romantic Relationships 
 
"It was so devastating to tell her I was HIV positive. It ended the relationship."  
 
 The rejection participants faced from others is intensified in the context of 
romantic relationships. This is exacerbated by the perception that they may have 
potentially infected a partner or that a partner infected them.  Because HIV transmission 
is related to bodily fluids, it constrains sexual interactions that ultimately affect romantic 
relationships. In particular, some are inhibited about or simply reject engaging in intimate 
and romantic relationships. At the very least they are constrained in the expression of 
sexual and romantic needs, as this man who is in his 50s and was diagnosed with HIV 
infection almost 10 years ago said: 
When I first got it I thought I was a disgusting human being. I  
thought I was pretty repulsive. I happened to be going out with the  
woman who I loved and I, I really loved her and she is one of the  
most beautiful women that I have ever met and I got tested because 
of her, because of my love for her and it was so devastating to tell  
her I was HIV positive. Uh, it kinda ended the relationship. We both 
cried and I told her not to worry about it. I felt pretty disgusting as a  
human being.  
 
This is not an unusual scenario. The majority of the participants talked about their 
relationships or the lack thereof, as this African-American man in his 50s said:  
 
I’m not in a relationship. Have to tell [HIV status] someone you’re 
intimate with. Worries me because if you have a fall-out with that  
person what’s private isn’t private anymore. 
 
 Many participants talked about constraining their romantic relationships or 
avoiding them altogether. The majority referred to relationships with women, only a few 
discussed relationships with other men. One man said that he only allows relationships 
with women to continue until the woman wants to move forward to a sexual relationship. 
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He ends the relationship at that point. He worries that if he discloses his HIV infection, 
and the relationship ends, that the woman will divulge the information to others, 
especially if she is angry or hurt. He said that most of his relationships are short-lived. 
Another man said that he doesn’t allow his relationships with women to become 
romantic. He tries to maintain a friendship with them, which he admits, is hard and the 
women eventually move on. He talked about holding hands with women but not letting it 
go further physically. Both of these men said that they were continually worried that the 
women would become suspicious when they didn’t initiate a sexual relationship. Other 
men had sexual relationships with women and talked about always using protection. The 
few that were in long-term relationships had told their partners about their infection. 
Others had protected sex with women but did not disclosure their infection. None of the 
men talked about having unprotected sex with women. They talked about protected sex 
being necessary not only to protect their partners but also to protect themselves from 
reinfection.  
 Figure 5.1 summarizes the factors that contribute to the concept of “I don’t think 
about it”. 
 
 
Figure 5.1.  “I don’t think about it.” Contributing Factors 
Stigma  Controllable Disease 
Chronicity Co-morbidities and  "old age problems" 
"I don't think about it" 
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 For many of the participants, “I don’t think about it” also means “I don’t talk 
about it”. While it seems that some of the participants did not think about HIV much 
because they believed their disease was under control, others had no one to talk to about 
their disease so they put it out of their minds. For most of the participants, the only 
person that they talked to about their illness was their HIV health care provider and other 
members of the health team as these patients noted: 
When I see Dr. X, it’s the only time I get to talk to someone about it. 
It’s a privacy thing. I know people who are open about it. “How do  
you do it?” Where do they get the courage? 
(African-American man in his mid 50s who has lived with HIV infection for 
almost 20 years. He also suffers with depression and anxiety.) 
 
 No one outside the medical profession knows I have this. I’ve not  
 told anyone in my family including my wife. 
  (Caucasian man who is well over 60 years of age who has been diagnosed for less 
  than 10 years) 
 
  
This fear of disclosure not only weakens participants' social support systems but also 
increases their reliance on their health care providers to whom they look not only for 
disease management but for someone, in some cases the only one, who accepts them 
without judgment.  
 
HIV as a Serious, Life-shortening Health Problem 
 
 While some participants seemed matter-of-fact about not thinking about their 
disease, a few said that they tried not to think about it. Thoughts of HIV brought on 
feelings of fear, anxiety, and stress. It’s a “death sentence”, a “slow kill”, a “deadly 
serious disease”, a “dangerous disease.” They also talked about the infection being 
controllable, which mitigated some of their fear and anxiety, but the beliefs about the 
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virus being a death sentence or shortening one’s life span were ever-present, as this man 
noted:  
 
When I think about it [HIV] I think about how I got it, I think about 
how it would shorten my life span. 
(African-American man in his late 50s who has been diagnosed for   
 almost 20 years) 
 
 Another participant, who is in his early 50s and has been diagnosed with HIV for 
over 20 years, said that he thinks about HIV every day. He looks back and thinks about 
how he could have avoided acquiring the virus and thinks ahead about how to get things 
done before he becomes incapacitated. Another man said:   
I try not to think about it. It can kill me. It scares me. 
(African-American man in his late 40s who has had a diagnosis of HIV 
 infection for almost 15 years) 
 
 
 Many participants, however, manage their anxiety about HIV by focusing on 
taking the medications rather than thinking about the disease. 
 This dual belief among participants about HIV/AIDS as both an imminently fatal 
disease and a chronic disease that, when controlled, allows the ability to live a normal 
lifespan is an interesting aspect of the epidemic. Both are ultimately true. Sometimes 
individual patients express both ideas; other times patients adhere to one or the other 
belief. This shifting in perception is likely due to many things – how long the person has 
been infected, their age, how well the viral load is controlled, and what other 
comorbidities are present as well as the symptoms that are produced. Ultimately, HIV 
will contribute many participants’ deaths. At the same time, however, successfully 
controlling viral load allows sufferers not to really think about it. This may also be the 
case with other chronic diseases like diabetes and heart disease, where life can be 
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prolonged, but eventually the disease or the interaction with, or exacerbation of, other 
comorbidities of aging will eventually cause death.   
 
HIV as a Consequence of Behavior  
 
"Certain consequences of your actions you will pay for the rest of your life."  
 
 When asked how they think about HIV, some participants told me that it was a 
consequence of their personal behavior or “bad” choices. Although they knew HIV was a 
disease, they believed that they somehow deserved their illness. Although no one 
explicitly called HIV a punishment, self-blame and personal responsibility were prevalent 
for those who talked about having had “wicked ways” or not doing what they were 
“supposed to do” as these men said: 
Paying for my ways, the wicked ways in the past, ya know, I can’t  
blame anybody else but myself so who do I blame? I did some bad  
things and this is my payment, my suffering. It’s a cross I have to bear. 
It most likely won’t kill me but it’s gonna make me hurt and that I have 
to deal with that. 
(African-American man in his early 40s who has been diagnosed for 
 approximately 15 years) 
 
 
 They talked about sharing needles for IDU and unprotected sex with multiple 
partners. Alcohol lowered their inhibitions and affected their behaviors and the choices 
they made about drug use and unprotected sex. Drugs, alcohol, and unprotected sex were 
their “wicked ways”. One participant said that it was a disease brought on by 
carelessness. Another man said that he got it because he was irresponsible; he “slept with 
lot of women, did a lot of drugs”. For those who talked about HIV as a consequence, 
personal responsibility for their behavior and choices was evident in how they articulated 
their illness, as these two men noted that for them HIV is:  
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What you get when you do things you’re not supposed to do. 
(African-American man in his fifties who has been diagnosed for approximately 5 
 years) 
 
Something I did to myself. Have to live with it. 
(Caucasian man in his 50’s who has been diagnosed for almost 20 years) 
 
 While the majority of the participants acquired the virus through IDU and/or risky 
sexual behavior, some took responsibility for their choices that shaped how they thought 
about their illness. This is not to say that for those men who believe that HIV is a 
consequence, that all of their choices were consciously made (i.e., risky sexual behavior 
under the influence of drugs and/or alcohol) or that they deserved to acquire the virus 
because of their choices. As these men said:  
I made bad choices in my youth…experimenting with drugs. It's my consequence 
 
I think about it as a poor choice in my life. 
(Caucasian man well over 60 years of age who has been diagnosed for less than 
 10 years) 
 
 This self blame is also a consequence as well but of a different sort – the result of 
our social construction of the epidemic that frames sufferers as worthy of blame or 
blameless depending on their route of infection. Thus, these men's beliefs reflect the 
dominant social construction of this disease. The men assumed responsibility for 
acquiring the infection because of the moral overtones that surround this disease. People 
who are infected with HIV are thought to deserve their illness because of their behavior 
and choices and they embody these beliefs by blaming themselves. 
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Misfortune “A Bad Thing” 
 
 In contrast to those who thought about HIV as a consequence of their “bad” 
behavior, were those participants who talked about HIV as a misfortune that happened to 
them: “It happened for a reason.” or as one of the oldest participants shared, 
That’s the cards that were dealt to you. That’s all when I first got  
it in (mid-1990s). I thought I was gonna die anyway, didn’t think  
I’d make a year, but I didn’t care then, the hell with it.  
 
 These beliefs have a connotation of fate and may be related to a personalistic 
explanation of disease causation rather than a naturalistic one. Participants who thought 
HIV was a misfortune also tended to say that they thought about HIV often. For some it’s 
a “daily disease” or one that they are aware of all the time. When asked how they think 
about HIV they called it a “plague”, a “road block” or a “life sentence”.  Others viewed it 
as a “bad disease” or an “uncurable disease” and thought that they “will die sooner” 
because of it. 
 
Spiritual Beliefs 
 
[HIV is] Something God put there cuz I was messing up. Hey, you 
gotta slow down. 
(An African-American man in his late-50s who has been living with HIV infection 
for less than 10 years) 
 
 
 For some participants spiritual beliefs shaped how they experienced their illness. 
Consistent with the Western religious beliefs they held or had been raised with, these 
participants referenced “God” or their “higher power”. They did not believe that HIV was 
a punishment from a higher power, but rather that there was a spiritual influence on their 
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illness. When they think about HIV, they feel that much of the power over their disease is 
not in their own hands, as these men said:  
 
…a lot to do with attitude. Don’t be stressed out, eat properly,  
exercise, take meds, being prayful. God can turn anything around. 
(An African-American man in his mid-50s who has been living with HIV infection 
for almost 20 years) 
 
 God has everything to do with my health. 
(African-American man in his mid-50s who has been diagnosed for over 20 
 years) 
 
 I pray. I'm a believer. I'll be gone when its time to go. I just 
 pray on it. 
(An African-American man, one of the oldest participants who has had the virus 
 for almost 20 years) 
 
To me it’s one of the consequences I have to pay because of my 
actions so, ya know, when it comes to God forgiving me or did God  
do this or allow this, no, it be because of my lifestyle. 
(An African-American man in his mid-fifties who has been living with HIV 
infection for almost 20 years) 
 
 Many of the participants who talked about the importance of faith and prayer felt 
that God could heal them at any time, as these men noted:   
It’s up to my higher power who decides to control it or get rid of it. 
 (Hispanic man in his 60s who has had HIV infection for almost10 years) 
 
Faith works with the meds. God heals. At any given time he could  
heal me. In meantime lean on science. 
(Hispanic man in his fifties who has been diagnosed for almost ten years) 
 
 
 None of the participants expressed the belief that their illness was a punishment 
from their spiritual power. An African-American man in his 50s who has had HIV 
infection for over 20 years said, 
 He (God) may allow certain things to happen to you to get your  
 attention but He’s not going to let something bad happen to you.  
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One man expressed a personalistic explanation for his illness this way:  
Spiritually I think it’s a demon that God didn’t put on me or wish 
on me. It was something because of my own actions. Play with fire  
you’re gonna get burned. 
(An African-American man in his mid-50s who has been living with HIV infection 
for almost 20 years) 
 
 
 
Illness Trajectory 
 
“The trajectory of chronic illness assimilates to a life course,  
contributing so intimately to the development of a particular  
life that illness becomes inseparable from life history. (Kleinman, 1988) 
 
 A common theme in how participants talked about HIV was the perspective of 
time. Many said “in the beginning” to explain how they felt differently about HIV when 
first diagnosed compared to the present. Given the average length of time the study 
population has had HIV infection, about 15 years, most have had the opportunity to live 
with their infection for well over a decade. 
 
In the beginning 
 
 Participants talked about being frightened, scared to death, and thought of the 
disease as a death sentence when they first found out about being infected with HIV as 
these men attest: 
When I first got it I was devastated. It was the end of the world.  
(African-American man in his mid-50s who has had HIV infection for almost 
 10 years) 
 
 Back then I thought it was a death sentence. Everybody I knew  
 that had it before me seemed to pass away shortly after…I didn’t  
 get sick for the first 15, 16 years. No side effects, nothing. 
(Caucasian man in his late 50s who has had HIV infection for almost 20 years) 
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 Indeed, there was little hope in the early days of the epidemic until well after the 
efficacy of HAART was identified in 1996. In the 1980s, people watched as others 
contracted the virus and died a rather horrible death because there was no effective 
treatment. When those who had experienced that era were diagnosed, it truly felt like a 
death sentence. Even as treatment became available, access to medications was limited to 
those who could afford it. For those who survived the early years of the epidemic or 
became infected after HAART became available, the ability to suppress the virus became 
a possibility. It allowed those infected with the virus to learn to survive. 
 
In the Present 
 
 Today, most HIV patients have learned to live with their illness; they have come 
to understand that the virus is likely to remain with them throughout their lives, much like 
other viruses. They have had the opportunity to see that the antiretroviral medications are 
effective with strict adherence, as these men indicated: 
I don’t give it [HIV] any weight. Back then, it was a death sentence. 
(Caucasian man in his late 50s who has had HIV infection for approximately 20 
 years) 
 
 
 It doesn’t bother me as much as it did when I first learned about  
it, that was back in the 70s. Had it almost 15 years. I’m doing as well 
as can be expected. 
(African-American man in his 40s) 
 
I think its hidden like chickenpox. It’s there but kept in check. 
 (An older participant who has had HIV infection for almost 10 years)  
 
 Participants talk about HIV infection as a disease they have to live with on a 
“daily basis”. Learning to accept their illness has been part of its trajectory. They talked a 
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lot about acceptance and the need to stay positive in order to survive. One man in his 
mid-50s with almost 20 years of living with HIV infection indicated: 
 
[It's] something you have to live with and accept. It is what it is.  
You got it, you got it. Didn’t feel like that in the beginning. 
  
An African-American man in his early 50s who has had a diagnosis of HIV for over 10 
years said, 
 [I] want to finally get rid of it. Millstone for 20 years. Didn't worry 
early on until I got sick. The doctor stood on the other side. Didn't  
want to touch you. Went few years before I saw a doctor. I had made 
a choice a few years back. Take meds or die…now it’s very little  
in the scheme of my life. 
 
 
Transformation 
 
 Some of the participants talked about the benefits of acquiring HIV, how it 
transformed their lives, their behaviors, and their social interactions, as this man noted: 
I’m better off with HIV. If not I might have gone on with a bad 
lifestyle. Grew up after I found out. 
(African-American man in his mid-50s living with HIV infection for almost 10 
years) 
 
 Many of the participants talked about how they have become more responsible in 
terms of their health and lifestyle choices. They changed their social environment, no 
longer associating with people who continued to participate in unhealthy and risky 
behaviors. HIV functioned as the proverbial “wake up call” prompting them to treat 
substance abuse, initiate healthy lifestyle choices, and understand the importance of 
protected sex. As this African-American man in his 50s who has been diagnosed for less 
than 10 years notes: 
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I really don’t think about it [HIV]. The only two times I think about 
it is in the morning and in the evening because those are the times that 
I have to take my medication. It has helped me to be very disciplined  
and other than that it’s not a burden. In fact HIV has kind of made me 
a better person, which is kind of weird to have a disease make you a  
better person but it makes me more responsible as when I view sex. I  
got HIV because I was irresponsible. I slept with a lot of women and I  
did a lot of drugs and I didn’t think I would get it.  
  
  
Other participants also talked about HIV helping to make them “a better person” as the 
following quotes show: 
 
[HIV] made me a better person. More responsible. I got it because 
I was irresponsible. Slept with a lot of women, did a lot of drugs.  
It changed my life.  
(African-American man in his mid-50s who has had HIV infection 
 for almost 10 years) 
 
It changed my life, made me more honest. More open with people 
about what was going on. 
(Caucasian man in his late 50s with a diagnosis of HIV infection 
for almost 20 years) 
 
 The transformative nature of illness has been discussed in relation to other 
illnesses. While HIV is transformative for some participants, for most it remains a deeply 
personal illness that is rarely shared within their social support system or even with others 
who have HIV infection.  
  Figure 5.2 provides a summary of some of the ways in which people infected with 
HIV come to understand their illness. It is multi-factorial and dynamic as is evident in the 
discussion of illness trajectory. The ways in which people conceptualize their disease 
frame and shape the illness experience. 
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                                 Figure 5.2. Conceptualization of HIV 
 
 
 
Visualizing HIV in the Body 
 
 To further understand how people infected with HIV infection think about their 
illness, I asked the participants questions about whether there were any visualizations or 
metaphors that they used to picture or talk about their disease. I was especially interested 
in militaristic metaphors that they might use to conceptualize their illness. Metaphors 
have been associated with other diseases such as cancer to visualize the immune system 
cells acting as an "army" to fight the cancer cells. Similar metaphors have been associated 
with HIV in terms of the white blood cells of the immune system “fighting” against the 
virus that has invaded the body. Some participants had difficulty understanding this line 
of questioning, and others said they didn’t “think about it that way.” Only one verbalized 
a visualization, saying that HIV was “like bug eating me from the inside out” and a few 
said they thought about it simply as a virus. Most of the participants just viewed HIV as a 
Conceptualization of  HIV Infection 
"I don't think about it" 
Death Sentence 
A consequence 
Misfortune Spiritual Beliefs 
Illness Trajectory 
Transformation 
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disease or medical condition that they had and did not report having visual images of 
precisely what was going on inside their bodies.   
 
Responsibility for Acquiring HIV Infection 
 People often search for a reason or a cause when they become ill to help make 
sense of their illness. Why me? What did I do to deserve this? Why now? (Erickson, 
2008)  I deliberately probed for participants' ideas about the cause of their infection to 
gain insight into beliefs about disease causation, the social construction of illness and 
responsibility, and how they think about, and come to understand their illness.  
 In this part of the interview I was mindful of making the participants 
uncomfortable. I didn’t want to infer that they were responsible in any way for acquiring 
the virus or to stimulate or exacerbate self-blame. Blaming people for acquiring HIV 
infection is a sentiment that has been prevalent and contributes to the suffering of those 
infected because of its moral overtones. I found that most participants answered quickly, 
without pausing for thought. This may be, in part, due to the frequency with which the 
question is asked as a part of health care to collect information about transmission. While 
this information is used for public health statistics, treatment decisions are not made 
based on transmission so it raises the question of why these data are necessary.  Not all 
infectious diseases warrant this question. When someone has a viral upper respiratory 
infection, they are not typically asked what they did to acquire the illness because the 
route of infection, the air we breathe, cannot be avoided. This highlights the social 
construction and resultant moral overtones that shape the illness experience of people 
with HIV infection.  
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 Most of the participants ascribed responsibility for their infection to themselves, 
their choices and lifestyle behaviors, and to other people. These beliefs were not 
independent and, for many, they were interdependent. Only a few of the men said they 
didn’t know how they acquired the virus and only one man said he didn’t “assign 
responsibility”.  
 
“Me. No one else.” 
 
 Most of the participants assumed personal responsibility for acquiring the virus. 
They talked about being “careless” or “stupid” and making “bad choices”. One man said, 
“No idea. I'm responsible.” These responses reflect a pattern of self-blame and an 
acceptance of their own “irresponsibility”. The lifestyle behaviors and choices that were 
discussed included sex and “promiscuity”, IDU, and alcohol use. 
 Unprotected sex was a prevalent theme. A few participants assumed full 
responsibility even though they believed that they had acquired the virus through sex 
with someone who was HIV positive and didn’t disclose the information as these men 
said: 
 
I put myself in that situation. My partner was positive. 
I didn't know. 
(Hispanic man in his late 50s living with HIV infection for over 20 years) 
 
Me, but with someone who didn't know they were infected. 
But I didn't take enough precautions. Responsibility is usually shared. 
 (Caucasian man well over 60 years of age with a diagnosis of HIV 
  infection for less than 10 years) 
 
Don't put blame anywhere. If any, on myself. I was too promiscuous. 
 (An African-American man well over 60 years of age who has  
been living with HIV infection for over 10 years) 
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 In contrast, some participants placed the onus of responsibility on their sexual 
partners. Absent from these explanations was the lack of protection during sex reflecting 
an unawareness of their role in not protecting themselves. These men's comments 
illustrate this pattern of blaming a partner: 
 
The person I caught it from is dead. I’m still living. 
 
My ex-girlfriend who died. 
 (African-American man in his early 50s who has been living with HIV infection 
for almost 20 years) 
 
Someone else who didn't tell me. 
 (Hispanic man in his early 50s who has been living with HIV infection for less 
than 10 years) 
 
 Sharing needles with IDUs was mentioned by many of the men. Of the 
participants who participated in the interview component of the study, almost half had a 
history of drug use. Many of those who mentioned IDU talked about it as a “choice”, not 
aware of the social structural factors that influence this behavior, as one of these men 
indicated: 
 I'm responsible totally. In my younger years I was involved  
in IV drugs. 99.9% sure that’s how I got infected. I was careless. 
(Hispanic man in his early 60s who has had a diagnosis of HIV infection for less 
than 10 years) 
 
I had choices. I shared syringes. I took a chance. 
(Caucasian man in his early 50s who has had a diagnosis of HIV infection for 
over 20 years) 
 
Needles. I know that's how I got it. I shared with someone who 
had AIDS. I knew they had it. Drugs controlled me. 
(Caucasian man in his early60 who has had a diagnosis of HIV infection for 
almost 15 years) 
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 Many of the participants noted a lifestyle of risk through substance use, IDU, 
alcohol, and unprotected sex. One man said, “Too much partying.” while another said, 
“Alcohol is one of main reasons I have it.” Some explained that the use of alcohol and 
drugs fostered an environment that exposed them to increased risk through sharing of 
needles and unprotected sex. The comments form the men below reflect this theme:  
The life I chose with drugs. 
(Caucasian man in his mid-50s who has had a diagnosis of HIV infection for 
almost 20 years)  
 
Needles; too many women. Too much drugs. 
(African-American man in his mid-50s who has been living with HIV infection for 
over 20 years) 
 
 Women. Sex. Needles. I was promiscuous.  I didn’t use protection. 
(African-American man well over age 60 who has been living with HIV infection 
for over 20 years) 
 
 Me. Sex; I let other things take control. Alcohol. I hold myself  
 responsible. I let others take control like alcohol. 
(Caucasian man in his late 40s who has been living with HIV infection for almost 
15 years) 
 
 Most of the participants expressed some degree of personal responsibility for 
acquiring HIV. Although they talked about drug and alcohol use as being responsible for 
their HIV infection, most expressed their own role in terms of lifestyle behaviors and 
decision-making. They assumed the negative connotations associated with alcohol and 
substance abuse and “promiscuity” and blamed themselves.  A man in his 50s who has 
had the virus for over 20 years said,  
 I was living a promiscuous life and I shouldn’t have been doing  
 half the things  that I was doing far as getting high and having sex 
 with all these females and not protecting myself, just promiscuous. 
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This reflects the moral judgments and “blaming the victim” mentality that has defined 
this disease since its inception and contributes to the social suffering of those afflicted. 
 Not one participant blamed God or a higher power for the illness but some talked 
about the power of prayer to assist with healing. None of the participants referred to HIV 
infection as a “punishment” for their behaviors and choices, but some viewed it as a 
“consequence” as previously discussed.  
 
Summary  
 
 The beliefs illuminated through the interviews shape the individual illness 
experience; the participants' personal agency and that of others, including spiritual 
beings. The participants take responsibility for their health and for acquiring the 
infection; they live in fear of disclosure and mortality or learn to accept their illness and 
live with it; they are often more troubled by the diseases of aging rather than HIV 
infection; and many live in secrecy and isolation, which exacerbates their suffering. 
Many say they “don’t think about it” but in truth, they experience “it” daily and suffer 
because of it. Most don’t think about it because they have no one to talk to about it or 
with whom to share their fears and their feelings. They fear disclosure and the anticipated 
rejection and discrimination that come with it. The nuanced meanings of “I don’t think 
about it” tell us that the social suffering caused by stigma plays a large part in how people 
infected with HIV think about, and experience their illness.  Table 5.1 provides a 
summary of the factors that shape the illness experience for people living with HIV 
infection. 
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Table 5.1.  HIV Infection: The Illness Experience 
 
 
 
 
 In the next chapter I shift to a discussion of the construct of responsibility for 
health related to HIV infection and participants' beliefs about their ability to impact the 
course of their disease using both quantitative data from the MHLC survey and 
qualitative data derived from the interviews. . 
 
   
Responsibility for Acquiring HIV Infection 
         Personal  
              “Bad” Choices  
                      Unprotected Sex 
                      Social network of risk 
              “Bad” Behavior 
                      Drug and/or Alcohol Impairment  
               Bad Luck 
         Spiritual entities (God, Higher Power) 
         
 Illness Experience 
         Vigilance with medication adherence 
         Health-enhancing behaviors 
         Chronic Illness 
         Co-morbidities 
         Stigma 
                Fear of disclosure and exposure 
                Social Isolation 
                Loneliness 
                Fear of relationships 
         Acceptance 
         Transformation 
 
Social Supports          
         Doctors and health care team 
         Family, Friends, Partners   
         Other people with HIV infection 
         Spiritual/religious beliefs  
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 Chapter 6    Locus of Control, Disease Management and HIV Viral   
Suppression 
 
 
Overview 
 
 Responsibility has become an overarching theme in health management for all 
Americans but in particular for people with chronic diseases. In chronic disease care, the 
onus of responsibility and care-taking shifts from the health care team, whose focus is 
treating the acute phase of the disease, to the individual, who must then take on various 
levels of daily self-care in order to minimize disease progression.  
 This chapter explores beliefs about responsibility for health, disease management, 
and personal ability to impact disease progression. I use both qualitative and quantitative 
research methods. The quantitative data are from the MHLC survey, which explores 
health locus of control and was completed by 69 participants, It helps us to understand 
whether people believe they are responsible for their own health (i.e., have an internal 
locus of control) or whether they have an external locus of control exemplified by the 
belief that health is under the control of others (e.g., physicians; higher power; God), that 
health is controlled by external forces such as fate or chance, or that heath is a 
combination of these beliefs. Qualitative data come from semi-structured personal 
interviews conducted with 57 participants in order to provide insight into the illness 
experience and beliefs about locus of control (i.e., beliefs about responsibility) both in 
terms of disease management and progression. In addition, HIV Health Care Visit 
Attendance data was used as a measure of personal responsibility for health. Attending 
routine HIV health care visits to monitor general health status and immune system health 
is viewed within biomedicine as a health-enhancing behavior. HIV viral load data, a 
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marker for disease suppression, were analyzed to determine whether beliefs about the 
ability to impact one’s disease were related to disease suppression in patients. The HIV 
viral load measures disease progression by letting the HIV health care provider and the 
patient know how much virus is actively circulating in the blood. HIV suppression is 
indicated by a non-detectable HIV viral load in the blood, although virons are still present 
in dormant state in particular body organs and tissues. Strict adherence to antiretroviral 
treatment has been shown to be effective in suppressing the virus resulting in a non-
detectable viral load. Thus, the ultimate goal in HIV treatment is to attain viral 
suppression, which has a positive effect on immune health by decreasing susceptibility to 
opportunistic infections but requires strict patient adherence to medications and follow-
up.  Moreover, viral suppression decreases infectiousness preventing HIV transmission 
by as much as 30-fold (Quinn et al., 2000). Thus it is reasonable to expect that 
individuals who assume personal responsibility for their health would engage in 
behaviors that would enhance their health such as adhering to medication regimens as 
evidenced by HIV viral load suppression. In the main study, the outcome data of HIV 
health care visits and viral load test results occurred at four time points over the course of 
the year on study. Participants optimally attended four HIV health care visits with their 
health care provider and had a HIV viral load test performed in conjunction with each of 
these visits. These results are an objective measure of adherence and the construct of 
personal responsibility for health. 
 This chapter explores whether people who believe they have the ability to control 
the virus had a higher prevalence of adherence to health care visits and a higher rate of 
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suppressed HIV viral loads. A positive association would indicate that responsibility for 
health manifested itself in health-optimizing behavior.  
 This chapter discusses the quantitative analysis of the MHLC survey and the 
outcome data of HIV Health Care Visit Attendance and HIV Viral Load Suppression and 
the qualitative analysis of the interview data.  
 
Locus of Control and Disease Management: Results from the MHLC Form C 
Survey 
 
 The MHLC survey was administered to 69 Veterans who were participating in the 
main study. This survey measures four dimensions of health locus of control (HLOC) – 
internal (self), chance, or external (doctor and others). Scores on the first two dimensions 
range from 1 to 36 and on the second two dimensions from 1-18 as noted in Table 6.1, a 
high score indicating greater agreement with that dimension. 
Table 6.1. MHLC – HLOC Dimensions and Score Range 
MHLC 
Dimension 
Belief Score Range 
Internal The individual has responsibility for, 
and has the ability to control the course 
of their disease. 
1-36 
Chance The course of a disease is due to 
chance or fate and not under the 
control of the individual 
1-36 
Doctor Doctors are responsible for controlling 
a person’s disease 
1-18 
Others Other people or entities are responsible 
for controlling a person’s disease (e.g., 
family; partner; God) 
1-18 
  
   The median for each of the four health locus of control (HLOC) dimensions was 
calculated (Table 6.2) and was used as the cut-off value to dichotomize the data into high 
and low HLOC scores (i.e., above and below the median) for each dimension (Wallston 
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et. al, 1994). This provides a reference for determining high and low scores in each of the 
four dimensions. For example, for the Internal HLOC, which has a median of 26, a low 
Internal HLOC score would be between 1 and 25 and a high score would be between 26 
to 36. Table 6.2 provides the mean, median, and range values calculated for each HLOC. 
This table provides information for both the survey and interview participant populations 
to show that there was little difference between the two groups, as the interview 
participants were a subset of the survey participant population. Table 6.3 provides the 
high and low ranges that were determined for all four HLOC dimensions.  
 
Table 6.2. MHLC Dimensions Scores for Participant Populations 
MHLC Dimension Survey 
Participants 
(n=69) 
Interview 
Participants 
(n=57) 
Internal HLOC 
score 
(range 1-36) 
  
    Mean 25.8 25.6 
    Median (IQR)          26 (21-31)          26 (20-31) 
    Range   11-36  11-36 
Chance HLOC score 
(range 1-36) 
  
    Mean 15.7 15.6 
    Median (IQR)          15 (11-21)         15 (11-20) 
    Range 5-36 5-34 
Doctor HLOC score 
(range 1-18) 
  
    Mean              15 15.5 
    Median (IQR)          17 (12-18)          17 (13-18) 
    Range 5-18 5-18 
Others HLOC score 
(range 1-18) 
  
    Mean 10.5 10.2 
    Median (IQR)        11 (8-13)        11 (8-13) 
    Range 3-18 3-18 
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Table 6.3.  MHLC High and Low Score Ranges for All Dimensions  
                   for Participant Population 
MHLC Dimension Low Score High Score 
Internal  1-25 26-36 
Chance 1-14 15-36 
Doctor 1-16 17-18 
Others 1-10 11-18 
  
 
 T-tests determined there were no significant differences between the two samples 
for the HLOC scores by selected participant characteristics. The results are noted in Table 
6.4 for the Internal HLOC scores and in Table 6.5 for the three dimensions that comprise 
the External HLOC.  The analysis showed that there was no significant difference 
between any of the participant characteristics for each of the four MHLC dimensions.  
Table 6.4. Comparisons of Internal MHLC by Selected Participant   
   Characteristics of Survey Participants 
Participant Characteristics 
(n=69) 
MHLC 
Internal 
Mean 
p-value* 
Self-reported Race  0.79 
Black/African American  (n=36) 25.7  
White  (n=26) 25.8  
IDU  0.39 
None      (n=27) 25.1  
History  (n=35) 26.7  
Alcohol Abuse  0.88 
None     (n=25) 26.6  
History  (n=33) 26.5  
Hepatitis C infection  0.59 
Yes  (n=35) 26.1  
No   (n=34) 25.5  
Depression  0.45 
Yes   (n=26) 25.1  
No    (n=43) 26.3  
Psychiatric Diagnoses  0.64 
 No diagnoses  (n=36) 26.1  
 1 or more diagnosis  (n=32) 25.5  
* Based on Wilcoxon Two-Sample Test 
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Table 6.5.  Comparisons of External HLOC by Selected Demographic   
Characteristics 
Population  
Characteristic 
(n=69) 
MHLC 
Chance 
Mean 
p-value MHLC 
Doctor 
Mean 
p-value MHLC  
Others 
Mean 
p-value 
Race  0.38  0.60  0.56 
      Black/African     
American  (n=36) 
15.8  15.0  10.3  
      White  (n=66) 14.9  15.6  10.9  
IDU  0.27  0.58  0.74 
      None    (n=27) 14.7  15.3  10.2  
      History (n=35) 16.3  15.6  10.5  
Alcohol Abuse  0.26  0.50  0.39 
      None     (n=25) 14.8  15.7  11.0  
      History  (n=33) 16.6  15.3    9.9  
Hepatitis C 
infection  
 0.95  0.55  0.73 
      Yes  (n=35) 15.8  15.7  10.4  
      No   (n=34) 15.6  15.0  10.6  
Psychiatric 
Diagnoses 
 0.92  0.77  0.44 
     No Diagnoses 
(n=36) 
15.9 
 
 15.4 
 
 10.3 
 
 
1 or More   
Diagnoses (n=32) 
15.4     15.2  10.8  
Depression  0.86  0.58  0.23 
     Yes  (n=26) 15.9  15.5  10.1  
     No   (n=43) 15.4  15.1  11.1  
 
 
 
MHLC and Adherence to Health Care Visit Attendance and HIV Viral Suppression 
 
 
 Table 6.6 provides basic data on the outcome variables for the survey and 
interview participants. Data for both the MHLC survey and interview participants are 
included to demonstrate that there were no apparent differences; in fact, the data are 
almost identical for both groups.  A little over half of the participants in both groups 
attended all of their HIV Health Care Visits and achieved HIV Viral Load Suppression 
over the course of the study year and almost all attended all of their HIV health care 
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visits. Regarding HIV Viral Load Suppression, 52-53% had a non-detectable viral load at 
all of the four time points during the course of the study year. Approximately one third of 
the participants achieved viral load suppression at 75% of the time points during the 
study year. The percentage of participants who had viral load suppression ≥ 50% of the 
time was only 19% and 8.5% respectively for the survey and interview participants. Thus, 
while adherence to visits was high, viral suppression was more variable. As discussed 
earlier there are many factors beyond adherence to visits and medication that can affect 
viral load. 
 
Table 6.6.  HIV Health Care Visit Attendance and HIV Viral Load Suppression  
        Data Over the Study Year* 
 Number  (%) 
who Attended all 
HIV Health Care 
Visits and had 
HIV Viral Load 
Suppression at 
all time points 
Number  (%) 
who Attended 
all HIV 
Health Care 
Visits 
 
Number and Percent with HIV 
Viral Load Suppression by 
Number of Time Points 
4/4 
time 
points 
3/4 
time 
points 
2/4 
time 
points 
1/4 
time 
points 
MHLC 
Survey 
Participants  
(n=69) 
36  (52%) 64  (93%) 36  
(52%) 
20  
(29%) 
8 
 (12%) 
5 
 (7%) 
Interview 
Participants 
(n=57) 
30  (53%) 54 (95%) 30  
(53%) 
17  
(30%) 
5  
(9%) 
5  
(9%) *  Note: 4 time points over the course of the study year for both HIV Health Care Visits and HIV viral load suppression. HIV suppression relates to a non-detectable viral load. 
 
 
To begin the investigation of the relationship of the MHLC dimensions to the 
outcome variables described in Table 6.6, Pearson’s correlation coefficients were used to 
determine the relationship of the four MHLC dimensions to the outcome variables of 
interest, HIV Health Care Visit Attendance and Viral Load Suppression over the course 
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of the study year. The analysis showed that for HIV Health Care Visit Attendance, only 
the Other HLOC dimension was borderline significantly associated with the outcome 
(Rho[ρ] = -.23; p-value=.06). Although this inverse association was weak it indicates that 
those participants who believed that other people or entities control the course of their 
disease (i.e., high Other HLOC score between 11 and 18) were less likely to attend their 
HIV Health Care Visits, which represent personal responsibility for health in the context 
of this research. In relation to HIV Viral Load Suppression, the two HLOC dimensions 
that were significantly associated were the Chance HLOC (ρ =- .26; p-value=.03) (i.e., 
the course of their disease is determined by chance or fate) and the Doctor HLOC (ρ = 
.29; p-value=.02). These results indicate that participants who had a high Chance HLOC 
score (i.e., between 15 and 36) were less likely to achieve HIV Viral Load Suppression. 
They also suggest that a high Doctor HLOC score was associated with greater HIV Viral 
Load Suppression. Interestingly, there was no association between internal LOC and 
either of the outcome variables. 
 Chi Square tests were also conducted to determine whether there was an 
association between the MHLC dimensions and the outcome variables. The findings are 
represented in Tables 6.7 and 6.8. There was no statistically significant association 
between any of the HLOCs and the HIV Health Care Visit Attendance outcome variable. 
The only statistically significant finding for the HIV Viral Load Suppression outcome 
variable was the Chance HLOC for which a low score was related to higher suppression. 
There was also a trend (p=.12 but not significant at the .05 level) for higher scores on the 
Doctor HLOC to be related to greater viral suppression. These results suggest, overall, 
that rejection of Chance HLOC and embracing Doctor HLOC are the important factors in 
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the psychology of disease management among these veterans. Indeed, the role of doctors 
as health providers and perceived nonjudgmental witnesses may be a primary motivator 
for adherence.  
 
 
Table 6.7. HIV Health Care Visit Attendance Over the Study Year by Level of  
      MHLC Dimension 
MHLC Dimension Number  (%) 
All Visits Attended 
Number  (%)Not 
All Visits Attended 
p-value 
Internal HLOC   NS 
     High 33  (48%)  3   (4%)  
     Low 31  (45%) 2   (3%)  
Chance HLOC   NS 
     High 34 (49%)     3   (4.5%)  
     Low    30  (43.5%) 2   (3%)  
Doctor HLOC   NS 
     High 36   (52%) 2   (3%)  
     Low 28   (41%) 3   (4%)  
Others HLOC   NS 
     High 34  (49%) 4   (6%)  
     Low  30  (43.5%)   1   (1.5%)  
 
 
Table 6.8.  Viral Suppression Status Over the Study Year by Level of MHLC 
Dimension  
MHLC Dimension All Visits Attended Not All Visits 
Attended 
p-value 
Internal HLOC   0.71 
     High 18   (26%) 18    (26%)  
     Low 18   (26%) 15    (22%)  
Chance HLOC   0.01 
     High 14   (20%) 23   (33.5%)  
     Low 22   (32%) 10   (14.5%)  
Doctor HLOC   0.12 
     High 23   (33%) 15   (22%)  
     Low 13   (19%) 18   (26%)  
Others HLOC   0.76 
     High 18   (26%) 20   (29%)  
     Low 18   (26%) 13   (19%)  
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 Odds ratios were calculated to identify which MHLC and patient characteristics 
predicted the outcome variables (i.e., HIV Health Care Visit Attendance which represents 
responsibility for health, HIV Viral Load Suppression which is a measure of disease 
progression) (Table 6.9). The analysis showed that none of the MHLC dimensions (i.e., 
Internal, Chance, Doctor, Others) had a significant effect on HIV Health Care Visit 
Attendance. For participant characteristics (e.g., demographic information, IDU, alcohol 
abuse, Hepatitis C infection, psychiatric diagnoses), the only Years form HIV Diagnosis 
was a significant negative predictor for this outcome variable. The greater the length of 
time since HIV diagnosis, the less likely the participants were to attend all of their HIV 
Health Care Visits. In regards to HIV Viral Load Suppression, only the Chance HLOC 
dimension (i.e., control due to chance or fate) was a significant predictor of non-
adherence to scheduled visits. The data suggest a trend toward high Chance HLOC score 
i.e., control over disease assigned to chance or fate) was related to less likely HIV Viral 
Load Suppression.  However, none of the participant characteristics was significant for 
this outcome variable.  
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Table 6.9.  Odds Ratio for MHLC and Participant Characteristics  
(Significant results bolded).  
 Variable HIV Health Care Visits 
Attended 
OR ** (95% Confidence 
Interval) 
HIV Viral Load Suppression 
OR  (95% Confidence Interval) 
MHLC 
Variables 
    MHLC Internal 0.71    (0.11, 4.54) 0.83    (0.32, 2.15)   MHLC Chance 0.76  (0.12, 4.83) 0.28   (0.10, 0.75)   MHLC Doctor 1.93  (0.3, 12.34) 2.12  (0.81, 5.58)   MHLC Others 0.28   (0.03, 2.68) 0.65   (0.25, 1.69) 
Participant 
Characteristics 
    Age * 0.98 (0.88, 1.09) 1.01 (0.96, 1.07)   Race 0.71 (0.09, 5.37) 1.36 (0.49, 3.77)   Ethnicity *** 1.1 (0.35, 3.5)   Level of    Education 1.0 (0.56, 1.79) 1.34 (0.98, 1.84)   Years of HIV   Diagnosis * 0.81 (0.67, 0.99) 1.00 (0.93, 1.08)   IDU 1.32 (0.17, 10.3) 0.65 (0.24, 1.79)   Alcohol  Abuse 0.42 (0.04, 4.27) 0.63 (0.22, 1.80)  1 or >   Psychiatric   Diagnoses 0.21 (0.02, 1.96) 0.60 (0.23, 1.54)  Religious  Affiliation 0.22 (0.03, 1.46) 0.75 (0.21, 2.65)  Hepatitis C 0.67 (0.10, 4.26) 1.19 (0.46, 3.06)  Homelessness 0.42 (0.06, 2.85) 0.69 (0.14, 3.3) * Continuous variable.   
** Odds Ratio reflects increasing odds per units of variable.  
*** None of the participants in this ethnicity category met the No HIV Health Care Visit Attendance 
variable. 
 
 A stepwise logistic regression model was performed to predict whether the 
participants attended their HIV Health Care Visits and had HIV Viral Load Suppression 
based on the MHLC dimensions and participant characteristics. Variables with a p-value 
that was less than 0.2 significance in the univariate analysis were included in the 
multivariate models (Table 6.9). A conservative cut-off was established in order to 
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include those variables that might be associated and to exclude those variables for which 
an association is unlikely.  
 Variables included in the logistic regression analysis of HIV Health Care Visit 
Attendance (Table 6.9) were religious affiliation (p value 0.12), years of HIV diagnosis 
(p value 0.04), and having one or more psychiatric diagnoses (p value 0.17). As with the 
univariate analysis, only the Years of HIV Diagnosis remained significant in the model. 
The longer the participant had been diagnosed with HIV adherence to attendance at HIV 
Health Care Visits decreased. However, the sample size for this variable was very small 
as there were only five missed visits for all of the participants over the study year. This 
represents a 2% missed visit rate for this participant population. 
 In the logistic regression analysis of HIV Viral Load Suppression, the variables 
that were included in the models were level of education (p value 0.07), Chance HLOC 
(p value 0.01), and Doctor HLOC (p value 0.12). Only the Chance HLOC (i.e., control 
over disease assigned to chance or fate) emerged as a significant predictor of HIV Viral 
Load Suppression. Participants with a high Chance HLOC score were less likely to have 
HIV Viral Load Suppression. 
 
Table 6.10. Multivariate Logistic Regression Model for HIV Health Care Visit 
Attendance and HIV Viral Load Suppression  
Variable HIV Health Care Visit 
Attendance 
OR (95% Confidence 
Interval) 
HIV Viral Load 
Suppression 
OR (95% Confidence 
Interval) 
Chance HLOC NS 0.28 (0.10, 0.75) 
Years of HIV Diagnosis 0.81 (0.67, 0.99) NS 
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 In sum, for the most part, neither the MHLC dimensions nor the participant 
characteristics had a significant impact on the outcome variables of interest – adherence 
to HIV Health Care Visits and HIV Viral Load Suppression. For HIV Health Care Visit 
Attendance, the longer the participant was infected with HIV infection, the less likely he 
was to attend their HIV health care visits (Table 6.10). This may be related to beliefs 
about the controllability of the disease and its chronicity or simply after years of living 
with HIV to feeling that in the long run missing an appointment is not going to affect 
health significantly. Thus, patients may not adhere to their visit schedule if they feel that 
their disease is under control or they may be experiencing health care visit fatigue. In 
terms of the HIV Viral Load Suppression, it makes intuitive sense that those participants 
who believe that they have no control over their disease (i.e., high Chance HLOC score) 
would be less likely to have HIV Viral Load Suppression (Table 6.10). If an individual 
does not believe that he can impact the course of his disease, he may not engage in 
behaviors that would enhance viral suppression (i.e., adherence to antiretroviral 
medication).  
 
HIV Health Care Visit Attendance and HIV Viral Load Suppression Data By 
MHLC Dimension  
 
 Table 6.11 reflects how selected MHLC dimension scores relate to the outcome 
data of HIV Health Care Visit Attendance and HIV Viral Load Suppression. Data are 
presented for the number of participants who had a high score in each dimension in order 
to explore whether one or more dimension was dominant.  Although the number of high 
scores in each dimension is presented (i.e., Internal, Chance, Doctor, Others), some of 
these scores were in combination with other dimensions (e.g., high Internal HLOC, high 
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Chance HLOC, low Others HLOC). For example, a participant could have a high score in 
more than one dimension but each is counted separately in the first four rows of this 
table. Data are also presented for participants who had high or low scores in all four 
dimensions as well as for selected combinations of MHLC scores.  
 An overview of the data show that the number of high scores for each MHLC 
dimension was very similar with a range from 36 to 38. The percentages for higher visit 
attendance and viral load suppression were very similar among all four dimensions with 
the exception of the Chance HLOC dimension. The men who had a high Chance HLOC 
score were less likely to have HIV Viral Load Suppression at all time points during the 
study year, which is what was found in the quantitative analysis. The participants with 
high scores in the Doctor HLOC dimension had the highest percentages of HIV Health 
Care Visit Attendance and HIV Viral Load Suppression and were the least likely to have 
at least one episode of viral non-suppression.  
 In addition, data for those participants who had high scores or low scores in all 
dimensions are included. Although the numbers are small, those participants who had 
high scores in all of the MHLC dimensions had a higher occurrence of a missed health 
care appointment and at least one episode of viral non-suppression than those with low 
scores in all of the dimensions. For those with low scores in all of the MHLC dimensions, 
there was a higher incidence of viral non-suppression although all of these participants 
attended all of their health care appointments. 
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Table 6.11. HIV Health Care Visit Attendance and HIV Viral Load Suppression 
Data By Selected MHLC Dimension Scores During the Study Year* 
MHLC 
Score 
Number  (%) who 
Attended all HIV 
Health Care Visits 
and had HIV Viral 
Load Suppression 
at all time points 
Number (%) who 
Attended all HIV 
Health Care Visits  
Number (%) with 
HIV Viral Load 
Suppression at all 
time points  
High 
Internal  (n=36)  19 (53%)  33 (92%)  19 (53%) High 
Chance (n=36)  22 (61%)  33 (92%)  14 (39%) High 
Doctor (n=38)  24 (63%)  36 (95%)  24 (63%) High 
Others (n=37)  19 (51%)  33 (89%)  19 51%) High all  dimensions (n=13) 6 (46%) 11 (85%) 6 (46%) Low all dimensions (n=9) 5 (56%) 9 (100%) 5 (56%) High  
Internal, 
Doctor, 
Others (n=7) 
5 (71%) 7 (100%) 5 (71%) 
High  
Internal, 
Doctor, 
Chance (n=4) 
2 (50%) 4 (100%) 2 (50%) 
High 
Chance 
Others (n=5) 
2 (40%) 4 (80%) 2 (40%) 
High 
Doctor 
Others (n=4) 
4 (100%) 4 (100%) 4 (100%) 
High 4 (100%) 4 (100%) 4 (100%) 128  
Doctor 
Internal (n=4) High 
Chance 
Internal (n=3) 
 1 (33%)  3 (100%)  1 (33%) 
*  Note: 4 time points over the course of the study year for both HIV Health Care Visits and HIV viral load suppression. HIV suppression relates to a non-detectable viral load. 
 
 
  
Responsibility for Disease Management and Viral Suppression: Results from Semi-
structured Interviews 
 
 In the semi-structured interviews I wanted to understand whether people infected 
with HIV believe that they are responsible for disease management and progression and 
overall health. Individuals who believe they have responsibility for their health would be 
expected to engage in behaviors that would enhance their health such as adhering to 
medication regimens. To elicit this information, the participants were asked who they 
thought was responsible for suppressing their HIV viral load. Do they think they are 
primarily responsible and if not, if anyone or anything else was primarily responsible? I 
also asked if HIV viral suppression (i.e., controlling their disease) made them feel 
successful. Given the moral overtones and perceived and enacted stigma associated with 
HIV infection, I wanted to know if they internalized the need to be responsible and 
translated that into feeling like a success or failure regarding viral suppression and would 
they use other qualifiers like “successful”, “failure”, “good” or “bad” in reference to 
themselves? 
 In the presentation of these data I was constrained in my freedom to include 
detailed characteristic and demographic information about participants to contextualize 
the quotes that are presented. The Infectious Diseases Clinic is small and the people who 
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participate in the clinic for their HIV care are distinct individuals. The rich detail that 
permeates their responses could potentially identify them to those who know them 
thereby creating more burden for them than they already carry due to their illness. Their 
words, without identifiers, provide a lens into their lives and illness experience. 
 
Responsibility for Viral Suppression 
Personal Responsibility 
 Approximately two-thirds of the participants expressed the belief that they were 
primarily responsible when their HIV viral load was suppressed. They were very clear 
about their beliefs about personal responsibility.  
 
It’s always an individual responsibility. 
 
One of the older participants who has had the virus for about 10 years related,  
 
Yes. I think so because I do what I'm told by the doctor. 
 
Absolutely because I take care of myself. 
(African-American man in his early 50’s who has been diagnosed for   
approximately 25 years)  
 
 Demonstrating responsibility by following instructions given by their health care 
provider was a common theme. They used phrases like “doing what I’m supposed 
 to do” and “doing what the doctor tells me to do”. Doctors, in addition to representing an 
authority figure, also served as a trusted person for their patients, because so many had 
little or no support system. This may be a major driver of their belief about responsibility 
and the significant role of the health care provider. Following orders was also expressed 
in militaristic terms by a few participants; “army discipline” and “obey the rules and 
regulations”. This was the only context in which any reference was directly made to their 
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military background, but the comments about doing what they’re “supposed to do” and 
what they are “told to do” may reflect this influence. Some also referred to the VA health 
care system and the need to follow the rules expressing concern that failure to do so 
might jeopardize their entitlements. One man, well over 60 years old, who has lived with 
HIV infection for almost 20 years said, 
 
First do exactly what I’m told to do by the doctor, don’t drink,  
smoke, get rest, don’t eat things I shouldn’t and eat things I should. 
 
An African-American man in his mid-50s, who has been diagnosed with HIV for at least 
two decades, said, 
 
I’m responsible for doing what I’m told to do. Dr. X tells me to 
take these medicines. Can’t take credit for myself. If up to me,  
probably wouldn’t take my meds. They encourage me to do it 
and that’s a lot. 
 
 
 Doing what they were told to do involves taking their antiretroviral medications, 
attending their HIV health care appointments, and engaging in positive lifestyle behaviors 
like “eating right”, exercising, getting enough rest, and avoiding drugs and alcohol. They 
discussed medication adherence as a primary driver of viral suppression. One participant 
talked about his “compliance with medications” using biomedical language that he 
clearly absorbed from his health care provider.  Following doctors' orders is recognized 
as important in managing their illness. 
 The participants who believed that they were not responsible for viral suppression 
ascribed responsibility to the antiretroviral medications, their doctor, and their higher 
power or “God”. This reflects the nuances in belief systems; for those who believe in 
personal responsibility, it is their agency that enhances viral suppression while for those 
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who don't it is their doctors and the medications that impact disease progression rather 
than their own actions. As one participant, who assumes responsibility, said, 
The doctor can only say here's your meds. You have to take 
the meds every day. 
 
 I gained more insight into this understanding by probing whether there was 
anyone or anything else that may be primarily responsible for viral suppression. Some of 
the participants said that they shared the responsibility for suppressing the viral load with 
their doctors or attributed the suppressed virus to the antiretroviral medications. Others 
believed the responsibility for disease progression was not in their control but rather in 
the hands of others who included doctors, who were the most frequently mentioned, 
family and friends, and God or a higher power.  
Doctors as Motivators 
 
My doctor of course. That bond. The confidence you have  
between you and the doctor. 
 (Hispanic man in his late 50s who has been infected with HIV infection for over 
20 years) 
 
 A participant in his 60s with multiple psychiatric diagnoses and HIV infection for 
almost 15 years said, 
My doctor. The people who help me along.  I couldn't do it 
myself but it’s basically on my back. 
 
 The importance of trust and reliance on the physician is not surprising particularly 
in the face of chronic disease.  What emerged from my interviews was that this reliance 
was intensified when the disease is so stigmatized that it is often not shared outside of the 
clinic creating an environment with little social support for many of those who are 
infected. The participants talked about the secrecy of their HIV infection and not 
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speaking to anyone else about it except their health care provider. One man said that he 
couldn’t identify anyone else who is responsible because he keeps his illness hidden. 
I don’t speak about it to anyone else. Keep it to myself. 
 
 Some participants acknowledged that the VA health care system and its staff were 
responsible for their disease suppression.  A man well over 60 years of age, with the 
disease for almost 15 years, said, 
 
Very few things you do by yourself…the VA doctors, all the 
people the VA provides access to. 
 
 I’m lucky to have the VA or I’d be dead by now. I feel safe 
 when I’m here. 
 (Hispanic man in his 50s with a diagnosis of HIV infection for almost 20 years) 
 
 Although only a few of the participants mentioned the health care team, it is clear 
from spending time in the ID clinic that there are other people with whom the men are 
comfortable discussing their HIV infection. The clinic nurses, the ID administrative 
assistant who schedules appointments and fields patient calls when clinic is not in 
session, and the PA-C are all available and willing to talk to the patients. Yet it is during 
the clinical appointment that much of the discussion of disease progression and 
management takes place. The time with the health care provider provides an opportunity 
to discuss other issues that impact health as well (e.g., smoking cessation; housing) and to 
talk openly about their disease and illness without fear of repercussions. 
 
Family and Friends as Social Support 
 
The significance of the social support system is clearly referenced in how the 
participants talked about who or what was responsible for the management of their 
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disease. This support system was primarily related to spouses and parents and, as this 
man indicated  
  
 
The people surrounding you who care about you regardless  
of who you are. 
 (An African-American man in his mid-50s who has had  
 HIV infection for less  than 10 years.) 
 
 One participant said that his mother reminded him to take his medications, and 
another man said that his “grandkids” were responsible because he wanted to live to see 
them grow up.  
 An African man in his 50s who has had HIV infection for only a few years said, 
 
My wife and family. They’re very supportive. That's helpful. 
 
My wife since I live with her. She knows and isn’t ignorant of the 
disease. It makes it easier. Don’t talk about it much. She accepts me.  
That’s the most important thing. 
 (A Caucasian man in his 50s who has been diagnosed with HIV for over 20 
 years) 
 
 Some of the men recognized that being “accepted” and cared about “regardless of 
who you are” had a profound effect on disease and health. They attributed viral 
suppression to their support system. This is particularly poignant given the stigma and 
marginalization that many people infected with HIV face and their lack of spouses or 
partners and family and friends to lean on. It is interesting to note that some of the 
participants have disclosed their illness to their families or significant others but indicated 
that no one talks about it like the man quoted above who said they “don’t talk about it 
much”. He seems to value acceptance more than being able to talk about his illness. 
Optimally, though, the ideal environment would allow people feel accepted and also be 
able to share thoughts, feelings, and the burden of the illness. 
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Spiritual Beliefs: God and Higher Power  
 
 For some of the men I interviewed success or failure at viral suppression was 
ascribed to fate, but for most of them it was about faith. This is not surprisingly given that 
85% ascribed to a religious affiliation, mostly Christian. Approximately one-third of the 
men I spoke with talked about God in relation to their illness. Of the participants who 
talked about God, approximately three-quarters were African-American and over half of 
this group had been infected with HIV for two decades. There were only a few Hispanic 
men who talked about God but they represent almost half of that ethnic group in the 
participant population. The following quotes illustrate their reliance on God: 
 Just me and God 
(A man well over 60 years of age who has been diagnosed with HIV infection for 
 almost 20 years) 
 
God has everything to do with my life as far as my health is concerned. I have no 
control over it. 
 
God. Who could do what he does? 
(African-American man in his mid-50s who has been diagnosed with HIV 
infection for almost 25 years) 
 
 Some of the men believed that they had no control over their disease or health, 
while others said that they shared the responsibility with God or a higher power. 
 
I realize that it’s something I have to accept and it’s up to my  
higher power and my doctor to control it or get rid of it. 
 (Hispanic man in his 60s who has been diagnosed with HIV infection for less 
 than 10 years) 
 
 An African-American man in his mid-50s who has been diagnosed with HIV 
infection for almost 25 years believed the responsibility was shared between God and the 
medical team expressing that he had no control. 
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God has everything to do with my health; along with the doctor 
and nurses. I have no control over it. 
 
 Another African-American man in his early 50s who has been diagnosed for   
approximately 25 years had a holistic perspective about managing his disease,  
 
“God, the medical team, my family, the whole picture. Well I 
can go into my spiritual thing. I pray and thank God on a daily  
basis but with the medical team and the love of my family helps.  
It's the whole picture. I have a lot of support, tremendous amount.  
It makes a difference. It affects your attitude, how you view yourself.” 
  
Feelings about Successful and Unsuccessful Viral Suppression  
 
 I was curious about how the men responded to successful and unsuccessful viral 
load suppression and asked them directly about this in the interviews. To understand the 
nuances of belief systems related to responsibility, I asked whether they felt successful 
when their HIV viral load was suppressed and paid careful attention to the use of words 
like “success”, “failure”, “good”, or “bad” when they discussing their agency and disease 
progression. Society tends to “blame” people for acquiring the disease based on lifestyle 
choices so the use of these words might elucidate whether people infected with the virus 
internalized this “blame” if their virus was not suppressed. 
  
Feelings of Success 
 Some of the participants clearly felt a sense of success and accomplishment in 
relation to viral load suppression and talked about the importance of having a positive 
attitude, as this man noted: 
 
Yes. From day one I feel very successful because people who  136  
contracted the disease, they're dead in less time than I had it  
and I'm still here. 
(African-American man well over 60 years of age who has been diagnosed for   
 almost 20 years) 
 
 Another man in his 50s, who has been infected for over 10 years, said,  
 
I’m keeping the virus under control. I was told early on to have 
a positive attitude so I would have positive outcomes. 
 
I tell myself I'm standing up against HIV. I laugh to myself a lot  
because I got the best of it. 
 (Caucasian man in his 60s with HIV infection for over a decade) 
 
 Some of the men used words like “good,” reflecting their need to be good and “to 
do what I’m told to do.”  They expressed feeling proud of themselves for doing the “right 
thing” lending some insight into the common theme of having made “bad” choices in the 
past.   
It makes me feel good. Proud of myself. I’m doing the right thing.  
share with the whole family, my wife, my sister, my son. 
(African-American man in his early 50s who has been diagnosed for over 25 
 years)  
 
I do. Doing something right for once in my life. Doing good. 
(African-American man in his mid-50s who has been diagnosed for over 20
 years) 
  
  
 
Feelings of Gratitude 
  
 A number of the participants expressed gratitude rather than feelings of pride or 
success in relation to viral suppression. One man in his 60s, who has had the infection for 
a decade, said that it wasn’t a “success-failure thing” but that he just felt grateful. 
Another man who has been infected with HIV for over 20 years said that when his viral 
load was non-detectable he “got to live another day”. Some talked about “doing what I 
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need to do to survive” referring to both adherence to and the effectiveness of the 
medications. Some of the participants talked about having watched others die who didn’t 
have access to treatment, hadn’t been adherent to their antiretroviral medication, or had 
continued to participate in risky behaviors. This “survivor” perspective has created an 
awareness of feeling grateful. 
Yes because I know a lot of people who didn’t survive. 
(African-American man in his early 50s who has been diagnosed for   
over 25 years)  
 
 
Not feeling successful 
 
 There were some participants who said that they did not feel successful despite 
having a non-detectable viral load. This may reflect their realization that viral 
suppression is not easy to achieve and that viral resistance often occurs in spite of 
medication adherence leading to disease progression. Many of the participants had a least 
one episode of viral non-suppression over the course of the study year. One man said that 
he doesn’t feel successful but feels less worried while another said it was “part of God's 
plan.” A Caucasian participant in his 50s who had the infection for over 20 years said,  
No, I’m just glad the med I'm now taking is strong enough 
to make me not get sicker. 
 
No. I feel I’m doing the best I can do under situation. Not 
jumping for joy. 
(African-American man in his 60s who has been diagnosed for   
almost 10 years) 
 
 
Feelings when Viral Load Is Not Suppressed 
 
 I also asked the participants how they felt when they were not successful in 
suppressing their viral load, what they thought was responsible for failure, and whether 
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they felt they had failed themselves or others.  Approximately half of the participants said 
that they would feel responsible if their viral load was not suppressed like this man:  
Me. That’s me because of something I did wrong. 
 (African-American man in his 40s who was diagnosed with HIV infection over 
 10 years ago) 
 
 Many men had experienced a detectable viral load at some point during their 
illness and most related it to non-adherence to their medication regimens. This reiterates 
the strong sense of responsibility that many people with HIV infection feel to manage 
their illness. They not only feel responsible for positive results but also take responsibility 
when the outcome is not favorable. It was not completely clear that all of the men were 
aware that viral non-suppression can occur even with strict adherence to medication 
regimens.  One participant, who is in his 50s, with multiple psychiatric diagnoses and 
Hepatitis C, said, 
I start recollecting about missed doses. Not much you can do 
when you miss a dose. Just be aware. It's not deliberate. I take  
so many meds you just forget. 
 
An African-American man who was one of the oldest participants, and has had HIV 
infection for almost two decades said, 
 
I didn't take meds on time. I was disobedient to myself, not 
the doctor. The doctor told me what to do. I took a gamble.  
Thought I didn't need it but I do. 
 
 A few believed that they had some responsibility but that viral resistance was also 
a factor. This is in contrast to those participants who took full responsibility for viral 
suppression despite the fact that they cannot fully control the virus.  
I don't know what caused it. Is my body immune to drugs?  
Did I do something wrong? Combination of both. 
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(An Hispanic man in his late 50s who has been diagnosed for over two decades)  
 
60% me; 40% resistance. 
(African man in his 50s who has had HIV infection for almost a decade) 
 
The participants who did not assume responsibility for a detectable viral load 
ascribed failure to suppress to lack of efficacy of the antiretroviral medications or the 
virus “becoming more aggressive”, which relates to viral resistance. Their sense of 
responsibility is mediated by the reality that viral suppression is difficult to achieve and 
maintain.  A few of the men assigned responsibility to fate believing that they have no 
control over disease progression. One of the men said, “No. Fate. It is what it is”.  None 
of the participants blamed other people, their doctors, or God; they blamed themselves 
and fate.  
  A man who is in his late 50s who has been diagnosed with HIV infection for a 
few years said, 
 
No just the med. It happened when the meds stopped working.  
I don’t get depressed.  Even sickness builds resistance. I just took  
a different med and I knew the doctor will do the right thing. Me  
and my doctor, we’re partners. I do my part and he does his part. 
  
 
 Approximately a third of the participants said that they held only themselves 
responsible when viral load was not suppressed. When asked if anything else could be 
responsible they said things like "just me" and "only me". These beliefs are present even 
though most have the understanding that HIV has the ability to mutate and become 
resistant to the antiretroviral medications. Although viral resistance is more common in 
the presence of non-adherence to medications, it can also occur in people who are strictly 
adherent to their medication regimen. The sense of responsibility is compelling in view of 
140  
the medical uncertainty of effectively controlling the virus and the deeply rooted cultural 
ideology about individual responsibility. 
 Others believed that they shared responsibility for non-suppression with their 
doctors and the antiretroviral medications themselves. Some thought that the medications 
were “not strong enough” or were “not working anymore”. This reflects an understanding 
that viral resistance is often the reason for a detectable HIV viral load. A Caucasian man 
in his 60s who has been diagnosed with HIV infection for almost 15 years said, 
 
No, because I would see if I missed a dose here and there but 
I don’t. Maybe the pills aren’t working anymore. 
 
A man who is in his 50s who has lived with HIV infection for over 20 years attributed 
disease progression to the failure of his body to suppress the virus. 
  
No, my body. Me, myself, no, because since I decided to fight 
this. I take my meds at the right time. I don't like losing…me  
against this virus. 
 
 For others, responsibility fell to their mental illness or addictions. A few talked 
about their alcohol abuse while one man discussed his addiction to sex which he thought 
impacted his ability to fight the virus.  Although he did not have a clinical diagnosis of 
depression, one man in his mid-50s who has had HIV infection for over five years, said,  
...could be depression that's partly responsible. 
 
Other participants believed that suppressing the virus is not under their control. An  
African-American man in his mid-60s who has long-standing HIV infection expressed, 
 
God. Higher power. What's going to be will be. Doing what 
I need to do to keep on positive track. 
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Feelings of Failure with Viral Non-suppression 
 
 Participants' responses to my questions about whether failure to suppress the virus 
made them feel like a failure to themselves or others indicated that only a small number 
felt a sense of failure when their viral load was not suppressed. They voiced 
responsibility for management of their disease even in the face of other contributing 
factors like viral resistance. One man believed he was responsible because he knew he 
had not been strictly adherent to his medication regimen. Another talked about failing his 
family, friends, and doctor stating that everyone tried to help but it was his fault that his 
viral load was detectable.  
  
Certainly I feel failure because I’m the one responsible for the  
virus in my body so I’m a failure that it’s there but as far as the 
 progression of the viral load, that’s something I have tried to  
control. Then if it gets detectable then it’s because I’m not being  
treated properly. 
  
  
Of course, because I don't want to fail. It's a function of the  
strength of the virus versus the treatment available. There's only 
so much I can do. 
 
Me or the meds. I failed or something failed like the drugs. 
 (An Hispanic man who is in his mid-fifties and has been diagnosed with HIV 
 infection for over two decades) 
 
 An African-American man in his late fifties who has been diagnosed for less than 
ten years said,  
 No, just stupid. All I had to do was take the medicine. 
 
We're responsible for our problem. The doctor helps you but the  
problem is yours. 
(An Hispanic man in his mid-50s who has been living with HIV infection for a few 
years) 
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Interestingly, though, the pervasive response from participants was denial of the feeling 
of failure. They attributed disease progression to factors outside of their control such as 
viral mutations, God, and fate.  
No, I always take my med. I can't affect the way the meds 
work in my body. 
 
A Caucasian man in his 60s who has had HIV infection for at least 15 years said,  
 
No, its just part of life. I also believe HIV has a mind and a will  
of it’s own and I try to outsmart it. 
 
Gratitude surfaced again as a response to disease progression. One man, who is in his 
mid-50s with over 20 years of experience living with HIV infection, said with respect to 
feeling like a failure, 
 No, no, no…so many people passed away. I'm so grateful. 
 
Others did not relate to the concept of failure and viewed viral non-suppression as 
a call for action. An African-American man in his mid- 50s who has been diagnosed for  
less than 20 years used militaristic terms to discuss his response to failure to suppress: 
 
Ask what I need to do. Snap into line. Got to step it up. 
 
 
 In sum, the concept of responsibility peppers the narratives of most participants 
when talking about their illness; responsibility for their health and for disease 
management (i.e., viral suppression). Their relationship with their health care provider 
and their reliance on their spiritual entities are also significant elements of their belief 
systems. They talk about obedience; following their doctor’s orders and obeying the rules 
and regulations. This speaks in part to the authoritative role of the physician in the 
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biomedical system but may be also driven by their military background and the social and 
economic control of the VA health care system in their lives.  
 
Beliefs about the Ability to Impact Disease Progression 
 
 Through the interview process, I wanted to explore how the participants 
understood their illness experience and their role, if any, in trying to limit disability and 
disease progression.  In particular, I asked whether they felt they had the ability to impact 
the course of their disease (i.e., have some control over it) and how that related to  
engaging in health optimizing behaviors. I also wanted to understand whether people who 
do not believe they have control over disease progression still try to impact it’s course as 
opposed to becoming fatalistic about the outcome. These questions were raised with the 
understanding that beliefs and any related agency may not successfully translate to 
disease suppression. 
 
Taking Medications, Living Healthy Lifestyles, Maintaining a Positive Attitude 
  Of the 57 men who participated in the interview component, well over half 
clearly expressed their belief that they could affect the amount of HIV in their blood. 
Some felt that they could do so with the help of medications, their doctor, and/or God. 
Only a small number talked about not having any control over their disease or that 
control was in the hands of others (e.g. doctor; God).  
 Among those who believed that some measure of control is possible, the themes 
discussed were similar to those that emerged when talking about responsibility for 
disease management: the importance of antiretroviral medication adherence; following 
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the instructions given by their health care providers; and making good lifestyle choices, 
as these men explained:  
Yes, I can, by taking the medicines and continuing to take care 
of myself and not doing what I used to do.”   
 (African-American man in his late 50s who has been diagnosed with HIV 
 infection for less than five years) 
 
If I don't take med. Drug interruptions a big thing a while ago.  
Didn't work out for me. 
 (African-American man in his early 50s who has been diagnosed with HIV 
 infection for over 10 years) 
 
I know I need to take my HIV medicine but it’s beyond that.  
You have to live healthy in every way, um, and what you do. Get  
up at a certain time, get enough sleep, get enough exercise, eat  
your food, pay your bills so there’s nothing stressful in your life.  
Don’t hang out with people who don’t do good things, use drugs  
or steal or get in trouble. 
 (African-American man in his early 50s who has been diagnosed with HIV 
 infection for less than 10 years) 
 
 
 According to many of the participants, impacting their disease was not only about 
positive actions, it was also about avoidance of behaviors and choices that could have 
adverse effects on their health and the disease. An awareness of the deleterious effects of 
alcohol and drug use was apparent, particularly in combination with antiretroviral 
medications. One man said, “drinking, drugs, not taking meds speeds it up.”  Another 
talked about being a “lifetime drug addict” and said “taking drugs affects how the meds 
work.”  
 A few of the men talked about avoiding behaviors that could potentially cause re-
infection. They have been educated, primarily by their HIV health care providers, about 
the risk of acquiring a different strain of HIV (i.e., a drug-resistant strain) through risky 
145  
behavior such as sharing needles or participating in unprotected sex.  One man said that 
he could impact his disease by a “lack of habits that cause reinfection”. 
 
 Only a few of the participants said that didn’t believe they could impact the 
course of their disease. “It’s too tricky.” One man said he could “make it better” by 
taking medications as a precaution but that disease management is the responsibility of 
the doctor. Another participant who is well over 60 years of age, with HIV infection for 
almost 20 years said that he could get “rid of it through faith if you have enough belief, 
enough faith.”   
 Many of the participants expressed an understanding of what they needed to do to 
impact the course of their disease. This likely reflects information that they have received 
from discussions with their health care providers as well as their personal experience with 
the disease. Many of these men have watched others who had not engaged in health-
optimizing behaviors and suffered deleterious effects or didn’t survive. 
 
Because you’re healthy and it affects your health and if your  
health is deteriorating then the virus has a free ride, but if your  
organs and your basic metabolism is a function of the exercise,  
the health and lifestyle you lead then the virus is going to be  
suppressed and is going to be contained by the regimen you’re on. 
 
If I were to drink or smoke, if I were sedentary and ate poorly,  
I think my viral load would go up tremendously regardless of  
the regimen. 
 
I take care of myself. I exercise. I don’t drink. No cigarettes.  
No drugs. My whole lifestyle is healthy. I’m better off with HIV.  
If not I might have gone on with a bad lifestyle. I grew up after I  
found out. 
 (African-American man in his early 50s who has been diagnosed with HIV 
 infection for less than 10 years) 
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 The men's beliefs about the importance of adherence to antiretroviral medications 
were predominant, which reflects a biomedical understanding and hence the influence of 
their doctors and other providers as well as their own experience. As previously noted, 
many of the men had experienced HIV viral progression when they had not been taking 
antiretroviral medication or had seen a similar effect with other people infected with the 
virus. They defined a healthy lifestyle as getting exercise and rest, eating a healthy diet, 
abstinence from drugs, alcohol, and tobacco. They also identified the importance of 
having a “positive attitude” or mindset.  
 Some of the things the participants talked about as health-enhancing included; 
“socialize with different people”; “follow doctor orders”; “don't do things detrimental to 
my health”; “continue to take meds. Pray. It helps you a lot.”; “No promiscuity, no drugs, 
no stress.”; “live healthy”; “safe sex…pray”; “living clean”. One man, in response to the 
question, replied, “hope”. 
 Table 6.12 summarizes the behaviors and lifestyle choices that emerged when the 
participants talked about impacting the course of their disease. Adherence to 
antiretroviral medications is only one piece of the “illness work” that people infected 
with HIV feel that they must to do to manage their disease.  
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Table 6.12.  Impacting HIV Infection 
Impacting HIV Infection 
Adherence               Antiretroviral Medications  Health care appointments  Prescribed medical orders 
 
Healthy Lifestyle   Diet  Rest  Exercise  Positive mindset 
 
Avoidance                             Stress  Drugs and alcohol  Smoking   Reinfection   Unprotected sex  Shared or old needles               People with risky behavior 
 
Prayer 
Hope 
 
 In sum, this line of questioning revealed that almost all of the men believed that 
there were measures and behaviors that they could undertake to impact disease 
progression and morbidity. This gave them a sense of hope and some control over their 
lives, which is important for those who are afflicted with a disease that is associated with 
significant mortality. The participants have been educated about their responsibilities 
related to suppressing the virus and optimizing their health. Strict adherence alone is 
difficult to achieve but to add the other lifestyle behaviors that they talk about multiplies 
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the self-care that is expected of them. Belief in the ability to impact HIV progression 
ultimately provides hope but also intensifies the burden of the person who is ill. 
 
Integration: Feelings about Personal Responsibility for Health and Disease 
Management Outcome Data 
 
 The following discussion reflects the analysis of the qualitative data from the 
semi-structured interviews with the outcome data (i.e., HIV health care visit attendance; 
HIV viral load suppression), which provides some insight into the potential translation of 
belief systems into agency. Quantifying qualitative data risks reductionism yet I believe 
that this quantitative information many enhance our understanding of how people think 
about their illness. In quantifying responses to the interview questions, I used only those 
responses that were definitively “yes” or “no” or  “me” as a preface to the rest of their 
answer to questions about responsibility. This analysis is not hard quantitative evidence 
but rather provides some information about how the participants talked about 
responsibility and impacting their disease and how their beliefs relate to adherence to 
care (i.e., HIV Health Care Visit Attendance, HIV Viral Load Suppression). 
 
Responsibility for Viral Load Suppression  
 Table 6.13 details the number of the participants who believed they were 
responsible for viral suppression and non-suppression and the extent to which they 
related to the concepts of success and failure.  
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 Table 6.13.   Participant Responses to Interview Questions related 
                       to Responsibility  
Interview Questions Related to 
Responsibility 
% Yes 
Response 
What do you think when your health care 
provider tells you your viral load (i.e., 
amount of virus in your blood) is well 
controlled? 
Do you think you are primarily 
responsible?  
61% 
Does this make you feel successful? 
 
56% 
What do you think when your health care 
provider tells you your viral load (i.e., 
amount of virus in your blood) is not being 
well controlled? 
Do you think you are primarily 
responsible?  
44% 
Does this make you feel like a failure? 
 
14% 
 
  
 The data show that 61% of the participants believe that they are responsible when 
their HIV viral load is suppressed suggesting that many believe in their ability to impact 
the course of disease progression. As previously discussed, many of the participants 
talked about the importance of taking antiretroviral medications as prescribed and 
participating in other positive lifestyle behaviors in suppressing the virus. Over half of the 
participants felt successful when their HIV viral load was suppressed which suggests that 
they believed their actions could impact the course of their disease and translated into 
positive results. This data suggests that many of the participants believe that they can 
impact the course of their disease through their actions and that when they receive 
positive results they feel that they are able to make a difference in their health status.  
 When asked about personal responsibility in relation to non-suppression of the 
virus, only 44% believed that they were responsible. As previously discussed, the 150  
participants felt that there were other reasons for non-suppression over which they had no 
control (e.g., viral resistance) which may help explain why only 14% felt as though they 
had failed when the virus was not suppressed. It is interesting to note that, in general, 
they felt successful when their HIV viral load was suppressed but did not feel like a 
failure if it was not suppressed. This may be an indication that they understand that viral 
load suppression is not completely under their control. Even with strict adherence, some 
people are unable to achieve a non-detectable HIV viral load due to their response to the 
medications or viral resistance among other factors. 
 Table 6.14 shows that of the participants who ascribed responsibility to 
themselves for viral load suppression, 60% had a non-detectable viral load during the 
entire year on study. All of these participants attended all of their HIV health care visits.  
Seven participants said that they did not believe they were responsible for HIV viral load 
suppression and of these men, only 43% had a suppressed viral load over the course of 
the study year and five of them (71%) attended all of their health care visits.  All of the 
participants were suppressed at some point during the study year. The remaining 
participants were either unclear in their response or believed that they shared 
responsibility for viral load suppression with others who included their doctor, family and 
significant others, and God. The data suggests that the participants, who believed they 
were responsible for viral suppression, also engaged in the health-enhancing behavior of 
attending their health care visits. The fact that 60% of these participants achieved 100% 
viral load suppression over the study year exceeds the result found by Braithwaite et al. 
(2010) of 40% in the U.S. Veteran population. 
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Table 6.14. Participant Beliefs about Responsibility for HIV Viral Suppression and 
Visit Adherence Outcome Data for Interview Participants Over the Study 
Year* 
Interview 
Participants  
n=57 
Number (%) 
Attended all HIV 
Health Care Visits 
Number (%) with HIV Viral Load 
Suppression 
4/4 
time 
points 
3/4 
time 
points 
2/4 
time 
points 
1/4 
time 
points 
Responsible for viral 
suppression 
35 (61%) 
 
35 (100%) 
 
21 (60) 
 
9 (26) 
 
1 (3) 
 
4(11) 
Not responsible for 
viral suppression 
7 (12%) 
 
5 (71%) 
 
3 (43) 
 
4 (57) 
 
0 
 
 
0 
 
Ambivalent or share 
responsibility for 
viral suppression 
15 (26%) 
 
14 (93%) 
 
 
6 (40) 
 
4 (27) 
 
4 (27) 
 
1 (6) 
* Note: 4 time points over the course of the study year for both HIV Health Care Visits and HIV viral load suppression. HIV suppression relates to a non-detectable viral load. 
** All of the participants achieved viral load suppression at some time point during the study year 
 
 
Beliefs about Impacting Disease Progression and Outcome Data 
 
 When asked whether they believed they could impact the amount of HIV in their 
blood, 63% of the participants responded affirmatively (Table 6.15). Of these men, 97% 
attended all of their HIV health care visits but only 58% had a suppressed viral load over 
the course of the study year. Of the 14% of participants who expressed a lack of ability to 
impact disease progression, only 50% achieved viral suppression and only three-quarters 
attended all of their HIV health care visits. Belief in the personal ability to impact disease 
progression seems to have a weaker effect on HIV viral load suppression than beliefs 
about responsibility for disease progression. It may be that beliefs about the ability to 
suppress the virus are mitigated by the illness experience and having had a non-
suppressed viral load in spite of adherence to medication regimens. There may also be 
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dissonance between beliefs about importance of positive lifestyle behaviors and choices 
and the ability to engage in those behaviors.  
 
  Table 6.15. Participant Beliefs about Impacting Disease Progression and Adherence          
Outcome Data 
Number (%) who 
believe they can 
impact disease 
progression 
Number (%) Attended 
all HIV Health Care 
Visits 
Number (%) with HIV Viral Load 
Suppression  
4/4 time 
points 
3/4 time 
points 
2/4 
time 
points 
1/4 
time 
points 
Yes  
36 (63%) 
35 (97) 21 (58) 8 (22) 5 (14) 2 (6) 
No    
8 (14%) 
6 (75) 4 (50) 3 (38) 0 1 (12) 
Ambivalent or unclear 
 13 (23%) 
13 (100) 5 (39) 6 (46)  0 2 (15) * Note: 4 time points over the course of the study year for both HIV Health Care Visits and HIV viral load suppression. HIV suppression relates to a non-detectable viral load 
 
 
Integrating Locus of Control, Attitudes towards Responsibility and Ability to Impact 
Disease, and Adherence Outcome Results 
  
 In this section I integrate the quantitative and qualitative results to gain some 
understanding of how people infected with HIV think about their illness and the construct 
of responsibility and then link these qualitative results with the locus of control (MHLC) 
and adherence outcome results. I include information on the number of years form HIV 
diagnosis to help further contextualize the data.   
 Among participants who had high scores in all of the MHLC dimensions 
(Internal, Chance, Doctor, Others), there was little consistency in how they talked about 
responsibility for disease progression. This reflects how the beliefs about locus of control 
can be concurrent. One man who has had the infection for 19 years said that it is “always 
an individual responsibility” but that the outcome is part of “God’s plan”. He had rarely 
missed any doses of antiretroviral medication but the virus was only suppressed at 75% 153  
of the time points. Another participant said that the responsibility for viral suppression 
belongs to the medications. This man has been infected with the virus for 17 years and 
missed one of the health care visits and had viral suppression at 75% of the time points. 
Another man who was diagnosed six years ago said that responsibility for disease 
progression was shared between him and “God”. He talked about HIV as a death 
sentence and said that when his viral load was detectable that it could be due to 
depression. He attended all of his health care visits but had viral suppression at only one 
of the time points. Overall, participants with high LOC scores showed little consistency 
in how they talked about responsibility and with whom they shared it.  
 Inconsistencies also exist with participants who had low scores for all of the 
MHLC dimensions. One participant who has had HIV infection for 10 years, expressed 
no beliefs about responsibility or the ability to impact disease progression but attended all 
of his health care visits and had consistent viral suppression. For him, HIV infection is 
“not a death sentence anymore.” He shared that his family doesn’t know about his illness 
and that he only talks about it to others who have HIV infection. Another man who has 
had HIV infection for the same period of time, expressed responsibility for his disease 
management and affirmed that he believed he could impact it. Although he attended all of 
his health care visits, he had viral suppression at only one of the four time points. He 
talked about the importance of his family support although this was not reflected in his 
MHLC Others score. One other participant with all low scores talked about responsibility 
for viral suppression but also had a non-detectable viral load at only one of the four time 
points. He was diagnosed with HIV infection 18 years ago and said, “they say it’s a death 
sentence”. 
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 There was more consistency for those participants with high MHLC Doctor 
scores. They talked about sharing responsibility for disease management with their 
doctors and being able to impact the course of their disease. Most attended all of their 
health care visits and had consistent viral suppression. One man who has had the 
infection for seven years believes he can affect disease progression and shares 
responsibility with his doctor. He said that he thinks about HIV every day. Another 
participant who was diagnosed 20 years ago said that he is responsible for doing what his 
doctor tells him to do. He shared that he feels alone with his illness and “lives in 
secrecy.” He has been diagnosed with depression and anxiety yet he attended all of his 
health care visits and had consistent viral suppression like the others discussed. This data 
highlights the significance of the relationship with the health care provider. 
 Two participants who had only high Other HLOC scores differed in how they 
talked about their illness. Both have had HIV infection for over 20 years. One of the men, 
who suffers from depression and anxiety, expressed that it was “too tricky” to impact the 
course of his illness and he didn’t think about responsibility in relation to his illness. This 
man attended three of four health care visits and had viral suppression at only one of the 
time points. He says that he tries not to think about his HIV infection and didn’t talk 
about people who impact his life. There was little congruence between his high Other 
HLOC score and the significance of other people or entities.  The other participant 
believes that he can impact disease progression and said that he shared responsibility for 
viral suppression with God and the doctors and nurses. He said that “everyone expects to 
live forever, I don’t” but that with strong faith, God could rid him of the virus. This man 
attended all of his health care visits but had viral suppression at only two time points. For 
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this participant, there was some consistency between his MHLC score and the importance 
of others that he expressed during the interview.  
 Many of the participants who had a high Chance HLOC score, attended all of 
their health care visits but did not achieve HIV viral load suppression at all time points.  
Interestingly many of them expressed a high level of responsibility for viral load 
suppression but were ambivalent about the ability to impact disease progression.  One 
participant, who has been infected with HIV for 11 years, attended all of the health care 
visits but only achieved viral suppression at half of the time points. He shared that he 
feels responsible because “too much partying” caused him to acquire the virus, but that 
he was acting responsibly because he was taking his medications. Another man said that 
he was responsible for viral suppression but did not believe he could impact disease 
progression. He attended all of his health care appointments and had viral suppression at 
75% of the time points. He has had the disease for 18 years and shared that no one knew 
that he has been taking antiretroviral medications and that he doesn’t “see anyone 
anymore” by his choice. He has been diagnosed with depression. A participant who has 
only had HIV infection for seven years, expressed a high sense of responsibility and 
thought that he might be able to impact disease progression. He shared that he doesn’t 
think about his illness and tries to always be a “positive person”.  One of the men with a 
high MHLC Chance score but a low Others score, talked about sharing responsibility 
with his doctor and his support group of friends who also have HIV infection.  He has 
had the infection for 16 years but said that it is a “daily disease”.  He attended all of his 
health care visits but only experienced viral suppression at half of the time points. He has 
been diagnosed of depression. In reviewing the participants who had a high MHLC 
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Chance score, the only consistencies seem to be that they express a belief in their 
responsibility for disease management but have difficulty achieving consistent viral 
suppression. They also tended to have a higher incidence of other co-morbidities (e.g., 
depression; anxiety, Hepatitis C). 
 None of the participants had only a high Internal HLOC score. This dimension 
was always associated with other dimensions with a high score, most typically Doctor 
and/or Others.  One participant who had high scores in both the Internal and Doctor 
dimensions has had HIV infection for 17 years. He believes that he shares responsibility 
for disease progression with his doctor. He doesn’t think about his illness because he 
considers it controllable and that it is “up to me to do everything.” Another man who had 
high scores in the Internal, Doctor, and Chance dimensions expressed little responsibility 
but believes he can impact the course of his disease. He said that he takes his medications 
but  “can’t affect the way the meds work in my body.” He has had HIV infection for 23 
years. The Internal dimension seems to be an adjunctive component of locus of control 
rather than a primary focus.   
 
Summary 
 In sum, the quantitative and qualitative analyses discussed in this chapter 
illuminate themes related to beliefs about responsibility for disease progression and 
health optimization. The MHLC survey data provided insight into beliefs about whether 
people infected with HIV believe they have control over their health and their disease. 
The availability of outcome data allows further exploration into whether beliefs translate 
into agency. The quantitative analysis found that the Chance HLOC was significant for 
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predicting non-achievement of HIV Viral Load Suppression. This is not surprising given 
that one would expect that if someone believes strongly that health and disease 
progression are related to chance or fate, they may be less likely to engage in behaviors 
that would optimize viral load suppression (e.g., medication adherence).  Wallston and 
Wallston (1982) found that people with chronic illness tended to have a high scores in the 
Chance HLOC and Others HLOC dimensions and hypothesized that they shifted 
responsibility for their illness over time to their health care providers and their family, 
significant others and friends. The information obtained in this research shows that the 
majority of the participants assume responsibility for not only acquiring their disease but 
for helping to suppress it.  
 My original hypothesis for this research was that individuals with greater Internal 
HLOC would be expected to maintain better adherence to their medication regimens and 
participate in health-enhancing behaviors to optimize therapeutic benefit resulting in HIV 
viral load suppression. The results show that the hypothesis was not upheld. While it 
seems intuitive that people who take responsibility for their health would have a high 
Internal HLOC, this dimension did not significantly predict either HIV Health Care Visit 
Attendance or HIV Viral Load Suppression. It would be of interest to study HLOC with 
people who do not have access to health care and treatment or are receiving an incentive 
for viral suppression. What does hold true is that people seem to hold concurrent beliefs 
about responsibility for management and control of their disease. All of the MHLC 
dimensions (Internal HLOC, Chance HLOC, Doctor HLOC, Others HLOC) were 
similarly distributed in various iterations for the participants. Some assumed full 
responsibility for their health, others shared responsibility with their social support 
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system, their doctor, or a spiritual entity, and some felt that their health was controlled by 
fate. Most assigned responsibility and control to multiple entities validating that HLOC 
beliefs are concurrent. 
  The other significant finding from the quantitative analysis was that the length of 
time the participants had been diagnosed with HIV infection predicted their attendance at 
their HIV health care visits; the longer the years of diagnosis, the lower the attendance at 
HIV health care visits. Possible explanations might include visit fatigue due to years of 
attending multiple visits per year for health monitoring, or that some felt that their disease 
was under control and that they only need to see their HIV health care provider when 
they are feeling ill. This finding bears more research to try to understand how people 
think about their health care visits. What is more interesting is that the percentage of 
missed health care visits is so low for the participants in this study. This may be driven by 
the access to health care that is provided to those with VHA benefits eliminating financial 
barriers to health care visit attendance. It is not known if this is representative of the 
overall population of people infected with HIV in developed nations.   
 Although the quantitative analysis did not show any statistical significance for the 
Doctor dimension related to the outcome data, it is apparent that those participants with a 
high Doctor score were more likely to have HIV Viral Load Suppression and to attend all 
of their HIV Health Care Visits. The influence of the physician may seem intuitive given 
the seriousness of the disease and the need for treatment to prevent morbidity and 
mortality. This may also reflect the authoritative status of biomedicine within society, and 
the social control of biomedicine and resultant sufferer reliance on the health care 
provider. Yet the interview data illuminated that this reliance on the health care provider 
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also has a social support component. For those individuals who hide their illness and do 
not talk to anyone about it, the opportunity to trust and talk to their doctor intensifies the 
relationship.  
 The value of HLOC for this research was in trying to determine if the participants 
believed they had responsibility for and control over their health and where these beliefs 
were situated.  This information, in the context of the interview and outcome data, 
provided an opportunity for multi-layered analysis. In general, the results of the MHLC 
survey did not provide any consistent or significant findings to help us understand how 
people infected with HIV think about responsibility and control in relation to their illness. 
It does suggest, as Wallston came to realize, that it is not as important to know where the 
LOC is situated but that it exists.  
 The interviews provided insight into the beliefs held about responsibility for 
health and disease management as well as the illness experience. Responsibility is clearly 
a driving force in most of the participants' lives; responsibility for acquiring their illness 
and for impacting disease progression. In this participant population, many of the men 
believed that they could impact disease progression and this may be one of the most 
significant findings because it indicates they have hope. They talked about a constellation 
of behaviors and choices that they believed would impact the amount of virus in their 
bodies.  
 The interviews also gave the men an opportunity to share their thoughts. Even 
though many said that they “don’t think about it”, they talked about it. They shared with 
me the ways that they think about their illness, their beliefs about disease management 
and health optimization, and how they feel about viral load suppression and non-
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suppression.  Some only spoke to their health care team members, mostly their doctor, 
about their HIV infection. Most expressed their gratitude for the opportunity to talk about 
it even though it was clearly an uncomfortable experience.  It is significant to note that 
many of them waited after their clinic appointment to participate in the interview, and 
some scheduled time to come back to the clinic to do so. They were not compensated for 
the interview, but many told me how valuable it was to be able to talk about their illness 
and tell their story to a nonjudgmental person. 
 As the interviews progressed, I could see some of the threads that comprised their 
belief systems about disease and illness. Their beliefs were constructed by how society 
views HIV infection and those who have acquired it. They experienced or perceived the 
stigma, and it constrains their activities and their social relationships. 
 Their reliance on their health care provider was driven in part by the need for the 
biomedical treatment. Whether they believed they could impact disease progression and 
assumed responsibility for managing their disease or the converse, the themes that 
emerged were the importance of adherence to antiretroviral medications and health care 
provider instructions, engaging in health-enhancing lifestyle behaviors and choices, and 
maintaining spiritual beliefs. Of note, the lack of access to health care or medications was 
not expressed by any of the participants, which might heighten their sense of 
responsibility. Gratitude was often expressed for the entitlements and access to care and 
support services provided by the VHA. These men were aware that others do not have the 
same access to health care and medications. While there may be other mitigating factors 
that might affect responsibility (e.g., mental illness and substance abuse), access to 
medications and care was not an issue. While reliance on biomedicine and their health 
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care provider is understandable for disease management, some of the participants 
expressed that the psychological and social aspects of HIV infection are not adequately 
addressed by biomedicine. 
 The following chapter will attempt to synthesize the quantitative and qualitative 
findings that have been presented to contribute to the understanding of the belief systems 
and illness experience of people with HIV infection.  
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 Chapter 7    Synthesis and Discussion   
   
“In the course of socially constructing an illness, symptoms are identified, and the 
disease is named.  Theories of origin, transmission, prevention, and cure are 
formulated, promulgated, criticized, and revised. Responsibility and blame often 
are assigned. Those who contract the disease come to be regarded as victims or 
patients, guilty or innocent, dangerous or benign, heroic or pitiable.” (Herek et al., 
2003:533)  
 
 
 As the quote above indicates, belief systems about health and illness are 
constructed by biomedicine, the individual sufferer's experience and the local and wider 
social worlds. They are shaped by cultural, social, political, and economic forces and 
assigned cultural meanings. My research, though grounded in a clinical space, examined 
meaning-centered understandings of HIV infection and responsibility from the patient's 
perspective. It provides a lens into the illness experience of those who have been 
diagnosed with this disease. In this chapter I summarize the understanding that I have 
gained from my research about how people infected with HIV think about their illness 
and their beliefs about responsibility related to health optimization and disease 
management and I contextualize this information within the context of the social 
construction of illness and the social suffering experienced by the men with whom I 
talked about HIV infection in the clinic. I hope this analysis will help medical 
professionals and patients achieve a nuanced understanding of how some people think 
about and experience HIV infection in the world today. 
  
Conceptualizing HIV 
 
 How people infected with HIV conceptualize their disease is multifactorial and is 
ultimately socially constructed; it is learned and shaped by cultural and structural factors, 163  
particularly social. This is evidenced by the men’s narratives about how they think about 
HIV infection, which ranged from “I don’t think about it” to “a death sentence”.  
 The concept of ‘not thinking” about a disease that is responsible for the mortality 
of millions is difficult to comprehend. Although denial can be a coping mechanism for 
people with life-threatening illnesses, this is not what seems to taking place with the 
people with HIV infection with whom I spoke. They are aware of their illness because 
they take medications daily to treat it but their conceptualization encompasses multiple 
intercurrent and nuanced understandings. They talked about the chronic manageability of 
the disease, the acceptance of the illness over time and learning “to live with it”, other co-
morbidities that are more distressing and disruptive, and the stigma that they face which 
results in social isolation among other deleterious effects. In addition, some of the 
participants have internalized the belief that biomedicine and their own adherence to 
antiretroviral medication regimens and health-enhancing behaviors can control this 
disease. They have seen evidence that adherence to antiretroviral medication and the 
avoidance of IDU and alcohol can suppress the virus for some people turning HIV into a 
chronic condition. Baumgartner (2007) has written about how people integrate their 
chronic illness into their lives over time such that it becomes less part of their everyday 
consciousness, except for times of ill health. This sums up what many of the men I 
interviewed meant by "not thinking about it." 
 Alternatively, Kendall and Hill note that, “HIV/AIDS continues to be experienced 
by many, through intermittent acute episodes of symptoms of disease, with underlying 
worry about disease progression and worry about the perpetuity and life-threatening 
nature of the illness, rather than a relatively low-level, long-lived, condition “under 
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control” (2010:176). A small number of the men I interviewed appeared to adhere more 
to this interpretation of HIV. Hence they tended to think more about the disease than not 
to think about it.  
 With the advent of efficacious treatment, however, biomedicine has transitioned 
the labeling of HIV from an acute, fatal disease to one that is chronic and manageable 
with an extended life expectancy. Manderson and Smith-Morris (2010) write that while 
this dichotomized labeling is functional within biomedicine for understanding disease, it 
ultimately contributes to the “invisibility of suffering”. Acceptance of this revised 
biomedical labeling of HIV infection allows those afflicted, and the wider social 
community, to think of the disease as no longer imminently fatal. Although this may be 
true for some with access to antiretroviral medications, the disease still causes significant 
morbidity and continues to be a deadly epidemic in many areas of the globe.  
 Antiretroviral treatment is not a cure, and the virus often develops resistance to 
many of the available medications, requiring constant medical supervision. Some of the 
men talk about HIV as a chronic or a manageable disease and say they are living longer, 
yet chronic and manageable diseases do cause disruption and require self-care on the part 
of the ill person. One man said that it is a “daily disease” illustrating how HIV shapes the 
everyday lives of the people it infects and how they interact in their local world. They 
may integrate their illness and not “think about it” but it is perennially running in the 
background shaping their lives and their social relationships. This kind of  “illness work 
includes all the daily caretaking that becomes the responsibility of the patient once 
diagnosed with a chronic illness resulting in the majority of the care shifted from the 
165  
health care system to the patient who manages disease in the home with occasional 
monitoring by the health care team (Corbin and Strauss, 1995).  
 The men that I talked with have accepted the responsibility for managing their 
own health by adhering to their prescribed medication regimens and other health-
enhancing behaviors and choices. They talk about “following orders” and “doing what 
I’m supposed to do.” They say that they don’t think about HIV but they do think about 
adherence to medication regimens, about making sure to eat well and sleep enough, and 
about doing what they’re “supposed to do”. In fact, it consumes their lives.  
 Another major concern is protecting others from transmission and themselves 
from reinfection. The majority of the participants have not disclosed their HIV status. 
These men worry about disclosure, how to hide their medications, and how to maintain 
secrecy about their infection. Taking medications, living a healthy lifestyle, and 
maintaining secrecy -- this is also the daily work and the daily suffering of HIV. They say 
they don’t think about it, but they suffer because of how the disease called HIV is 
constructed in contemporary society.  
 The stigmatization and marginalization of those afflicted with HIV infection 
disease has a long history and has socially constructed HIV infection as a “hidden thing” 
as one man said, adversely affecting health and quality of life and intensifying the 
suffering that is part of the illness experience. Stigmatization is experienced on an 
individual level, but is a socially constructed phenomenon. I suggest that stigma is a 
major driver in why many of the participants "don’t think about it.” They are aware of the 
stigma whether they have faced it themselves or have seen how others have been treated. 
It is a solitary illness for most; they don’t talk about their illness, which drives, in part, 
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why they don’t think about it. Thus, another part of the illness work for this “daily 
disease” is not disclosing their illness.  
 However, different men keep different levels of secrecy. Some actively keep their 
illness a secret; disclosing to no one, hiding their medications, and isolating themselves 
from social relationships. They are concerned that others will treat them differently if it 
becomes known they are infected with HIV. They guard themselves from this perceived 
stigma but ultimately deny themselves social support. This active secrecy is in contrast to 
what I have termed passive secrecy. This refers to the disclosure of their HIV infection to 
someone but no one speaks about it. Both the person with the illness and their significant 
other/family member/friend avoid the topic thereby constructing HIV infection as the 
proverbial “elephant in the room”. This validates the isolation and stigmatization that 
people with HIV experience, even with the people with whom they are close.  
 The presence of a social support system and the ability to discuss fears and 
concerns as well as positive outcomes can help to alleviate the stress of being ill and 
improve quality of life. It is hard to discern which causes more suffering, having no one 
to talk to about one’s illness or having those who know, avoid addressing it. It is now 
clear that lack of support and psychological stress resulting from stigma can contribute to 
disease progression (Golub et al., 2003). Hence, we need to help HIV sufferers to  
“reconstruct social networks according to the new boundaries set by the disease” after a 
diagnosis of AIDS (Barosso and Powell-Cope 2000:346). This renegotiation of social 
relationships occurs on the interpersonal level and within the local and broader social 
worlds. The social isolation that results from stigmatization has shaped HIV infection for 
many into a solitary illness and created silent suffering. 
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 Some of the men talked about various co-morbidities, such as cancer, respiratory 
problems, and other diseases of aging being more of disruption in their lives than HIV 
infection. These other diseases have become much greater health concerns for them. 
Since recent research has shown that people with HIV seem to have accelerated aging 
and an increased susceptibility to other co-morbidities such as cardiovascular disease, 
cancer, osteoporosis and bone fractures, and neurocognitive conditions (Brooks et al., 
2012), it is not surprising that these more disruptive co-morbidities and the physical 
effects of what they termed “getting old” have replaced HIV as the major concern since 
they impact daily life and even life itself more directly than HIV. However, the stigma of 
HIV may erase its daily presence in the lives of people with serious co-morbid 
conditions, which are much easier to talk about and garner social support for than HIV, 
and which, symptomatically, may be much more pressing on their daily lives and 
experiences.  
 While the men talked about many of their other illnesses, there are some co-
morbidities that they hide. While almost half of the participants had at least one 
psychiatric diagnosis, most did not mention their mental health issues. A few talked about 
depression and feeling anxious or “nervous” and some talked about PTSD. Even when 
they talked about what they needed to do to manage their health (i.e., diet, exercise, rest), 
no one mentioned mental health care issues. Mental illness is another devaluing  “medical 
condition” that ultimately multiplies and layers the stigma that many people with HIV 
infection face. It would be worth investigating whether those with HIV consciously hide 
their mental health issues, whether it is a biomedical diagnosis that they don’t accept or 
acknowledge, or whether it is just another illness that they don’t think about because they 
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anticipate further stigmatization.  
 “I don’t think about it” provides insight into the nuances of how people infected 
with HIV conceptualize their illness. The men talked about learning to accept their 
diagnosis and integrating their illness into their lives and about the degrees of disruption 
created by various illnesses, HIV infection among them. They talked about the stigma 
they perceived and felt, but didn’t consciously relate this to why they didn’t think about 
their illness.  
 Other participants acknowledged the impact of HIV infection on their lives and 
talked about it on a continuum that ranges from a death sentence to a transformative 
agent. In spite of the current rhetoric of HIV as a chronic manageable disease, some 
people with the illness acknowledge that it is still an illness that is limiting, both in terms 
of time and capacity.  
 One of the common themes during the interviews was the acknowledgement of 
how time and experience have changed how they think and feel about their illness, 
expressed as “in the beginning” and ‘now”, reflecting the trajectory of illness narratives. 
When first diagnosed many understandably were frightened and anxious and thought 
about the disease as fatal. With the availability of treatment, many have survived long 
past the time they had expected to die and it is no longer life-consuming. They believe 
that for the majority of those who have access to medical care and treatment, the disease 
has become manageable. While this has helped some to learn to live a “normal” life, for 
others, the disease remains a daily reminder of mortality.  
 For those who think about their illness, their suffering is apparent in their 
discourse. Some of the men expressed their fear of incapacitation and death. They talked 
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about trying not to think about it because of the distress caused by these thoughts. Many 
talked about HIV infection as a misfortune or a consequence of their behavior or choices. 
They believed that their illness was a result of their history of IDU, unprotected sex, and 
their social environment of risk and risk taking. These beliefs illustrate the trajectory of 
their belief system related to HIV infection and were shaped not only by individual 
experience, but also by social, political, and economic forces – what Brown has framed 
as “… a set of understandings, relationships, and actions that are shaped by diverse kinds 
of knowledge, experience, and power relations, and that are constantly in flux.” (Brown, 
1995: 37). HIV as a transformative force reflects the sometimes subtle shifting that takes 
place over time as people try to find meaning in their illness. People living with HIV 
infection become introspective and integrate the illness into their lives (Allan, 1990). The 
men who talked about the changes that HIV has wrought in their lives referred to 
becoming more responsible and leading lives without substance abuse and other risks.  
 Erickson (2008) wrote that how people understand an illness is dynamic both for 
the individual experiencing the illness and for society at large. One result of this 
reframing of HIV as chronic disease is that it has receded from the previous panic 
discourse of the wider community during the first two decades of the epidemic when 
AIDS was a large part of the societal, biomedical and public health discourse. As 
mortality has decreased for those with access to medical care and antiretroviral 
medication, the general public has come to view HIV infection as a manageable disease. 
While progress has been made in treating the physical disease, the stigmatization, 
discrimination, and social isolation of those with HIV infection persists. This increases 
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the marginalization of the disease, making the epidemic and those who suffer from it 
diminished in the consciousness of our society.  
 
Responsibility for Health Optimization and Impact on Disease Progression 
 
 Responsibility is a central theme in the disease of HIV infection. People afflicted 
with this disease hold themselves responsible for acquiring the infection, for health 
optimization, and for disease management. The labeling of HIV as a chronic disease by 
biomedicine has created more responsibility for the person who is infected and creates 
more “illness work” for the patient (Corbin and Strauss, 1995). In chronic disease 
management, treatment adherence and maintaining other health-enhancing behaviors 
become the work of the patient. This is also true for HIV patients who also become 
responsible for doing what they are “supposed to do” to suppress the virus and optimize 
health. Gaskins and Brown (1992) termed these activities the everyday work of living 
with HIV infection, which has been shown to give patients a sense of control over their 
illness (Allan, 1990; Barosso, 1995; Barroso and Powell-Cope, 2000).  
Regimens for Life  
 Strict adherence to antiretroviral medications and the importance of engaging in 
other health-enhancing behaviors has been stressed for people infected with HIV.  
Beyond taking medications, the participants talked about a constellation of lifestyle 
behavior and choices that were crucial for HIV viral suppression and disease 
management. They talked about getting sufficient rest, exercise, and eating a healthy diet; 
avoidance of drug, alcohol, and tobacco use; and incorporating safer sex into their life 
regimens. Many also talked about the spiritual side of health, such as the importance of 
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prayer and faith in God or a higher power, as favorably impacting the course of their 
disease.  
 Adherence applied not only to taking medications but also to attending HIV 
health care appointments. My research suggests that how long a person had been living 
with HIV infection had little effect on medication adherence, but did make him less likely 
to attend all HIV health care visits. Men who did not attend all of their visits have had 
HIV infection for over 15 years. One could posit that as the disease becomes more 
“chronic” or “controllable”, and the symptoms less pressing compared to those of co-
morbid conditions attendance at health care visits becomes less important. This illustrates 
that there are many factors that impact adherence to disease management and health 
optimization behaviors. 
 My research also suggests that awareness of what needs to be done to help 
suppress the virus and optimize health does not always translate into agency or success 
for a variety of reasons. HIV is an evolving organism that can mutate to render 
medications ineffective, and human behavior is notoriously inconsistent. Overall, 
however, those living with HIV infection have to adhere to their medication regimens and 
the prescription for health-enhancing behavior to protect their immune system; and as the 
participants said, they do so to live even though they may have setbacks along the way. 
Importance of Biomedicine and Doctors 
“The deep involvement of medicine in reorganizing the disruptive experiences of 
chronic illness in reordering its arbitrary and threatening characteristics, 
inevitably involves issues of social control.” (Bury, 1982: 179) 
 
  My research elucidated the significant role that the health care provider, most 
often referred to as "my doctor", plays in the lives of people infected with HIV. The 
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doctor is often the one person with whom people infected with HIV discuss their illness. 
The importance of trust in and reliance on the physician is not surprising particularly in 
the face of this devastating disease. Moreover, this reliance is intensified in the setting of 
a disease that is stigmatized and creates an environment of little social support for many 
of those who are infected. Many of the participants talked about the secrecy of their HIV 
infection and not speaking to anyone else about it except their health care provider. Yet 
the time with their health care providers is often spent discussing the clinical aspects of 
their disease (e.g., symptomology, medication adherence, laboratory results) and there is 
little time to talk about their illness experience.  
  In biomedicine, the doctor’s main role is to monitor health and prescribe 
treatment. As Kleinman notes, this “…ethnocentric and reductionistic view of the 
biomedical model, in which biological processes alone constitute the “real world” and are 
the central focus of research interpretation and therapeutic manipulation” (Kleinman, 
1980: 25) leads the clinical encounter to exclude other important aspects of health, 
especially the psychological, social, and spiritual aspect. As I have shown in this thesis, 
these aspects are of tremendous importance to the patient. 
   A few of the men expressed a desire to have their time with their doctors involve 
more than discussing “the numbers” (their HIV viral load and T-cells counts) that 
measure immune health. This focus on physiological functioning and diagnostic testing is 
the hallmark of biomedicine and does not recognize and value the mind-body connection, 
the whole person. It ignores the distress and suffering that people with HIV infection 
experience. The disconnect between the full scope of the patient’s needs and the 
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physician’s focus is intensified when dealing with HIV given the lack of social support 
that many people face and their reliance on the physician. 
 Although the health care provider is the only person that many of the men speak 
to about their disease, there is little time or attention paid to their illness experience. 
Educating health care providers to increase their awareness of their role as social support 
for their patients would enhance the patient-provider relationship, allow them to assess 
the psychological, emotional, social needs of their patients holistically, and hopefully 
improve the quality of life for people infected with HIV. Many of the participants talked 
about spiritual beliefs but this is typically not addressed at all during clinical care 
appointments. Physicians have parceled out their patient’s psychological and spiritual 
dimensions to other practitioners and religious or spiritual entities. 
 How people infected with HIV come to understand and experience their illness is 
socially constructed. Knowledge that people infected with HIV and the contemporary 
society have attained about the disease has been constructed by biomedicine and other 
political, economic, and social forces, many of which have an interest in how this 
information is constructed and conveyed (Conrad and Barker, 2010). Health care 
providers assume the authoritarian role in the patient-provider relationship, which is 
illustrated by how the participants talked about “doing what I’m supposed to do” and 
following “doctor’s orders” and the “rules and regulations. This social control is evident 
even in the ways participants talk about the medication and behavioral regimens that have 
been prescribed by their health care providers. They must take prescribed medicines at 
the right times, monitor their viral load on a regular basis, and follow other health-
174  
enhancing advice. The Veterans who participated in this study not only felt the pressure 
to obey the instructions set forth by their providers, but also those of the VHA. 
   Even the term “adherence”, a seminal word in biomedicine, connotes obedience 
and social control.  When a person’s HIV viral load is detectable, one of the first 
questions asked by the health care provider is whether the person was adherent with their 
antiretroviral medications. This question clearly places the onus of responsibility for 
suppressing the virus on the person with the illness. It also creates suffering because the 
individual is held responsible not only for their infection but now also for disease 
progression.  
 Some of the participants worried about losing the benefits and entitlements that 
they have attained through the VA, constructing the VHA as a benefactor that must be 
pleased. They valued the access to medical care and medications as well as the other 
support services and feared doing something that would cause them to lose this aid. They 
had to follow orders given by their physician as well as obey the rules and regulations of 
the VA, which is a difficult system to navigate.  Reliance on the VACHS for medical care 
as well as other services is another layer in the power differentials inherent in the patient-
physician relationship. The issue of power and authority is also a part of the military 
culture (i.e., hierarchy; obedience) and contributes to the social control that infuses the 
relationship that the men have with their doctors and the VA system. The onus of 
responsibility that is placed on people afflicted with a “chronic” illness intensifies this 
power inequity, given the expectation to “obey orders”. 
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Social Suffering 
 “Social suffering results from what political, economic, and 
institutional power does to people and reciprocally from 
how these forms of power themselves influence responses 
to social problems.” (Kleinman, Das, and Lock, 1997:1033) 
 
 HIV has become a source of suffering on many levels for those who have 
acquired the infection. As the disease has transitioned from one that was imminently fatal 
to one that is “chronic” for those with access to treatment, so has the suffering that people 
living with HIV infection experience. At the beginning of the epidemic, the public health 
system identified risk groups (e.g., homosexuals, IDU) (Farmer, 1988, Singer 2006), 
which allowed the wider social world to moralize and label these groups of people as “the 
other”, contributing to the stigmatization and marginalization of people with the disease. 
Kleinman stated this more succinctly writing that “Cultural representations, authorized by 
a moral community and its institutions, elaborate different modes of suffering.” 
(Kleinman et al., 1997:2).  
 Such labeling continues as biomedicine’s practitioners continue to ask people 
with HIV infection how they acquired the virus so that public health can monitor the 
epidemic. This question is asked whenever the person with HIV infection sees a new 
health care provider and reiterates the blame and stigma that society places on those with 
this disease. For many of the participants in this study, their physician is their main social 
support for their illness. Thus, the one person that represents a safe place is also an 
authority figure, even for those who express a partnership with their health care 
providers. The social construction of HIV and the social structure of biomedicine has 
created a reliance on the physician, both for medical care and social support, which 
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contributes to an intensified power differential for people with HIV infection and 
exacerbates distress and suffering. 
 Biomedicine has struggled to find effective treatment that endures but has yet to 
find a cure. What it has done is to reframe the illness into one that is chronic and 
manageable, extending the lives of people with HIV infection but also intensifying the 
responsibility and illness work. This has created additional disruption, distress and 
suffering for HIV patients. Biomedicine has focused on curing the physical disease, but 
the social disease and suffering persists.  
 
Summary 
 The state of ill health causes disruption and distress on many levels, physically, 
psychologically and socially among others, and creates suffering on all dimensions. 
Although mortality associated with HIV is decreasing where antiretroviral treatment is 
available, HIV is still a non-curable disease that results in significant morbidity and 
mortality. It is a disease for which personal responsibility is an overarching theme. It is 
also a disease that causes significant suffering both on an individual and social level. In 
spite of this, people with HIV infection have assumed responsibility for acquiring their 
illness, optimizing their health and managing (i.e., suppressing viral load) their disease. 
They believe in the value and effectiveness of ART and in their ability to impact the 
course of their disease. They trust their health care providers and believe that adherence 
to their prescriptions for medications and lifestyle is paramount. They take responsibility 
for managing a disease that is not truly controllable and remains associated with 
uncertainty and peril.  Much of their illness work is conducted in a social milieu that is 
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stigmatizing and marginalizing, creating dependence on their physicians as their sole 
social support for their illness. 
 The process of constructing disease and illness is a dynamic social processes in 
which biomedicine, whose practitioners are recognized as the experts of biological 
disease (Singer, 2004), plays a major role. As my research suggests, biomedicine’s focus 
on treating and curing disease needs to broaden to include how patients understand, think 
about, and experience, their illness. While this is imperative for all who are ill, it has an 
even greater relevance for people living with HIV because of their reliance on their health 
care providers for both medical and social support. Each individual has a unique 
understanding of health and disease that is based on individual worldview. It is this 
understanding that shapes the patient’s role in managing health and illness. As discussed 
in Chapter 2, the questions that Kleinman (1978) developed to elicit beliefs systems of 
illness and curing are constructed for cross-cultural care, these questions would be useful 
for gaining an understanding of how any patient thinks about his illness. One of the ways 
that people come to understand their illness is by talking about it, which is often 
constrained in the case of HIV infection. These understandings provide powerful and 
symbolic information that can inform health care providers about how to participate in 
their patients’ health care and help to heal as well as cure. These understandings need to 
become more valued and recognized as a necessary component of the treatment plan. 
 Through the narratives of the study participants I listened to their silent suffering. 
They say that they don’t think about their illness but it still impacts their everyday lives. 
By not talking about it, they construct a solitary illness. They value and appreciate 
opportunities to tell their stories in an environment that is free from judgment. 
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Understanding the forces that contribute to the social construction of the illness 
experience and the resulting suffering is the beginning of learning how to heal 
holistically, a lesson that biomedicine needs to embrace.  
Conclusion 
 
“…so that he should not be one of those who held their peace but should bear 
witness in favor of those plague-stricken people; so that some memorial of the 
injustice and outrage done them might endure; and to state quite simply what we 
learn in a time of pestilence; that there are more things to admire in men than to 
despise" (Camus, 1948: 278). 
 
 
 In concluding my thesis I want to make the case, like Camus, that medicine and 
society need to take a new direction in treating HIV patients from one that treats just the 
physical body to one that reduces the multiple physical, psychological, and social 
suffering related to this disease and restores dignity to the patient. It is my hope that by 
bearing witness to the personal struggles of the men who talked to me about their illness 
experiences that the medical profession will begin to understand the desperate need for 
connection among their HIV patients so poignantly expressed by this participant: . 
 
“I feel, I feel, whew, somewhat alone, I do. I feel like it ain’t nobody that’s there. 
I feel like I live my life in secrecy.” 
(A man in his mid-60s with a diagnosis of HIV infection for over 20 years) 
 
 Life with HIV infection, whether it is acute or chronic, is one of disruption. The 
focus of biomedicine is on treatment, extending the lifespan of those who are infected 
with HIV, and ultimately curing the disease. In the beginning of the epidemic, people 
were in a desperate fight alongside their doctors to control the disease and to survive. 
Although biomedicine has developed treatment and disease management that has allowed 
those infected with HIV who have access to treatment and medical care to live longer and 
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with better physical quality of life, many still suffer emotionally and socially. The social 
isolation, stigmatization, often co-morbid mental illness (e.g., depression; anxiety), and 
fear of disclosure causes significant suffering affecting, and constraining their everyday 
lives, opportunities, and social relationships. This social suffering also impacts 
medication adherence and hence the ultimate course of the disease. Biomedicine has 
made great strides in accomplishing these goals of fighting the physical disease but the 
social disease persists.   
 The reframing of HIV infection as a chronic illness has had many affects. To 
some degree it has been a source of reassurance and comfort for people who are infected 
because they no longer believe their illness is imminently fatal. As this research has 
demonstrated, they believe that they can impact the course of their disease; they have 
hope. Yet it has also increased the illness burden by placing more responsibility on the 
patient for disease management and disease progression. Not only do people infected 
with HIV believe that they need to strictly adhere to their antiretroviral medication 
regimens in hopes of suppressing the virus, but they must also adhere to a constellation of 
health-enhancing behaviors that they are told is necessary to optimize health and suppress 
the virus. Yet for most, this is solitary work; they do not have, or choose not to utilize, 
their social support system. In the developed world, where people have access to 
antiretroviral medications, many people view HIV infection as a chronic, manageable 
disease that is no longer fatal. The belief that fewer people are dying from the disease has 
diminished the urgency and discourse about the disease over the years the world has been 
living with HIV. Yet the marginalization and stigmatization of people with HIV infection 
continues; fear of transmission still exists and those afflicted continue to hide their 
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illness, their medications, and their suffering. HIV is a solitary disease for most and the 
suffering that was so apparent in the early days of the epidemic has been become more 
invisible.   
 
As one participant said so eloquently,  
  
 “The social ramifications on the individual, cultural, family, friends  
because there is no doubt that it has a psychological effect. That should 
be addressed, the psychological effect of HIV/AIDS and that’s a who  
different set. See, the physical thing is one thing, how you feel, but what you do 
psychologically. That  bothers, I’m sure, everyone including myself. You have to 
think about how it constrained what you do in life. It’s important to look at the 
other side. It’s not just the physical side, it’s the psychological side. It’s not just 
the viral load, it’s really suffering mentally.” 
 (Man well over 60 years old who has had HIV infection for less 10 years) 
 
 
 HIV is the last epidemic nor will it be the last one where people are blamed, 
stigmatized and marginalized for acquiring a disease. Biomedicine’s practitioners, as well 
as the global community, need to understand how the labeling of disease and the social 
construction of health and illness creates more distress and suffering for people who are 
already enduring the physical and social life disruptions that are part of the illness 
experience. Many health care providers are aware of the mitigating factors that impact the 
patient’s ability to manage their disease including other co-morbidities, mental health 
issues, and structural factors such as housing, transportation, and economic means. 
However the social aspects of the disease often do not receive the same consideration. 
Health care practitioners also need to understand the belief systems and illness experience 
of their patients and recognize the extraordinary level of reliance that many of their 
patients have on them for both medical and social support.  Biomedicine has evolved in 
such a way that treatment of the social body has been moved out of the realm of the 
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physician and parceled out to other health practitioners (e.g., psychologists; social 
workers, support groups). HIV infection has created a renewed dependence on the 
physician for social healing.  Biomedicine’s practitioners need to be aware of their role in 
the social construction of illness, the power that they hold in their relationship with their 
patients who are infected with HIV, and the need to treat both the physical and the social 
disease. Kleinman talks about the dynamic interaction between the biological, 
psychological and socio-cultural dimensions that construct illness (Kleinman, 1978). For 
those who participate in the health care of people infected with HIV, the calling is to not 
only treat the disease but to heal the whole person. 
   
 
Implications of the Research 
 
 “They should get out about the effects of HIV.  There should be more 
 commercials. It’s a closed society. It should be more open. What it's really like to 
 have the disease. Doctors should do more of that. We all should.” 
(African-American man in his late 50s who has had HIV infection for less than 5 
years) 
 
Those who are infected with HIV have much to say and they can teach us about what it 
means to have this extraordinary and devastating disease. It is through their stories that 
the sufferers make sense of the disruption in their lives and help us to understand their 
illness experience. Much of this knowledge is not being passed on to those who can make 
a difference in the ways this disease continues to constrain those who are afflicted. Many 
people infected with HIV have no one with whom to share their thoughts, feelings, and 
how they understand and experience their illness. The social suffering persists, although 
it is less visible, and has been intensified through the relabeling of HIV infection as a 
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chronic disease. For those living with HIV infection, managing their disease and 
experiencing their illness is solitary work and their suffering is often silent. 
 The research, education, and communication cannot not stop until HIV/AIDS is 
part of the discourse of everyday life, when those who are afflicted with this disease can 
talk about their illness, their treatment, and their suffering without fear of discrimination 
or stigma. Even though HIV/AIDS has been seemingly over studied, so much needs to 
done to combat the ignorance and prejudice that still exists. Only then, can those who are 
infected with HIV not suffer alone. The onus is not just on biomedicine, but it is on all of 
us who study humankind.  We produce knowledge about the human experience but to 
whom do we communicate this information. It is the global community that needs to be 
educated about the disease that has been labeled HIV so that they do not further intensify 
the burden of those who are ill with an incurable disease. Cultural knowledge is dynamic 
and while much of the onus is on biomedicine as the “medical experts”, it is also our 
responsibility as social scientists to bear witness to the suffering and share our 
understandings with the wider social network and advocate for education and policy 
change.      
Limitations 
 
 There are some limitations to this research that can be identified.  Major 
limitations include the gender and age homogeneity of the participant population given 
that the research was conducted with U.S. Veterans at the VA Health Care System in 
West Haven, Connecticut. All of the participants were male and almost all were over the 
age of 50. Another limitation is that the participant population has long-term experience 
with HIV infection. Another confounder was the Veteran’s Healthcare system which is 
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similar to a socialized medical system in that it provides health care, medications, and 
other supportive services (e.g., transportation; housing) for those who qualify for little, if 
any, financial, outlay from the veterans. While this has provided a unique vehicle to study 
responsibility for health, some of the factors that affect antiretroviral adherence and 
disease management may not be relevant.  
 The uniqueness of the study setting in the American health system, however, may 
also have been an advantage. My research clearly showed that even under the best 
medical conditions, the social suffering of HIV patients is omnipresent. Under conditions 
of lack of access to good health care how much more would people be suffering? 
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